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Abstract
Alzheimer’s disease (AD) is the most common form of dementia affecting the elderly 
population today; however, there is currently no accurate description of the etiology of 
this devastating disorder. No single factor theory has been demonstrated as being 
causative; however, an alternative theory suggests that the interaction of multiple risk 
factors is responsible for AD. In this thesis I present data suggesting a neuroprotective 
role for acetylcholine during aging. Using a rat model of cholinergic depletion of the 
medial septum, I explored the effects of four common risk factors for AD (stress, 
seizures, stroke and circadian dysfunction) targeted at the hippocampus and examined the 
effects on measures of hippocampal dependent (water maze) and hippocampal 
independent (fear conditioning) memory. Here, I propose a role for acetylcholine- 
mediated compensatory mechanisms in the functional recovery observed following sub­
threshold insults similar to those commonly observed in the elderly.
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Chapter 1
General Introduction
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Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that 
currently affects approximately 300,000 individuals in Canada (~7% of the population 
over 65) and according to the Alzheimer’s Society of Canada, this number is expected to 
increase to 750,000 by 2031. The financial cost of caring for these patients, who often 
spend 3-4 years in an institution, was estimated at $3.9 billion annually in 1994, and is 
thought to be closer to $5.5 billion today (Ostbye and Crosse, 1994; Alzheimer’s Society 
of Canada). Apart from the financial costs, the emotional cost to caregivers, family and 
friends of the patient is immeasurable. Patients suffering from AD exhibit a severe loss of 
memory, coupled with dramatic mood swings, personality changes and sleep disorders 
that influence all aspects of their daily living.
Memory loss is the most noticeable characteristic of AD. The inital impairment 
reported by AD patients and/or their caregivers can be described as mild forgetfulness for 
recent experiences, but eventually patients begin to experience difficulty recollecting 
more distant memories (Carlesimo and Oscar-Berman, 1992; Fleischman and Gabrieli, 
1999). As AD progresses, patients’ memory becomes severely affected leading to an 
incapacitating memory loss (Carlesimo and Oscar-Berman, 1992). This severe, 
progressive loss of memory often leads to a diagnosis of “Alzheimer’s-like” dementia by 
the 6th or 7th decade of life and patients are given a life expectancy of 8-12 years.
A diagnosis of AD can only be made conclusively by a post-mortem autopsy that 
reveals the presence of senile plaques and neurofibrillary tangles (the characteristic 
neuropathology of AD). Unfortunately, there are currently no treatments that are able to 
completely stop or slow the progression of this disorder, though some patients do obtain 
temporary relief of symptoms from approved drugs targeting the cholinergic or
2
glutamatergic neurotransmitter systems. One of the major deterrents to progress in this
i .
field is a lack of understanding as to what precisely causes AD. There have been a 
number of single factor theories proposed to explain the etiology of AD, but to date, no 
one theory can adequately explain all aspects of this disorder. Determining the cause of a 
neurodengerative disorder such as AD is essential to the development of effective 
treatments and the discovery of an eventual cure for these patients.
What is Alzheimer’s disease?
AD is a neurodegenerative disorder that is characterized by a severe and 
progressive loss of memory, combined with characteristic neuropathology such as 
amyloid plaques, neurofibrillary tangles and alterations in neurotransmitter levels, the 
most prominent of which is a loss of acetylcholine (ACh) in the cortex and hippocampus 
(Mesulam, 2004). This disorder was first presented as a single case study of a woman 
who suffered from early onset dementia with “unusual neuropathology” in 1907 by Alois 
Alzheimer, but it was not until 1911 when more patients had been described that the
disorder became know as “Alzheimer’s disease” (Alzheimer, 1907, 1911). The original
\
definition of AD was one of early onset senile dementia combined with neurofibrillary 
tangles and neuritic plaques. It is important to note that while tangles were first described 
by Alzheimer, both dementia and the occurrence of plaques in the aged brain had been 
previously described (as reviewed in Goedert et al., 2006). The note-worthy aspect of
«r
these cases was their early onset in middle age. Since the original description of AD, this 
definition has changed to encompass both presenile (<65 years of age at onset) and senile 
(>65 years of age at onset) forms of dementia. Presenile dementia is characterized by its 
early onset, rapid progression, and its hereditary nature, while senile dementia occurs
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later in life with a slower progression and has no known cause (although numerous risk 
factors have been associated with this form).
Classically, the first symptom of AD is memory loss; specifically, impairments in 
epsiodic memory (memory for personal events and experiences) are the first to be 
reported by AD patients, and/or their caregivers (Carlesimo and Oscar-Berman, 1992). 
This deficit initially can be described as forgetfulness for recent experiences, but 
eventually patients begin to experience difficulty recollecting more distant memories 
(Carlesimo and Oscar-Berman, 1992; Tulving and Markowitsch, 1998). Semantic 
memory (knowledge of objects, facts and concepts) is also negatively affected at early 
stages of AD (Hodges and Patterson, 1994). The processing of both episodic and 
semantic memory is dependent on medial temporal lobe structures that begin to show 
signs of damage in the early stages of AD, suggesting a correlation between structure and 
function in the progression of dementia (Hodges and Patterson, 1994). Other forms of 
memory such as implicit memory (procedural or habit learning) remain relatively intact 
until the latest stages of AD (Elridge et al., 2002; Fleischman et ah, 2005).
Senile plaques are one of the two defining features of AD and were noted by 
Alzheimer in his original description (Alzheimer, 1907). These plaques have since been 
characterized as being made up of deposits of the protein amyloid (Glenner et al., 1984; 
Masters et al., 1985). The amyloid precursor protein (APP) is normally (non- 
amyloidogenic pathway) cleaved by a-secretase to produce a soluble non-toxic amyloid 
protein, and by y-secretase to produce two non-amyloidogenic fragments. A second 
(amyloidogenic) pathway produces the soluble P-amyloid protein (p-APPs), when P- 
secretase cleaves APP at an alternative site, and one of two plaque forming P-amyloid
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fragments (Ap4o or Ap42) following cleavage by y-secretase. Both Ap fragments and P- 
APPs are thought to be neurotoxic as reported in both in vitro and in vivo studies (Lue et 
al., 1999; Verdile et al., 2004), but others have found no toxicity associated with either 
AP or P-APPs (Robinson and Bishop, 2002; Verdile et al., 2004). The AP40/42 fragments 
are deposited as diffuse plaques, which aggregate into mature plaques in the cortex and 
spread from there into subcortical areas. While amyloid plaques are a characteristic sign 
of AD, it is important to note that these plaques are often seen in the brains of cognitively 
intact individuals. Moreover, a correlation has been reported between the number of 
plaques and the severity of dementia in AD patients (Naslund et al., 2000), but this 
relationship is not as strong as that seen with neurofibrillary tangles (Arragada et al.,
1992; Guillozet et al., 2003; Barnes et al., 2006).
The second defining neuropathology of AD is the presence of neurofibrillary 
tangles which are made up of the protein tau (a cytoskeletal protein that normally binds to 
microtubules and regulates polymerization in healthy neurons; Goedert et al., 1988). Tau 
proteins become pathological when they undergo hyperphosphorylation causing it to self­
aggregate and form tangles. These tangles interfere with axonal transport leading to 
atrophy of axons and dendrites and the eventual death of the neuron such as that observed 
in AD brains (Goedert et al., 2006). While specific point mutations in the gene coding for 
tau have been identified and are thought to cause the abnormal phosphorylation, this 
process is not fully understood. Tangles originate in subcortical areas (predominantly the 
hippocampus) and spread out to cortical areas and show a high correlation with cognitive 
deficits in AD (Arragada et al., 1992; Tiraboschi et al., 2004).
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Models of Alzheimer’s disease
Severe progressive memory loss accompanied by plaques and tangles found in the 
brain at autopsy are essential to a diagnosis of AD. Any animal model proposed to study 
this disorder should be able to reproduce at least one (and preferably more) of these 
characteristic changes in cognitive ability and/or neuropathology. The most common 
models for AD research use transgenic mice that have been developed to overexpress 
mutated human genes implicated in AD (e.g., APP, PS1/2, APOE s4, FTDP-17). As they 
age, these mice develop plaques and/or tangles, cognitive impairment and reductions in 
cholinergic activity (Morley, 2002; Oddo et al., 2003; Oddo et al., 2003b; Belluci et al., 
2006). Studies in transgenic mice have resulted in an enormous amount of information 
describing the role of genetic factors to the development of AD. Other models of AD 
explore the effects of non-genetic risk factors for AD (e.g., stress, ischemia, 
excitotoxicity), on measures of learning and memory and/or changes in APP or tau 
neuropathology (Nabeshima and Nitta, 1994; Panegyres, 1998; Bennett et al., 2000; Han 
et al., 2008).
The cholinergic hypothesis of Alzheimer’s disease
The cholinergic hypothesis was the first theory proposed to explain AD and has 
since led to the development of the only drugs currently approved to treat mild to 
moderate AD (Bartus et al., 1982; Bartus, 2000). Thisjheory was based on the finding 
that a loss of cholinergic activity in the brains of AD patients (Davies and Maloney,
1976; Perry et al., 1981) coupled with experimental studies in humans and non-human 
primates. These studies reported that by blocking central cholinergic activity with 
scopolamine young subjects would demonstrate memory deficits similar to those seen in
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aged individuals. These impairments could be reversed by treatment with the cholinergic 
agonist physostigmine (Drachman and Leavitt, 1974; Drachman, 1977; Bartus, 1978). 
This theory led to early clinical studies utilizing another type of cholinergic agonist, 
acetylcholinesterase inhibitors (AChEIs) that initially showed promise in reversing the 
memory impairment in AD patients.
There are currently three AChEIs (donepezil, rivastigmine and galantamine) that 
have been approved by the Food and Drug Administration for the treatment of mild to 
moderate AD in Canada (Alzheimer’s Society of Canada). All of these drugs have been 
reported to have similar effectiveness; however, donepezil is the most widely prescribed. 
Clinical trials have reported small improvements in cognition and global functioning by 
treating patients with donepezil compared to placebos, but these effects were not 
permanent and patients still demonstrated a decline in cognitive functioning over time 
(Doody et al., 2001). Courtney et al. (2004) have reported similar small improvements on 
measures of cognition and functionality, but after two years, there were no differences in 
the overall progress of disability or rate of institutionalization in donepezil treated 
patients compared to placebo-treated controls. Taken together these studies show that 
AChEIs can provide small amounts of symptomatic improvement but no long term cure 
for this disorder. Moreover, not all AD patients are responsive to the effects of AChEIs 
and to date the differences between ‘responders’ and ‘non-responders’ remains unclear 
(Connelly et al., 2005; Lemstra et al., 2007). Connelly et al. (2005) have reported that 
AD patients with high levels of medial temporal lobe atrophy are less likely to respond to 
donepezil and other studies have suggested that patients carrying the APOE e4 allele are
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more likely to benefit from donepezil than non- APOE e4 carriers (Bizzarro et ah, 2005; 
Choi et ah, 2008).
The failure of AChEIs to cure AD was seen by some researchers as disproving the 
cholinergic hypothesis and the focus of AD research shifted away from acetylcholine 
(ACh) and towards Ap and mutations in APP processing genes as more likely causative 
factors. However, others have continued to explore the role of this neurotransmitter in the 
development of AD in hopes of explaining the consistency of this depletion in the brains 
of AD patients (Bartus, 2000; Mesulam, 2004).
The basal forebrain cholinergic system
The basal forebrain is a subcortical structure made up of a heterogeneous 
population of neurons that is important for many aspects of cognitive function. Of this 
neuronal population (made up of cholinergic, y-aminobutyric acid (GABA)-ergic, and 
peptidergic neurons) the cholinergic neurons have been extensively studied, due to their 
involvement in AD. Cholinergic neurons release the excitatory neurotransmitter ACh that 
is important for alertness and attention and can also play a role in both cortical and 
hippocampal plasticity. These neurons have high affinity choline transporters that 
internalize choline which is essential for the production of ACh (Karczmar et al., 2007). 
Figure 1.1 shows the complete reaction for ACh that is catalyzed by choline 
acetyltransferase (ChAT; a commonly used marker for cholinergic neurons) and broken 
down by acetylcholinesterase (AChE; commonly used as a measure of cholinergic 
activity)
8
ChAT ->
Acetyl Coenzyme A + Choline -> ACh + Coenzyme A
^AChE
Figure 1.1: Reaction for the synthesis of acetylcholine
There are two types of cholinergic receptors: nicotinic receptors (nAChR) and 
muscarinic receptors (mAChR). The mAChRs are seven transmembrane spanning G- 
protein metabotropic receptors. Apart from ACh, these receptors can also be activated by 
carbochol and pilocarpine, and antagonized by scopolamine and atropine. All of the 
mAChR subtypes can be found distributed throughout the brain, especially in the cortex 
and hippocampus (Karczmar et al., 2007). The nAChRs are ligand gated ion channels 
that can be activated by nicotine, and antagonized by mecamylamine. These receptors are 
also distributed throughout the cortex and hippocampus (Karczmar et al., 2007).
The cholinergic system has widespread projections throughout the brain. The 
basal forebrain of both human and non-human animals can be divided into four distinct 
regions based on connectivity and localization. Progressing in a rostral-caudal direction, 
the first region is the medial septum (MS) which projects through the fimbria-fornix to 
the hippocampus. The second region is the vertical limb of the diagonal band of Broca 
(VDB) which also projects to the hippocampus, but has additional projections to the 
cingulate cortex and hypothalamus. The third region is the horizontal limb of the diagonal 
band of Broca (HDB) that projects to the olfactory bulbs and entorhinal cortex. The final 
and largest region of the basal forebrain is the nucleus basalis (NB) that projects to the 
neocortex, amygdala and hypothalamus (Woolf and Butcher, 1982; Mesulam et al.,
1983). Although not the focus of this thesis, it is worthwhile to note two additional
9
cholinergic projections that arise from the pedunculopontine nucleus of the 
pontomesencephalic reticular formation and from the laterodorsal tegmental gray of the 
periventricular area of the brain stem that provide the majority of cholinergic input to the 
thalamus and hypothalamus, with some indirect connections to the cortex (Mesulam et 
al., 1983). This pattern of connectivity is remarkably similar in rats, monkeys and 
humans (Mesulam et al., 1983) making the rat an ideal subject to study the function of 
the cholinergic system in an animal model.
The role of the basal forebrain cholinergic system in learning and memory
The role of the basal forebrain cholinergic system has been extensively explored 
through a number of different methodologies. The first studies used centrally acting 
cholinergic agonists and antagonists in humans and non-human animals to enhance and 
impair learning and memory respectively. These studies were followed by animal studies 
using excitotoxins to damage cholinergic nuclei in the basal forebrain. The most recent 
studies have used a specific immunotoxin to damage cholinergic neurons of the basal 
forebrain and this technique has resulted in the most valid data to date describing the role 
of ACh in learning and memory.
Drug studies
Cholinergic agonists and antagonists have been long recognized as being capable 
of modulating learning and memory. Early studies in young adult human and non-human 
primates found that treatment with scopolamine could impair memory to levels 
comparable to aged subjects. It was then shown that cholinergic agonists such as nicotine 
and pilocarpine, as well as physostigmine (an AChEI) not only were able to promote 
learning and memory and improve performance on their own, but could reverse the
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scopolamine induced deficit suggesting an important role for the cholinergic system in 
learning and memory (Drachman, 1977; Bartus, 1978). Studies in rats have found a 
similar pattern of results as scopolamine, or other cholinergic antagonists can impair both 
spatial and non-spatial learning, and memory, and these impairments can be minimized or 
reversed by treatment with cholinergic agonists (reviewed in McGaughy et al., 2000). 
Excitotoxic lesions
A second method for determining the role of cholinergic projections in learning 
memory involves irreversibly damaging the basal forebrain neurons. These initial 
experiments utilized mechanical or electrolytic lesions to disconnect the basal forebrain 
neurons from the hippocampus, amygdala and cortical areas; however, this method 
damaged both axons of passage and non-cholinergic neurons, which did not allow for an 
accurate interpretation of the specific role of cholinergic neurons in memory (Schliebs, 
1998; McGaughy et al., 2000). The next evolution in lesion technique used excitotoxins 
that were able to damage cell bodies while leaving projections intact by binding to 
glutamate receptors on the cell surface and through an over release of Ca2+ destroyed the 
cell. By using the excitotoxin ibotenic acid to damage the basal forebrain, many 
independent groups were able to mimic the previously observed scopolamine related 
deficits on a wide variety of tasks. Apart from the behavioural impairment, ibotenic 
lesions reduced cortical and hippocampal ACh levels by 30-50% (Murrey and Fibiger, 
1985; Dunnett et al., 1987; Ridley et al., 1988; Page et al., 1991; Waite and Thai, 1996). 
These findings played a significant role in providing support for the cholinergic 
hypothesis of AD and the ibotenic lesion of the basal forebrain was proposed as a useful 
animal model for AD.
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The ibotenic acid model was short lived due to the discovery of two novel 
excitotoxins: a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and 
quisqualic acid. The use of these drugs to damage the basal forebrain produced a 
significantly higher cholinergic depletion and less non-specific damage to surrounding 
areas. Surprisingly, this also resulted in a milder behavioural impairment than expected 
and no effect at all on some tasks. These findings contributed to a re-examination of the 
role of ACh in learning and memory. Although the overall cognitive deficits were not as 
global as previously reported (using ibotenic acid), animals with AMP A- or quisqualate- 
induced lesions were impaired on the 5-choice serial attention task (Muir et al., 1994), 
passive avoidance (Dunnett et al., 1987; Page et al., 1991) and conditional discrimination 
(Marston et al., 1994). Some of these deficits could be reversed by treatment with 
cholinergic agonists (Murrey and Fibiger, 1985; Ridely et al., 1988) or by transplanted 
grafts from basal forebrain cholinergic neurons (Muir et al., 1994). Taken together these 
results still pointed to a role for ACh in learning and memory, but it was not as essential a 
role as once thought.
192-IgG Saporin lesions
While these more specific and thorough lesions were beginning to clarify the role 
of ACh in learning and memory, there were still a number of problems with the model. 
The discovery of the specific immunotoxin 192 IgG Saporin (IgG SAP) was met with 
great enthusiasm as this toxin was able to damage cholinergic neurons with minimal to no 
non-specific damage (Wiley et al., 1991). The 192 IgG antibody is raised against the p75 
neurotrophin receptor (p75 NTR) and conjugated to the ribosome-inactivating protein 
saporin to form the immunotoxin IgG SAP. When IgG SAP binds to the p75 NTR it is
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internalized where the saporin inhibits protein synthesis and destroys the cell (Wiley et 
al., 1991). The p75 NTR is found on basal forebrain cholinergic neurons of the MS, 
VDB, HDB and NB making this a useful tool to explore the role of ACh in learning and 
memory. Using this immunotoxin, it has since been demonstrated that collective damage 
to both the cholinergic and the non-cholinergic neurons of the basal forebrain were 
responsible for the impairments observed following excitotoxic lesions (Pang et al., 
2001).
The original experiments that utilized IgG SAP infused the drug into the lateral 
ventricles and found impairment in spatial memory (Berger-Sweeney et al., 1994; Waite 
et al., 1995, 1999). This method produces a reliable lesion of basal forebrain neurons, but 
also damages Purkinje cells in the cerebellum that express the p75 NTR. Motor 
impairment due to this non-specific damage is thought to account for the spatial memory 
deficit in these early studies (Waite et al., 1995, 1999; Parent and Baxter, 2004). More 
recent studies have infused IgG SAP directly into the MS/VDB or the NB and have not 
reported impaired learning and memory on spatial learning tasks. Several groups have 
reported that discrete lesions of either the MS/VDB or the NB, as well as a complete 
lesion of the entire basal forebrain (CBF) did not impair spatial working memory as 
tested in standard versions of the water maze and radial arm maze tasks (Baxter et al., 
1995; Pizzo et al., 2002; Vuckovich et al., 2004; Frielingsdorf et al., 2006). However, 
other groups using more challenging, or more sensitive tasks of spatial memory have 
reported deficits following MS/VDB lesions (Baxter et al., 1995; Bannon et al., 1996; 
Chang and Gold, 2004), NB lesions (Baxter et al., 1995) or CBF lesions (Pizzo et al., 
2002; Frick et al., 2004). A prediction arising from these studies was that the cholinergic
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system may play a role in strategy selection, rather than spatial memory per se. Janis et 
al. (1998) reported a preference for a cue-based strategy following CBF lesions in the 
cue-place version of the water maze task. However, this study was carried out 48 hours 
post surgery at a time when the cholinergic lesion is not complete. More recent studies 
have found an increased preference for a spatial strategy in rats with MS/VDB lesions 
(Bizon et al., 2003; Jonasson et al., 2004).
The effects of IgG SAP lesions on non-spatial memory tasks have not been as 
extensively studied, but a few studies have reported no effect on freezing behaviour 
during fear conditioning to tone or to context following a selective MS/VDB lesion 
(Craig et al., 2008) or a complete CBF lesion (Frick et al., 2004). Attentional processes 
are also affected following a NB lesion as tested on the 5-choice serial reaction task 
(Lehmann et al., 2003; Harati et al., 2008). While MS/VDB lesions do not affect 5- 
choice serial reaction task performance (Lehmann et al., 2003), this lesion does impair 
latent inhibition, which is a specific form of attentional processing (Baxter et al., 1997). 
Berger-Sweeney et al. (2000) has also found impaired social transmission of food 
preference in rats with either a MS/VDB or a NB lesion. Overall, it appears that 
cholinergic projections to the hippocampus and cortex do not play a major role in spatial 
learning and memory as previously suggested by early drug and excitotoxin studies. The 
most consistent findings following cholinergic depletion have been impaired attention 
tested directly using the 5-choice serial reaction task, or indirectly when using more 
challenging behavioural tasks which may also have an attentional or decision-making 
component.
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The current state of the cholinergic hypothesis of Alzheimer’s disease
The results of the IgG SAP lesion studies, combined with unsuccessful clinical 
trials have clearly demonstrated that a loss of ACh is not the sole cause of AD. However, 
the consistency of this finding in AD patients (Davies and Maloney, 1976; Perry et al., 
1981; Rossor et al., 1984; Quirion, 1993; Mesulam, 2004) suggests that, while not causal, 
the cholinergic depletion plays an important role in the development of AD. One such 
role may be involved in directly contributing to AD neuropathology.
Clinical studies have reported a positive correlation between the extent of the 
cholinergic depletion with the number of diffuse plaques in the non-demented elderly 
(Beach et al., 1997) and with the number of tangles in the brains of AD patients (Arendt 
et al., 1999). In vitro studies carried out in cultured cells, or in cortical and hippocampal 
slices have demonstrated a role for mAChRs in the processing of APP. Treatment with 
muscarinic agonists promoted the non-amyloidogenic pathway and increased the 
secretion of soluble APP while decreasing the production of the plaque forming A0. This 
effect could be blocked with muscarinic antagonists (Nitsch et al., 1992; Pittel et al., 
1996; Qiu et al., 2003). Moreover, studies in vivo have shown that cholinergic depletion 
of the basal forebrain can increase overall levels of APP in the hippocampus and cortex 
of rats (Leanza, 1998; Lin et al., 1999; Aztiria et al., 2008). This increase can be reversed 
in part by transplanting cholinergic cell grafts (Aztiria^ al., 2008) or by treatment with a 
muscarinic agonist (Lin et al., 1999). The interaction between the cholinergic system and 
the development of neurofibrillary tangles is not as well described. In vitro studies have 
found muscarinic agonists are able to decrease tau phosphorylation, while nicotinic 
agonists tend to increase tau phosphorylation (Kar et al., 2002). Additional studies are
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required to accurately describe the direct effects of ACh on tau phosphorylation. 
Alternatively, cholinergic depletion may have an indirect effect on tau phosphorylation as 
increased A(5 has been found to increase tau and the development of tangles (Rubio et ah, 
2006). A second possibility that will be explored further in this thesis is that ACh plays a 
protective role in the brain, and in its absence, individuals are more susceptible to 
additional risk factors associated with AD.
Risk factors for Alzheimer’s disease
The most prominent and best studied risk factors for AD are amyloid plaques, 
neurofibrillary tangles and the cholinergic depletion, but there are many other factors that 
have been correlated with AD, especially the senile form of the disorder. Several single 
factor theories of causation have been proposed to explain AD (Bartus et ah, 1982; Hardy 
and Allsop, 1991; Arriagada et ah, 1992; Munoz and Feldman, 2000; de la Torre, 2002), 
but it is most likely that a combination of multiple risk factors act synergistically to 
produces different variations of this disorder (Mesulam, 1999; McDonald, 2002; Driscoll 
et ah, 2007; Craig et ah, 2008; Kivipelto et ah, 2008; McDonald et ah, 2008). The risk 
factors that have been proposed as causing or putting an individual at risk for AD can be 
loosely divided into three categories: genetic, environmental and physical (Table 1.1). 
Most of these risk factors have not be proposed as causal factors, but correlative 
evidence, and their effects on learning and memory and AD neuropathology suggest that 
they may play a role in the development of this disorder. Some of the more common risk 
factors will be discussed in more detail.
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Table 1.1: A partial list of risk factors associated with the development of Alzheimer’s 
disease
Genetic Environmental Physical
APP Circadian disruption Stroke
PS1 Stress Seizures
PS2 Aluminum Loss of neurotransmitters
APOE s4 Environmental toxins Apoptosis
BACE1 Prions Glucose metabolism
BACE2 Dietary factors Head Trauma
FTDP-17 Estrogen
Low education level
Senile plaques
Neurofibrillary tangles
Oxidative stress 
High blood pressure 
Vascular disease
Genetic risk factors
Genetic risk factors include mutations in genes, or changes in allele distribution 
that are most often associated with the presenile form of AD. There are a number of well 
characterized mutations found in genes involved in the processing and expression of APP 
and AP that have been shown to cause AD (Selkoe and Podlisny, 2002). The most 
common mutations arise in the presenilin 1 gene (PS1) that increases production of the 
more toxic AP42 fragment either through alterations in y-secretase activity, or possibly, by 
shifting the binding site on APP to promote cleavage of AP42. Mutations in the APP gene 
itself are rare, but these mutations also enhance levels of AP42 leading to increased plaque 
formation (Verdile et al., 2007). These mutations have been used to develop transgenic 
mice that develop plaques and/or tangles as they age, accompanied by cognitive deficits
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and cholinergic depletion (reviewed in Games et al., 2006). One of these models, the
ti-;
3xTg-AD mouse developed by Oddo et al. (2003, 2003b) is promising as these mice 
express mutated APP, PS1 and tau genes simultaneously, and develop both plaques and 
tangles in a pattern similar to that seen in AD patients, making this an exciting new 
model to presenile familial AD. While there have been no mutations in the FTDP-17 
gene that codes for tau detected in AD patients to date, over 30 mutations in this gene 
have been identified and linked to other dementias that present with neurofibrillary 
tangles, suggesting that a similar mutation may still be found in AD patients (Goedert et 
al., 2006).
There is one genetic risk factor that has been associated with senile AD and that is 
the presence of the apolipoprotein E s4 (APOE e4) allele. Individuals with two copies of 
this allele are at a significantly greater risk of developing AD than those with a single 
copy, or none at all (Corder et al., 1993). Interestingly the presence of APOE e4 has been 
correlated with increased deposits of AP40/42 regardless of whether the individual 
develops AD or not (Berr et al., 1994) suggesting that this is one of many risk factors that 
is not causal on its own, but may interact with other factors to cause this disorder. It is 
thought that the APOE s4 allele decreases the clearance of AP40/42 and/or enhances the 
aggregation of AP40/42 fragments into senile plaques (Selkoe and Podlisny, 2002). APOE 
e4 has also been associated with decreases in cholinergic activity and decreased plasticity 
suggesting two more ways that this allele could lead to AD (Arendt et al., 1997) 
Environmental risk factors
Environmental risk factors include exposure to specific external toxins, dietary factors or 
a lifestyle that have been associated with the development of AD.
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Chronic stress
Chronic stress has been shown to be a risk factor for AD and Wilson et al. (2006) 
found that individuals who were prone to stress had a higher risk of developing AD than 
individuals who were not prone to stress. Moreover, elevated levels of glucocorticoids 
[the stress hormone: cortisol in human and corticosterone (CORT) in rats] have been 
correlated with poor cognitive aging in rats and humans (Lupien et al., 1998; Montaron et 
al., 2006). In patients diagnosed with AD, Davis et al. (1986) found increases in blood 
cortisol levels compared to non-AD controls. In addition, increased cortisol appears to be 
linked to hippocampal atrophy due to prolonged increases in glucocorticoid levels 
resulting in the over stimulation of their specific receptors, most of which are located in 
the hippocampus (Sapolsky, 1999).
Chronic stress and glucocorticoids have also been found to increase both plaques 
and tangles in transgenic mouse models of AD (Green et al., 2006; Jeong et al., 2006; 
Rissman et al., 2007). Green et al. (2006) reported naturally elevated levels of CORT in 
the 3xTg-AD mouse. Following chronic treatment with dexamethasone (to further elevate 
CORT levels) they found that Ap and tangles were apparent at a much earlier age in these 
mice compared to untreated controls, suggesting an acceleration of the progression of this 
disorder as a result of stress (Green et al., 2006). Jeong et al. (2006) found a similar 
pattern of neuropathology combined with a deficit in passive avoidance learning 
following stress in a mouse model of AD. Taken together, these studies provide support 
for a role for chronic stress in the development (or acceleration) of AD neuropathology.
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Circadian disruption
Circadian disruption is one of the most common complaints of AD patients and is 
the number one reason for institutionalization of AD patients (Pollack and Perlick, 1991; 
Hatfield et al., 2004). These disruptions appear in the form of increased night time 
awakenings and day time napping, as well as the characteristic “sundowning” behaviour 
(increased agitation and activity at dusk) and are accompanied by decreases in the 
hormone melatonin. These changes are apparent in both the pre-clinical and early clinical 
stages of AD, making them potential early markers for this disorder (Wu et al., 2003). 
Interestingly, Wu et al. (2003) have also shown that treatment with melatonin reduced 
neuropathology and increased survival in a mouse model of AD. In addition, there 
appears to be a stronger link between circadian dysfunction and the resultant cognitive 
impairment, than age alone. Hamsters with disordered circadian rhythms have greater 
difficulty learning a conditional place preference than age matched control hamsters with 
regular circadian rhythms (Antoniades et al., 1999). However, there have been no direct 
reports of phase shifting or circadian disruption causing the neuropathological signs of 
AD.
Physical risk factors
Physical risk factors are factors that have been shown to directly damage the brain as the 
result of some trauma or event that leads to neuronal death (e.g., stroke) or due to 
changes in neurotransmitter levels (e.g., ACh).
Seizure activity
Seizures and epilepsy become more common as an individual ages and seizure 
activity has been shown to result in cell death, particularly in the hippocampus, making it
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a potential risk factor for the development of AD. The development of late onset seizures 
or epilepsy is a common occurrence in AD patients (Hauser et al., 1986; Romanelli et al., 
1990; Hesdorffer et al., 1996) and some studies have even suggested that individuals 
suffering from epilepsy may be at risk of developing AD (Breteler et al., 1995;
Thompson and Duncan, 2005). Studies in both humans and animals have shown subtle 
cognitive deficits following seizures, particularly in tasks requiring hippocampal 
involvement (Cavazos et al., 1994; Gayoso et al., 1994; Breteler et al., 1995; Gilbert et 
al., 1996; Thompson and Duncan, 2005; Marques et al., 2007). Seizure induced and other 
forms of excitotoxicity (e.g., increases in reactive oxygen species) appear to be linked to 
neurodegenerative diseases (Reiter, 1995). A few studies have examined the effects of 
seizures on the development of AD neuropathology. Increases in specific APP transcripts 
are found following kainic acid induced seizures (Panegyres, 1998) and these transcripts 
have been found to be upregulated in AD brains (Johnston et al., 1988; Tanaka et al., 
1992) suggesting a possible relationship between the two. Moreover, Mohajeri et al. 
(2002) found increased susceptibility to seizures and increased A(3 in a transgenic mouse 
model of AD subjected to pilocarpine seizures. The effects of seizure activity on tangle 
formation have not been explored, but kainic acid treatment does causes tau 
hyperphosphorylation in neurons prior to undergoing apoptotic cell death (Crespo-Biel et 
al., 2006).
Stroke
Individuals who have suffered a stroke or transient ischemic attack are at a 
significantly greater risk of developing AD than the rest of the population. Indeed, the 
most common form of dementia found in a community based study was ‘mixed
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dementia’ where patients showed signs of both vascular pathology, as well as the 
traditional plaques and tangles (Snowden et al., 1997; Schneider et al, 2007). This 
finding has revived interest in Alzheimer’s (1907) original case study in which he noted 
vascular abnormalities in the brain of his patient and has led to a vascular origins theory 
of AD (de la Torre, 2002). Moreover, subcortical infarcts are commonly found in the 
brains of AD patients and their presence increases the severity of the dementia (Snowden 
et al., 1997; Song et al., 2007). It is interesting to note that there is significant overlap in 
the risk factors for vascular disease and for AD, as factors such as hypertension, high 
cholesterol, the APOE s4 allele and Ap deposits in blood vessels have been associated 
with both stroke and AD (de la Torre, 2002; Luchsinger et al., 2005). Recent studies have 
found Ap deposits and tau phosphorylation in the aged rat brain following either chronic 
hypoperfusion or stroke (Bennett et al., 2000; Han et al., 2008) and Sun et al. (2006) 
found increased levels of P-secretase and Ap following stroke in a transgenic mouse 
model of AD. Taken together these studies provide strong evidence for stroke as a risk 
factor for AD.
Multiple combinations of co-factors theory of Alzheimer’s disease
As an alternative to single factor theories of AD that do not adequately account 
for both the clinical and neuropathological symptoms of AD, McDonald (2002) proposed 
a co-factors model of aging in an attempt to explain the-etiology of AD. This model 
predicts that different combinations of multiple risk factors for AD interact to produce 
variants of this disorder. One of the strengths of this model is that it can explain the 
individual differences observed between AD patients, and the differential response to 
treatment of similarly demented individuals. The underlying theory of the model is that
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AD is fundamentally a hippocampal dementia (Ball et al., 1984; Hyman et al., 1984) and 
that the risk factors associated with AD all have converging effects on this structure 
leading to neuronal damage and death accompanied by progressive cognitive decline.
Risk factors for AD have previously been classified as genetic, environmental or 
physical, but McDonald (2002) has proposed an alternative classification that can narrow 
this to two groups; passive factors (stress, circadian disruption, cholinergic depletion, 
amyloid plaques), which can cause damage to, or increase the vulnerability of 
hippocampal neurons, and active factors (stroke, seizures, neurofibrillary tangles, head 
trauma) that have the ability to directly disrupt learning and memory, through the death 
or dysfunction of hippocampal neurons. These passive factors do not noticeably affect 
learning and memory, although if more passive factors are present prior to the occurrence 
of an active factor it should increase the severity of the dementia. It is important to note 
that many risk factors can be classified as either passive or active factors depending on 
their severity. For example, severe and prolonged stress can damage neurons and produce 
cognitive impairment (acting as an active factor), but mild to moderate stress has no 
obvious effect on either measure. Nonetheless, mild to moderate stress can increase the 
susceptibility of the hippocampus to subsequent damage (acting as a passive factor).
Table 1.2 lists some of these risk factors and their usual classification; although 
depending on the severity, each of these factors has thejjotential to change from passive 
to active and vice versa.
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Table 1.2: Risk factors for AD can be classified as passive or active factors
Passive Factors Active Factors
Stress Stroke
Cholinergic depletion Seizures
Circadian disruption Head trauma
Amyloid plaques Neurofibrillary tangles
The role of the hippocampus in learning and memory
The classification of AD as a hippocampal dementia is supported by the important 
role of the hippocampus in memory, and the awareness that the earliest forms of memory 
lost in AD are hippocampal dependent. The importance of the hippocampus for memory 
was most dramatically illustrated by the now famous case of H.M. and other patients that 
underwent bilateral medial temporal lobe resection in an attempt to treat epilepsy or 
schizophrenia (Scoville and Milner, 1957). These patients suffered retrograde amnesia for 
recent events and exhibited severe antereograde amnesia. This inability to form new 
memories and difficulty remembering past events suggested a role for the hippocampus 
in encoding new memories, storage and retrieval. Since then, several studies in rats and 
humans have confirmed the importance of the hippocampus in memory, particularly in 
the areas of spatial navigation, episodic memory, and memory consolidation (Morris et 
al., 1982; Sutherland etal., 1983; Squire, 1992; Nadel and Moscovitch, 1997; Vargha- 
Khadem et al., 1997; Tulving and Markowitsch, 1998; Ferbinteanu et al., 2003; 
Sutherland, 2005).
The theory of multiple memory systems states that there are different memory 
systems in the brain that simultaneously process information, but that certain systems are
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optimized for specific types of memory (McDonald et al., 2004). For example, 
McDonald and White (1993) were able to clearly dissociate three of these systems: the 
hippocampus was optimized for spatial memory, the amygdala for classical conditioning 
involving primitive reward circuits and the dorsal striatum was important for stimulus- 
response learning (habit formation). Animals with hippocampal lesions were found to be 
specifically impaired in the spatial memory task, but were able to learn the cue-response 
task, and conditioned place preference. In contrast, animals with amygdala damage were 
able to learn cue-response and spatial tasks, but not the conditioned place preference. I 
took advantage of this dissociation when designing my experiments. To show that the 
risk factors for AD were selectively targeting the hippocampus, and affecting this 
memory system, I used a spatial version of the water maze task to examine hippocampal 
dependent memory, and one of two hippocampal independent tasks (fear conditioning 
dependent on the amygdala, or the visible platform version of the water maze task which 
involves the dorsal striatum) to examine hippocampal independent learning.
Objective of the present thesis
The series of experiments presented here will begin to validate the multiple 
combinations of co-factors theory of AD, specifically focusing on the role of the 
cholinergic depletion as an early event in the aging process that predisposes the brain to 
additional insults resulting in hippocampal dependent memory loss.
Sub-threshold models o f risk factors for AD
The first two studies were conducted to develop sub-threshold models of risk 
factors for use in validating McDonald’s (2002) co-factor theory of AD. To clearly show 
that the interaction between two risk factors has an effect on learning and memory, it is
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important that neither factor on its own can produce a significant impairment. While there 
are a number of models that describe the effects of stress, stroke, seizures and circadian 
disruption on measures of learning and memory, there are no well defined models of 
these risk factors at a level that does not affect cognitive processes.
The first experiment is a series of pilot studies that establishes the parameters for 
a sub-threshold model of stress, seizures and stroke. The second experiment examines a 
novel schedule for repeated phase shifts and recovery sessions that demonstrates 
hippocampal impairment as the result of chronic phase shifting. This study provides 
further evidence for circadian disruption as a risk factor for cognitive decline possibly 
leading to AD. The acute phase shifting schedule presented in this study was validated as 
a sub-threshold risk factor and used in combination with cholinergic depletion in an 
additional study.
Cholinergic depletion combined with a secondary risk factor
The next four studies examine the effects of cholinergic depletion of the medial 
septum combined with a secondary risk factor (either active or passive) on measures of 
learning and memory. The third experiment shows increased seizure severity and 
impairment on the spatial version of the water maze task in cholinergic depleted rats 
given a non-convulsive dose of kainic acid. The fourth experiment found a spatial 
learning impairment in cholinergic depleted rats subjected to focal ischemia directed at 
the hippocampus. Both of these groups (cholinergic depletion and seizures and 
cholinergic depletion and stroke) were able to successfully learn the visible platform 
version of the water maze. The fifth experiment found impairment in spatial learning and 
memory that appears in cholinergic depleted rats following chronic stress. This
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impairment appears to be specific to hippocampal functioning as performance on a
t-;
hippocampal independent task (fear conditioning) remains intact. The sixth experiment 
shows that the previous findings are not simply the result of multiple sub-threshold 
insults on the hippocampus, as cholinergic depleted rats subjected to phase shifting are 
able to re-entrain following the phase shift and learn both water maze and fear 
conditioning tasks at control levels.
Taken together these experiments describe a role for the septal-hippocampal 
pathway in the development of AD; possibly by increasing the vulnerability of 
hippocampal neurons to future insults, or by impairing the capacity of the hippocampus 
for functional recovery following injury.
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Chapter 2
A series of pilot studies to determine the threshold for behaviourally sub-threshold stress,
seizures and stroke
2 8
Abstract
A proposed etiological model for Alzheimer’s disease (AD) describes the contribution of 
multiple combinations of risk factors that can lead to variants of age related cognitive 
decline and/or dementia. Many of these risk factors are present at levels that do not affect 
learning and memory, but still have the potential to cause neuronal loss or damage. As I 
was most interested in hippocampal function, I chose to use intact performance on the 
spatial water maze as a behavioural definition of a “sub-threshold” risk factor. Here I 
describe protocols for inducing sub-threshold levels of stress, seizures and stroke in the 
rat. First, I compared different schedules of restraint stress designed to raise 
corticosterone levels in the rat prior to water maze training and found that a variable 
restraint schedule was able to elevate corticosterone levels, without affecting the ability 
of the rat to learn the location of a hidden platform in the water maze. Next, I compared 
the effects of different non-convulsive doses of kainic acid injected prior to testing on the 
spatial water maze. No differences were found between groups on water maze 
performance; however, the highest dosage used (6 mg/kg) was the only group that 
consistently exhibited non-convulsive seizures as defined by freezing and wet dog 
shakes. I chose this dose as a reliable way to induce non-convulsive seizures in the 
absence of behavioural impairment. Thirdly, I compared the effects of infusing different 
concentrations of Endothelin-1 directly into the hippocampus to induce focal stroke. The 
lowest dosage used (7.5 pmol) did not impair acquisition of the task and was deemed to 
be sub-threshold. The importance of using well defined sub-threshold risk factors in a co­
factors animal model of AD reduces the risk of a ceiling effect when combining multiple 
factors, and allows for the appearance of impairment where there was none previously.
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1. Introduction
The quality of the aging process can be negatively affected by a number of 
seemingly innocuous, or sub-threshold insults that become more common with age, such 
as stress, seizures or stroke. These are just three of the many factors that have been 
identified as putting one at risk for poor aging, dementia and/or Alzheimer’s disease 
(AD) (Breteler et al., 1995; Snowden et al., 1997; McDonald, 2002; Wilson et al., 2006). 
The cause of AD is as yet unknown, but one theory suggests that it develops as the result 
of multiple risk factors that target the hippocampus (Hyman et al., 1982; Ball et al., 1985; 
McDonald, 2002). The hippocampus is especially vulnerable to ischemia, elevated 
glucocorticoids, excitotoxicity and oxidative stress; all of which tend to increase in 
frequency and severity with age (Auer et al., 1989; Reiter, 1995; Sapolsky, 1999; Back et 
al., 2004). Moreover, the initial memory impairments observed in AD are those thought 
to be mediated by the hippocampus (Fleischmann and Gabrieli, 1999) and studies have 
suggested that early AD pathology (plaques, tangles and cholinergic depletion) may 
originate from this region (Ball et al., 1985).
McDonald’s (2002) co-factor theory of aging and AD loosely divides risk factors 
contributing to AD into two categories: passive factors and active factors. Regardless of 
their primary classification (e.g., stress is a passive factor; stroke is an active factor), all 
of these risk factors can be potentially viewed as sub-threshold factors that when 
presented at a low level have little or no effect on cognitive processes, but in 
combination, or at a sufficient level can lead to neuronal damage and cognitive 
impairment. Here, I have used a behavioural definition of sub-threshold that is most 
applicable to elderly humans. During the normal course of aging, undetected neuronal
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dysfunction as a result of stress, seizure activity or ‘silent’ stroke can build up; however, 
unless cognition is impaired, the individual would remain unaware of this damage.
Recent imaging studies have detected a significant amount of neuronal damage in the 
brains of non-demented elderly suggesting there is a threshold at which this undetected 
brain damage can be expressed as a cognitive impairment (Vermeer et al., 2007).
Understanding the contribution of sub-threshold risk factors to the development of 
cognitive decline, and specifically AD is important, as an understanding of the etiology 
of a disorder is vital to developing effective treatments. The cause of AD is most likely 
due to the synergistic effect of two or more sub-threshold risk factors that have little 
effect on their own. In order to better appreciate the role of these factors in cognitive 
decline, well defined parameters are required for each factor in an animal model that can 
be used to exhaustively test the possible interactions, their effects on learning and 
memory and the potential mechanisms mediating these effects.
Here I present three models of common sub-threshold risk factors: chronic stress, 
seizure activity and ‘silent’ stroke. In the first experiment I describe a variable restraint 
stress procedure that can elevate corticosterone levels in the rat, yet has no effect on 
spatial memory. In the second experiment, I describe the effects of a non-convulsive dose 
of kainic acid that does not cause convulsive seizures, or impair water maze performance, 
and in the third experiment I describe a model of focal ischemia using Endothelin-1 
infused into the hippocampus that does not impair spatial memory.
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Experiment la: The effect of a chronic variable stress schedule on performance of 
the water maze task
Exposure to stress stimulates the increase in glucocorticoids [stress hormones; 
cortisol in humans and corticosterone (CORT) in rodents] which bind to low affinity 
mineralcorticoid receptors and to the high affinity glucocorticoid receptors found 
throughout the brain, but most prominently in the hippocampus (Sapolsky, 1999). The 
number of glucocorticoid receptors in this region makes the hippocampus particularly 
sensitive to the effects of chronic stress (Sapolsky, 1999). Indeed, chronic restraint stress 
in rats has been found to induce dendritic atrophy of the CA3 neurons and eventual cell 
death (Watanabe et al., 1992; Vyas et al., 2002; Sapolsky, 2000). Because of the well- 
known role of the hippocampus in learning and memory and correlations between the 
level of CORT and the quality of cognitive aging in rodents and humans (Lupien et al., 
1998; Montaron et al., 2006) many research groups have begun to explore the effects of 
chronic stress on learning and memory in young rats.
There are many stress procedures currently used to explore the effects of chronic 
exposure to glucocorticoids on hippocampal integrity and learning and memory. Some of 
these include restraint stress, chronic mild stress, foot or tail shock, daily injections of 
CORT or exposure to a predator. Of these, restraint stress is one of the most widely used 
in behavioural research (Glavin et al., 1994). The duration of the stress period and the 
length of time rats are restrained vary widely between studies. This variability makes it 
difficult to accurately assess the effects of stress on learning and memory as different 
groups have found enhancement (Luine et al., 1994), impairment (Conrad et al., 1996; 
Luine et al., 1996; Abidin et al., 2004; McLaughlin et al., 2007; Radecki et al., 2007) or
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no effect (Luine et al., 1996; McLaughlin et al., 2007) on spatial memory following 
various chronic restraint stress procedures. For my experiments I wanted to ensure I had a 
reliable restraint stress procedure that could elevate CORT levels, but did not impair 
learning and memory as tested on the spatial version of the water maze.
This experiment was a pilot study designed to examine the effects of various mild 
chronic restraint stress schedules on water maze performance, and particularly to 
determine the effect of a novel variable restraint stress paradigm. I stressed rats daily over 
a two week period for 10 minutes, one hour, or variable lengths of time each day. I 
predicted that the one hour and variable time schedules would impair learning and 
memory while the 10 minute schedule would have no effect on water maze performance. 
2.1a. Materials and Methods 
Animals
Twelve male Long Evans hooded rats (300-400g; CCBN breeding colony) were 
used for this experiment. They were divided into four groups. Three groups were stressed 
for 14 days and a fourth group of controls were handled daily. Animals were pair housed 
with food and water ad libitum, on a 12 hour light/dark cycle with lights off at 19:30. All 
animals were handled in accordance to guidelines set out by the Canadian Council for 
Animal Care.
Restraint stress
To induce chronic stress, rats were subjected to one of three restraint stress 
procedures. Animals were taken in their home cages to a testing room between 09:00- 
11:00 each day and restrained in Plexiglas cylinders (diameter 6.5 cm, length 15 cm) for 
the prescribed amount of time each day. One group (10 min; n=3) was stressed for 10
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minutes a day for two weeks, the second group (1 hour; n=3) was stressed for one hour 
each day for two weeks, the third group (Variable; n=3) was stressed for a different 
length of time each day (20, 5, 60, 15, 10, 30 or 40 minutes; this cycle was repeated twice 
for a total of two weeks) and the fourth group (Control; w=3) was handled briefly each 
day.
Behavioural testing
Behavioural testing began 24 hours following the final day of stress.
Water maze: Rapid Acquisition Task
I used a three stage variant of the spatial version of the Morris water task 
(McDonald et a l, 2005). A white plastic circular pool 1.4 m in diameter and 40 cm deep 
was filled to within 20 cm of the top of the wall with water (20 - 22°C) made opaque by 
adding skim milk powder. The invisible platform was 12 cm in diameter and made of 
white Plexiglas with holes drilled into the top of it to provide grip for the animals.
During training the platform was submerged 2 cm under water. Extra-maze cues in the 
training room included five posters of different sizes and orientations mounted on three 
of the four walls, a computer rack, a door, an animal rack and the experimenter. Four 
different start points were used [N, S, E, W (not true compass headings)], equally spaced 
around the pool. The order was randomly selected for each day and each start point was 
used twice for day one to four and day six. On day five only the three start points farthest 
from the platform were used (N, E, S) with each start point repeated five times and the 
initial start point repeated at the end for a total of 16 trials.
In the first stage (Original location training) rats were trained over four days for 
eight trials a day, to swim to a fixed, spatial location. The second stage (New location
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training) began twenty four hours after completion of stage one. This stage consisted of 
new spatial location training as animals were re-trained to swim to the new platform 
location over sixteen trials within two hours on a single day. Stage two allowed me to ask 
if rats could learn to go to a new location, during a single intensive training session. The 
third stage (Re-training to original location) occurred twenty four hours after stage two 
with the platform returned to its original (stage one) location and each animal was given 
eight trials. This stage allowed me to ask how the massed new location training during 
stage two affected re-learning to the original location. The platform location for each 
stage of training is depicted in Figure 2.1.
ORIGINAL
LOCATION
TRAINING
DAY 1-4: 
8 TRIALS 
PER DAY
NEW
LOCATION
TRAINING
DAYS:
16 TRIALS
RE-TRAIN TO 
ORIGINAL 
LOCATION
Figure 2.1: Setup for the three stage version of the spatial water maze
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the hippocampus to rapidly form a novel representation in a familiar 
context. The third stage measured the rats’ ability to re-leam the original location.
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Data collection: A computer based rat tracker (VP118, HVS Image) was used to collect 
and analyze data obtained from an overhead video camera. For all stages the measure of 
performance was swim time, defined as the latency between release and escape onto the 
platform and swim speed. If a rat did not reach the platform 60 seconds after release, a 
latency of 60 seconds was assigned, and the rat was guided manually to the platform and 
allowed to remain on the platform for 10 seconds before being removed to a holding cage 
until the next trial.
3.1a. Results
Water maze: Rapid Acquisition Task
One rat assigned to the 1 hour group died unexpectedly; the following analysis 
includes data from two rats in this group.
Original location training
There were no differences between groups in the rats’ ability to learn the platform 
location during original location training (Figure 2.2A). The latency (in seconds) to find 
the platform was recorded and averaged over the eight daily trials to obtain a single daily 
latency score for each animal. All groups showed a decrease in latency to find the 
platform from day one (23.03 +/- 2.92 seconds) to day four (4.85 +/- 0.33 seconds). The 
daily scores for all four days of acquisition were subjected to a two-way mixed analysis 
of variance (ANOVA) with Group (10 min versus 1 hour versus Variable versus Control) 
as the between subjects variable, and Training Day (four levels) as a repeated measure 
that revealed a significant effect of day [F(3,21)=35.98,/><0.001], but no effect of group 
[F'(3,7)=1.95,/>=0.21] or interaction [F(9,21)=1.43,/?=0.24]. There were no differences in 
swim speed during this stage of training. A two-way mixed ANOVA with Group as the
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between subjects variable and Swim Speed (four levels) as the repeated measure revealed 
no effect of group [F(3,7)=2.37,/?=0.16], day [F(3,21)=2.56,/?=0.08] or interaction 
[F(9,21)=1.21, / f=0.34].
A
ORIGINAL LOCATION TRAINING
CONTROL 
10 MIN  
1 HOUR 
VARIABLE
B
NEW LOCATION TRAINING
CONTROL 
10 MIN  
1 HOUR 
VARIABLE
Figure 2.2: Three different restraint stress procedures have no effect on performance in 
the spatial version of the water maze. All groups were able to learn the location of a 
hidden platform over four days of training (A), learn a novel location in a single day of 
massed training (B) and re-leam the original location on day six (C). Data are given as 
means +/- SEM.
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New location training
The platform was moved to the opposite quadrant of the pool and the latency (in 
seconds) to find the new platform location was recorded and averaged into eight discrete 
trial blocks (two trials per block). There were no differences between groups in their 
ability to rapidly acquire a new platform location on this stage of this task (Figure 2.2B). 
All groups showed a significant decrease in latency to find the platform from trial block 
one (19.93 +/- 2.41 seconds) to trial block eight (3.52 +/- 0.27 seconds). A two-way 
mixed ANOVA with Group as a between subject variable and Trial Block (eight levels) 
as a repeated measure, was used to assess the new location training and found a 
significant effect of trial block [F(7,39)=24.81, jKO.OOl], but no effect of group 
[F(3,7)=1.66,p=Q.26] or interaction [F(21,49)=0.19, p=0.99]. There were no differences 
in swim speed during the new location training. A two-way mixed ANOVA with Group 
as the between subjects variable and Swim Speed (four levels) as the repeated measure 
revealed no effect of group [F(3,7)=1.94,/?=0.21], trial block [F(7,49)=1.94,/?=0.08] or 
interaction [F(21,49)=1.06, p=0.41 ].
Re-training to original location
The platform was returned to the original location (from the first stage) and the 
latency (in seconds) to find this location was recorded over eight trials on the final day of 
testing. The results of the re-training trials are displayed in Figure 2.2C and showed that 
all groups were able to re-leam the original location on this stage of the water maze task. 
All groups showed a significant decrease in latency to find the platform from trial one 
(20.72 +/- 5.07 seconds) to trial eight (7.87 +/- 1.76 seconds). A two-way mixed 
ANOVA, with Group as the between subjects variable, and Trial (eight levels) as a
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repeated measure revealed a significant effect of trial [F(7,49)=5.72,p<0.001], but no 
effect of group [F(3,7)=0.80,/?=0.53] or interaction [F(21,49)=1.22,jp=0.27]. There were 
no differences in swim speed during re-training to original location. A two-way mixed 
ANOVA with Group as the between subjects variable and Training Day (four levels) as 
the repeated measure revealed no effect of group [F(3,7)=l. 14, /?=0.40], trial 
[F(7,49)=1.48,/>=0.20] or interaction [F(21,49)=0.40, p=Q.99~\.
Experiment lb: The effects of a variable restraint stress procedure on levels of 
blood borne CORT
I have previously shown that a chronic variable restraint stress procedure has no 
effect on water maze performance. It is possible that the lack of impairment was due to 
this procedure being insufficiently stressful and did not elevate CORT levels. This 
experiment was designed to ensure that this novel variable restraint procedure was able to 
increase circulating levels of blood borne CORT indicating its suitability as a model of 
chronic stress.
2.1b. Materials and Methods 
Animals
Sixteen male Long Evans hooded rats (300-400g; CCBN breeding colony) were 
used for this experiment. They were divided into two groups: One group received 14 days 
of variable stress (Stress; n=8) and the second group was handled only (Control; n=8). 
Animals were housed and cared for as described in Experiment la.
Variable stress
I used the variable restraint stress schedule as described in Experiment la.
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Blood collection and analysis of CORT levels
To assess levels of circulating CORT, rats were placed in a restraint tube and 
blood samples were obtained by tail nick with a scalpel blade on the final day of stress. 
Blood was collected from stress rats 30 minutes after being placed in the restraint tube to 
obtain a peak level of CORT in response to the stressor. Blood was collected from control 
rats within the first three minutes of being placed in the restraint tube to ensure CORT 
levels did not have time to significantly increase in response to the brief stress of the 
procedure. All blood samples (0.2 - 0.5 ml) were collected into tubes containing 100 pi of 
10% (v/v) ethylenediaminetetraacetic acid (EDTA), placed on ice, centrifuged (7500 
rpms for 10 minutes) and the plasma was immediately frozen at -20°C. A commercially 
available 125I radioimmunoassay kit (Coat-A-Count Rat Corticosterone, DPC, California) 
was used for quantifying levels of plasma CORT for each animal.
3.1b. Results
Analysis of blood borne CORT levels
To confirm that my stress procedure produced elevated glucocorticoid levels, I 
took blood samples on the final day of stress and analyzed them for levels of blood borne 
CORT. Stressed rats showed a significant elevation in CORT levels following two weeks 
of variable restraint stress when compared to control rats (Figure 2.3). Data were 
analyzed using a t-test that found stressed rats had significantly higher levels of blood 
borne CORT than control rats [f(14)=8.86,/K0.001]
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Figure 2.3: The variable restraint stress procedure reliably elevated levels of blood borne 
CORT measured on the final day of stress compared to non-stressed controls. Data are 
given as means +/- SEM.
4.1. Discussion
Here I show the effects of three mild chronic restraint stress schedules on 
performance of the water maze task. None of these schedules had any effect on learning 
and memory as tested on a three stage spatial version of the water maze task shown to be 
highly sensitive to hippocampal damage in the rat (McDonald et ah, 2005; McDonald et 
al., 2008).
Previous work exploring the effects of chronic restraint on spatial memory has 
been mixed. Impairment has been reported following one hour daily restraint for 21 days 
(Abidin et al., 2004), two hours for seven days (Radecki et al., 2005), or two hours for 21 
days (Trofimiuk and Braszko, 2008) but other groups have found no effect after two 
hours for 10 days, two hours for 21 days, six hours for ten days (McLaughlin et ah,
2007), or six hours for seven days (Luine et ah, 1996). Consistent impairment has been 
reported following six hours of restraint for 21 days (Luine et ah, 1994; Conrad et ah, 
1996; McLaughlin et ah, 2007). The discrepancy between the effects of mild chronic 
stress (one to two hours for less than two weeks) may be due to differences in the type of
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restraint used (wire mesh, plastic tubes or immobilization bags), rat strain ;or behavioural 
test used (water maze, radial arm maze or Y-maze). Future studies are required to fully 
understand the effects of chronic restraint stress on learning and memory.
There have been no reports to my knowledge examining the effects of extremely 
short (10 minutes) restraint stress and memory. This length of time has been reported to 
elevate COR.T levels in aged rats (Glavin et al., 1994), although CORT levels are found 
to increase further with longer durations of restraint (Aragon et al., 1990). I predicted 
there would be no effect on spatial memory as a result of this mild stress and my results 
have supported my prediction. The finding of no impairment in my one hour group was 
surprising as 21 days of one hour restraint is sufficient to cause impairment on water 
maze (Abidin et al., 2004); however, the studies by Luine et al (1994, 1996) have 
demonstrated that how many days a rat is stressed for is as important as the duration of 
daily restraint. They reported that seven days of stress (six hours per day) has no effect on 
performance and 14 days of stress can enhance performance, while 21 days of restraint 
impairs performance on the radial arm maze (Luine et al., 1994, 1996). The variable 
restraint stress schedule used here did not affect water maze performance. It is likely two 
weeks was not long enough, and if I had continued the cycle for an additional week, 
impairment may have become apparent in these rats. Alternatively, if I increased the 
daily duration of stress (vary between one to six hours) I may be able to observe an 
impairment in spatial memory. Although the number of animals used in this pilot was 
low, additional studies in our laboratory have consistently reported no effect of either one 
or two weeks of this variable restraint stress schedule on water maze performance
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providing further support for my sub-threshold stress model (Craig et al., 2008; 
McDonald et al., 2008).
Habituation to stressful experiences is often observed in stress research as 
exhibited by a decreased CORT response and enhanced return to baseline levels when 
compared to the CORT secretion profile obtained following acute stress (Magarinos and 
McEwen, 1995; Gadek-Michalska and Bugajski, 2003; Helm et al., 2004; Marin et al., 
2007). In an attempt to prevent habituation, the chronic mild stress procedure (CMS) was 
developed. This procedure rotates animals through a series of one or two stressors a day 
(e.g., soiled bedding, saline injection, foot shock, crowding or isolation) that change 
daily. This procedure has been shown to maintain high levels of CORT throughout the 
duration of the experiment (Song et al., 2006) and when compared to chronic restraint 
stress shows significantly less habituation (Maganinos and McEwen, 1995). There have 
only been two studies exploring the effects of CMS on spatial memory and these follow a 
similar pattern to single stress procedures. After 10 days of CMS, Gouirand and 
Matuszewich (2005) reported enhanced water maze performance, while after five weeks 
of CMS, Song et al. (2006) reported impaired performance. My findings from the 
variable restraint stress schedule are in agreement as no impairment is observed in the 
water maze task after two weeks of stress. The advantage to my variable restraint 
procedure is that it reliably elevates CORT levels and likely minimizes habituation 
without introducing the variability and potential confounds of using multiple different 
stressors. Although I did not perform a time course analysis of CORT levels in the 
current study or take blood from 10 min or 1 hour rats, I predict that following the 
variable restraint procedure, rats would exhibit higher levels of blood bom CORT than
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those rats exposure to 10 minutes or 1 hour of daily restraint stress. Future studies are 
required to fully describe the CORT profile induced by this novel stress schedule.
Although all three of my stress schedules had a similar effect on learning and 
memory, as tested in the water maze task, I chose to use the variable restraint procedure 
for all future studies. The variation in the length of time restrained each day should 
minimize habituation making this a useful model of behaviourally sub-threshold chronic 
stress in rats.
Experiment 2: The effect of various non-convulsive doses of kainic acid on water 
maze performance
Seizures are a common occurrence in the elderly population, especially in those 
diagnosed with AD (Hauser et al., 1986; Romanelli et al., 1990; Hesdorffer et al., 1996). 
The hippocampus is exceptionally sensitive to the excitotoxic damage caused by 
excessive glutamate released during seizures, due to the number of glutamate receptors 
found in this region (Ben-Ari, 1985). Patients suffering from epilepsy exhibit 
hippocampal sclerosis that may be correlated with cognitive decline in this population 
(Breteler et al., 1995; Thompson and Duncan, 2005; Marques et al., 2007). Animal 
models of epilepsy and seizures have also shown memory deficits and hippocampal 
damage similar to those reported in human studies (Cavazos et al., 1994; Gayoso et al., 
1994; Gilbert et al., 1996).
Two of the most common animal models of epilepsy are kindling and systemic 
injection of kainic acid. During kindling, a specific brain region (e.g., hippocampus, 
amygdala) is subjected to repeated electrical stimulation that results in the development 
and spread of seizure activity resulting in a heightened susceptibility to seizures in the
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fully kindled animal (Goddard et al. 1969). Kainic acid is a glutamate agonist that has 
been commonly used as a model for excitotoxic cell death and as an animal model for 
epilepsy. Systemic injections of kainic acid result in a characteristic response consisting 
of limbic seizures and a specific pattern of neuronal cell death. The severity of these 
seizures is dose dependent with concentrations of 10-12 mg/kg commonly used to induce 
convulsions and 6 mg/kg used as a non-convulsive dose (Lothman and Collins, 1981; 
Gobbo and O’Mara, 2004). Seizure progression follows a reliable pattern with initial 
freezing and ‘staring spells’, followed by wet dog shakes, mild automatisms, and 
eventual fully generalized tonic-clonic seizures that appear within one to two hours of 
injection (Lothman and Collins, 1981). Interestingly, within the first two weeks after the 
initial seizure, kainic acid treated rats begin to exhibit spontaneous seizures that persist 
for months (Hellier et al., 1998, 1999). In addition systemic kainic acid results in a 
characteristic pattern of neuronal cell death in the hippocampus, amygdala, piriform and 
entorhinal cortices, (Lothman and Collins, 1981; Ben-Ari, 1985; Sperk, 1995) which is 
due to over stimulation of glutamate receptors in these regions (Ben-Ari, 1985).
This experiment was designed to determine the effects of various non-convulsive 
doses of kainic acid on seizure severity and performance on the water maze task. I 
predicted that none of the doses would impair water maze performance. Furthermore, I 
predicted that I would observe increased seizure severity with increasing dosages of 
kainic acid, but none would lead to generalized convulsions. This was a pilot study 
carried out to describe a dose of kainic acid that could reliably cause non-convulsive 
seizures (freezing, wet dog shakes) as a sub-threshold risk factor.
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2.2. Materials and Methods
Animals
Twenty four male Long Evans hooded rats (300-400g; CCBN breeding colony) 
were used for this experiment. They were divided into four groups. Three groups 
received varying doses of kainic acid intraperitoneally [1 mg/kg i.p. (n=6), 3 mg/kg i.p. 
(n=5) and 6 mg/kg i.p. (n=6)] and the fourth group (n=7) were control animals that 
received a vehicle injection. Animals were pair housed with food and water ad libitum, 
on a 12 hour light/dark cycle with lights off at 19:30. All animals were handled in 
accordance to guidelines set out by the Canadian Council for Animal Care.
Seizures
All animals were injected with varying doses of kainic acid (1 mg/kg i.p., 3 mg/kg 
i.p. or 6 mg/kg i.p.; Ocean Produce International, Halifax, Nova Scotia) dissolved in 
sterile lx phosphate buffered saline (PBS) or PBS alone and observed in clear Plexiglas 
boxes. These doses are considered to be non-convulsive in normal adult rats (Mikulecka 
et al., 1999; Gobbo and O’Mara, 2004). Rats were observed for the first sixty minutes 
and scored for seizure severity using a four point scale based on Lothman and Collins 
(1981): 0-nothing, sleeping; 1-immobility, hunched posture, ‘staring’; 2-wet dog shakes; 
3-mild limbic convulsions, automatisms; 4-severe limbic convulsions, rearing, bilateral 
clonus, salivation, loss of postural control. A rat that display behaviours from stages 1-2 
was considered to have had a non-convulsive seizure, while rats that exhibited behaviours 
from stages 3-4 were considered to have had a convulsive seizure.
Behavioural testing
Behavioural testing began one week following the injection of kainic acid.
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Water maze task
I used a standard spatial version of the water maze task. The same pool that was 
described in Experiment 1 was used. Four different start points were used [N, S, E, W 
(not true compass headings)], equally spaced around the pool. The order was randomly 
selected for each day and each start point was used twice for a total of eight trials per day.
Rats were trained over six days to swim to a fixed spatial location. On day seven 
the platform was removed from the pool and each animal was placed in the pool for a 60 
second probe trial. On day eight the platform was placed in a new location opposite the 
original quadrant and rats were given eight trials to learn the new location.
Data collection: A computer based rat tracker (VP118, HVS Image) was used to collect 
and analyze data obtained from an overhead video camera. For the initial acquisition, and 
the reversal test on day eight, the measures of performance were swim time, defined as 
the latency between release and escape onto the platform, and swim speed. If a rat did not 
reach the platform 60 seconds after release, a latency of 60 seconds was assigned, and the 
rat was guided manually to the platform and allowed to remain on the platform for 10 
seconds before being removed to a holding cage until the next trial. For the probe trial the 
percentage of time spent in each quadrant of the pool was calculated and used to 
determine whether rats had formed a memory for the platform location.
3.2. Results
Seizures
Following the injection of 3 mg/kg or 6 mg/kg kainic acid, most rats had mild 
non-convulsive (stage 2) seizures consisting of freezing, and wet dog shakes which are
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common observations during kainic acid induced seizures in rats (Lothman and Collins, 
1981). One 3 mg/kg rat did not display any sign of behavioural seizures, and one 6 mg/kg 
only reached a stage 1 seizure, but the rest of the animals in these groups had stage 2 
seizures. A few of the rats that received a 1 mg/kg dose displayed some freezing and wet 
dog shakes, but 50% of rats did not exhibit any observable seizure behaviour. Figure 2.4 
shows the distribution of seizure severity in each of the dosage groups.
SEIZURE SEVERITY
120V.
CONTROL I mg/kg
m STAGE 0 
a STAGE 1 
a STAGE 2
Figure 2.4: Both 3 mg/kg and 6 mg/kg doses produced reliable Stage 2 seizures, while 
the lowest dose (1 mg/kg) resulted in no seizure behaviour in the half the animals. Data 
are given as means +/- SEM.
Water maze task
Acquisition
There were no differences between groups in the rats’ ability to learn the platform 
location during acquisition training (Figure 2.5 A). The latency (in seconds) to find the 
platform was recorded and averaged over the eight daily trials to obtain a single daily 
latency score for each animal. All groups showed a significant decrease in latency to find 
the platform from day one (27.46 +/- 1.88 seconds) to day six (5.64 +/- 0.41 seconds).
The daily scores for all six days of acquisition were subjected to a two-way mixed
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ANOVA with Group (1 mg/kg versus 3 mg/kg versus 6 mg/kg versus Control) as the 
between subjects variable, and Training Day (six levels) as a repeated measure, and 
revealed a significant effect of day [F(5,100)=67.38, / k 0.001], but no effect of group 
[F(3,20)=0.86,/?=0.48] or interaction [F(15,100)=0.31,/?=0.99]. There were no 
differences in swim speed between groups during the six days of acquisition training. A 
two-way mixed ANOVA with Group as the between subjects variable and Training Day 
(six levels) as the repeated measure found no effect of group [F(3,8)=0.20, p=0.89], day 
[F(5,40)=1.31,p=0.28] or interaction [F(15,40)=0.62,/?=0.84].
Probe trial
The platform was removed from the pool and the percentage of time spent in each 
quadrant was calculated. All rats showed a significant preference for the target quadrant, 
spending 42.7 +/- 2.08% of their time in that quadrant (Figure 2.5B). A two-way 
ANOVA (Group x Quadrant) revealed no difference between groups on the percentage of 
time spent in the target quadrant compared to the averaged percentage of time spent in 
the other three quadrants [F(3,20)=0.53,/>=0.67]. There were no differences between 
groups on swim speed during the probe trial. A one way ANOVA found no effect of 
group [F(3,20)=l .45, /?=0.26] on this stage of training.
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3 mg/kg 
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Figure 2.5: Three different non-convulsive doses of kainic acid did not affect 
performance in the spatial version of the water maze. All groups were able to learn the 
location of a hidden platform over six days of training (A) and show a preference for the 
target quadrant during a 60 second probe trial (B). On day eight, all groups were able to 
learn to find a hidden platform in a novel location (C).-Data are given as means +/- SEM.
Reversal test
On day eight, the platform was returned to the pool and placed opposite the target 
quadrant. The latency (in seconds) to find this new location was recorded over eight trials 
on the final day of testing. The results of the reversal are displayed in Figure 2.5C
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showing that all groups were able to learn a new location in a single day. All groups 
showed a significant decrease in latency to find the platform from trial one (48.85 +/- 
3.18 seconds) to trial eight (7.59 +/- 0.55 seconds). A two-way mixed ANOVA, with 
Group as the between subjects variable, and Trial (eight levels) as a repeated measure 
revealed a significant effect of trial [F(7,140)=47.62,/K0.001], but no effect of group 
[F(3,20)=0.28,p=0.84] or interaction [F(21,140)=0.90,/?=0.59]. There were no 
differences between groups in swim speed on the reversal training day, though all groups 
increased swim speed over the course of the trials. A two-way mixed ANOVA with 
Group as the between subjects measure and Trial (eight levels) as the repeated measure 
and revealed a significant effect of trial [F(7,56)=2.88,_p<0.05], but no effect of group 
[F(3,8)=0.37,p=0.78] or interaction [F(21,56)=0.76,p=Q.76\. Holm-Bonferroni post hoes 
revealed faster swim speeds on the final three trials compared to the first two trials 
(p’ s<0.05).
4.2. Discussion
Here I report the effects of three non-convulsive doses of kainic acid on seizure 
severity and spatial memory in the rat. None of the doses used impaired water maze 
performance and no convulsive seizures were observed in any of the groups. The 3 mg/kg 
and 6 mg/kg doses consistently induced freezing and staring spells, followed by wet dog 
shakes, indicative of seizures originating from a hippocampal focus (Damiano and 
Connor, 1984). The 1 mg/kg dose occasionally resulted in freezing and wet dog shakes, 
but this was not consistently observed in all animals.
My findings are consistent with previous reports of non-convulsive seizures on 
behaviour. Gobbo and O’Mara (2004) tested rats on the water maze two weeks after a
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non-threshold dose of kainic acid (6 mg/kg) and found no effect on spatial memory. To 
the best of my knowledge this was the only study exploring the effects of low doses of 
systemic kainic acid on spatial memory. Mickulecka et al. (1999, 2000) found changes in 
exploratory and anxiety behaviour measured in the open field and elevated plus maze 
immediately following non-convulsive kainic acid induced seizures; however it is likely 
these effects were transient and due to the effects of seizure activity in the brain caused 
by kainic acid. Convulsive doses of kainic acid have been consistently shown to impair 
spatial memory when tested 10-14 days post seizure, but these effects can be overcome 
through extensive training (Gayoso et al., 1994; Gobbo and O’Mara, 2004).
Reports on the behavioural effects of non-convulsive seizures are minimal, but 
there have been some studies examining the behavioural effects of partial kindling where 
similar findings have been observed. Gilbert et al. (1996) reported no effect on water 
maze performance in rats that had been kindled to non-convulsive seizures 24 hours prior 
to training, but in a later paper reported impairment in partially kindled rats that were 
trained and tested 25 -  45 minutes after kindling (Gilbert et al., 2000). Sutherland et al. 
(1997) reported no impairment on the standard version of the Morris water maze, 
following repeated afterdischarges that did not lead to seizures. Interestingly, they did 
find a deficit when rats were tested on a more sensitive moving platform variant of the 
water maze confirming the importance of taking into account the difficulty of behavioural 
tasks when comparing studies (Sutherland et al., 1997). Leung and Shen (1991) gave rats 
one week to recover after partial kindling and reported impaired retention in the radial 
arm maze suggesting that while rats are able to learn a new task (water maze) following 
partial kindling, the retention of recently learned behaviour may be disrupted. An
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alternate explanation for the impaired performance is that the working mejnory version of 
the radial arm maze places a high demand on hippocampal processing and as such is 
more sensitive to minor hippocampal dysfunction than the standard water maze task. 
Overall, it appears that 24 hours is sufficient for rats to recover from the effects of partial 
kindling when tested on the standard version of the water maze, which is consistent with 
my current finding of no impairment on the water maze task one week after kainic acid 
injection.
When hippocampal memory impairment is observed following seizures, it may be 
due to abnormal neuronal activity interfering with the formation of new memories 
(Buzsaki, 1989; Sutherland et al., 1997). Interictal spikes can be recorded from the 
hippocampus following partial kindling, but these spikes only persist for a day or two 
(Leung et al., 1990). A more lasting change (25 days post kindling) can be observed in 
the averaged evoked potentials in the CA1 which are increased in partially kindled rats 
(Leung and Shen, 1991). Interictal spikes are also observed following systemic injection 
of convulsive doses of kainic acid (Hellier et al., 1999), but to the best of my knowledge, 
it is not yet known whether there are long lasting changes in activity resulting from non- 
convulsive doses. Rats treated with convulsive doses of kainic acid begin to exhibit 
spontaneous seizures that can persist for months (Hellier et al., 1998,1999). It is possible 
that these electrophysiological abnormalities may underlie the learning and memory 
deficits following convulsive seizures in rats.
A second way that seizures can impair learning and memory is through 
excitotoxic damage to the hippocampus, particularly to the CA1 and CA3 regions that 
have been shown to be important for learning and memory. Specific lesions to either of
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these regions of the hippocampus can impair performance on the water maze task 
(Stubley-Weatherly et al., 1996). Convulsive seizures increase levels of excitatory 
neurotransmitters in the brain, particularly glutamate, which bind to N-methyl-D- 
aspartate (NMDA) receptors in the hippocampus (Fujikawa, 2005). The CA1 and CA3 
regions are the most susceptible to excitotoxic damage due to the density of glutamate 
receptors in these regions. CA2 neurons do not express the same amount of receptors and 
tend to be spared following seizure activity (Ben-Ari, 1985). Binding of glutamate causes 
a dramatic increase in intracellular Ca2+ leading to increased apoptotic and necrotic cell 
death. The non-convulsive seizures observed in the current study were likely not 
sufficient to damage hippocampal neurons. Though I did not conduct a histological 
assessment of the brains in the current study, additional experiments in our laboratory 
have found no evidence of gross hippocampal damage following the 6 mg/kg dose of 
kainic acid in the absence of convulsive seizures. This is in agreement with Lothman and 
Collins (1981) who did not detect hippocampal damage until convulsive seizures had 
been induced using doses in excess of 7 mg/kg i.p.
There were no effects on spatial memory in any of my groups receiving low doses 
of kainic acid; however, there were observable differences between groups in terms of 
seizure severity. I favored the highest dose (6 mg/kg i.p.) for two reasons. First, I could 
confirm the presence of seizure activity through behavioural manifestations (wet dog 
shakes) and secondly, it was near to the convulsive threshold allowing for the potential 
appearance of impairment or neuronal damage when combined with additional factors in 
McDonald’s co-factor model of aging (McDonald, 2002). This dose will be used in future 
studies as a reliable means of inducing non-convulsive seizure activity in the rat brain.
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Experiment 3: The effects of focal sub-threshold dose of Endothelin-1 on water 
maze performance
Ischemic stroke is the most common form of stroke and is caused by an 
interruption of the blood flow to the brain due to a transient or permanent blockage of the 
cerebral arteries. The specific brain region(s) deprived of oxygen undergo cell death 
resulting in an infarct (area of dead tissue); the size and location of which can be 
correlated with neurological deficits (Durukan and Tatlisumak, 2007). Not all strokes 
result in obvious symptoms and are referred to as ‘silent’ strokes which occur commonly 
in the elderly population. These asymptomatic events can be detected as small infarcts on 
magnetic resonance imaging (MRI) or computerized tomography (CT) scans. 
Approximately 20% of the healthy elderly population is found to have experienced a 
‘silent’ stroke in their lifetime, with this prevalence increasing in patients that have 
suffered a stroke or dementia (Vermeer et al., 2007).
The hippocampus is especially vulnerable to the effects of ischemia and cerebral 
hypoperfusion (Schimdt-Kastner and Freund, 1991; Farkas and Luiten, 2001). Both 
global ischemia and lacunar stroke have been found to preferentially target the 
hippocampus resulting in increased levels of apoptosis and hippocampal atrophy (Kirino 
and Sano, 1984; Honkaniemi et al., 1996; Back et al., 2004; Grau-Olivares et al., 2007). 
Stroke can be either global or focal in nature, referring, to the regions of the brain 
affected. Most studies are designed to detect impairment and recovery of a specific 
behaviour (e.g., skilled forelimb reaching, spatial memory, sensory deficits, etc) and for 
these studies, focal ischemia is preferred due to the specificity of the lesion. There are 
several models of focal ischemia currently used in animal research [middle cerebral
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artery occlusion, photothrombosis and administration of vasoconstrictive agents, such as 
Endothelin-1 (ET-1)], each of which has their own advantages and disadvantages. I was 
interested in creating a specific focal lesion of a subcortical structure (the hippocampus) 
that could be manipulated in a dose dependent fashion. For these reasons I chose to use 
the potent vasoconstrictor ET-1 in my model.
Topical, intracortical, or perivascular administration of ET-1 reduces blood flow 
to a specific region until it can be metabolized and allow normal blood flow to resume. 
The resulting infarct is highly reliable and its size is dose dependent. This technique was 
first developed by Fuxe et al. (1992) who infused small amounts of ET-1 into the 
striatum to create a focal lesion that was thought to be ischemic in nature. This lesion 
could be prevented by the co-administration of a vasodilator. In addition, application of 
ET-1 to neuronal cultures in vitro was not found to be neurotoxic, further supporting the 
idea that the damage resulting from ET-1 was ischemic in nature (Nikolov et al., 1993). 
Intracortical infusions of ET-1 have been used to damage the sensory and/or motor cortex 
(Adkins et al., 1993; Gilmour et al., 2004), the striatum (Fuxe et al., 1992) or a 
combination of motor cortex and striatum (Windle et al., 2006). The resultant lesions 
were found to be associated with motor deficits comparable to those observed with 
aspiration or excitotoxic lesions of the same region (Gilmour et al., 2004).
This experiment was designed to examine the effects of varying doses of ET-1 
infused directly into the hippocampus on performance on the water maze task. I predicted 
a dose dependent response to ET-1 with rats receiving the largest dose being the most 
impaired on the water maze task and rats receiving the lowest dose having little or no 
impairment when compared to controls. This was a pilot study carried out to describe a
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dose of ET-1 that can induce mild focal ischemia with the purpose of developing stroke 
as a sub-threshold risk factor for future studies.
2.3. Materials and Methods 
Animals
Twenty nine male Long Evans hooded rats (300-400g; CCBN breeding colony) 
were used for this experiment. Rats were divided into four groups: Low dose (7.5 pmol; 
n=8) rats were infused with 7.5 pmol of ET-1 (human porcine, Sigma), medium dose (30 
pmol; n -6) rats were infused with 30 pmol of ET-1, high dose (60 pmol; n=7) rats were 
infused with 60 pmol of ET-1 and control (Control; «=8) rats were infused with saline. 
Animals were pair housed with food and water ad libitum, on a 12 hour light/dark cycle 
with lights off at 19:30. All animals were handled in accordance to guidelines set out by 
the Canadian Council for Animal Care.
Surgery
Surgery was performed under Isoflurane anaesthesia (4% with 2.0 L/min of
oxygen for induction and 2% after surgical plane was established) in a standard
stereotaxic apparatus. An incision was made in the scalp and periosteum down the
midline. The fascia was pushed to the edges of the skull with a sterile gauze swab and
the skin retracted to expose the skull surface. Holes were drilled into the skull using a 1
•»
mm drill bit attached to a high speed drill. The vasoconstrictor ET-1 was used to induce a 
focal stroke in the hippocampus. I lowered a 30 gauge cannula, through holes drilled in 
the skull in to the dorsal (AP -4.1; ML +/-3.0; DV -3.7 mm from bregma and the skull 
respectively) and ventral hippocampus (AP -5.2; ML +/-5.3; DV -7.0 mm from bregma 
and the skull respectively) and bilaterally infused ET-1 (7.5, 30 or 60 pmol dissolved in
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sterile saline) at a rate of 0.1 pl/min using a Harvard mini-pump. Each animal received a 
total volume of 5 pi to each site. The cannula was then left in place for 10 minutes after 
each infusion to ensure diffusion of the toxin. Sham operated animals underwent an 
identical procedure, but were infused with sterile saline instead of ET-1. Following 
surgery animals were given buprenorphine (Temgesic; 1 mg/kg subcutaneously) as an 
analgesic.
Behavioural testing
Behavioural testing began one week following the infusion of ET-1.
Water maze task
I used a standard spatial version of the water maze task. The same pool that was 
described in Experiment 1 was used. Four different start points were used [N, S, E, W 
(not true compass headings)], equally spaced around the pool. The order was randomly 
selected for each day and each start point was used twice for a total of eight trials per day. 
Rats were trained over four days to swim to a fixed spatial location.
Data collection: A computer based rat tracker (VP118, HVS Image) was used to collect 
and analyze data obtained from an overhead video camera. The measure of performance 
was swim time, defined as the latency between release and escape onto the platform and 
swim speed. If a rat did not reach the platform 60 seconds after release, a latency of 60 
seconds was assigned, and the rat was guided manually to the platform and allowed to 
remain on the platform for 10 seconds before being removed to a holding cage until the 
next trial.
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3.3. Results
Behavioural testing
The three different doses of ET-1 had dramatically different effects on the ability 
of the rat to learn the location of a hidden platform during training. Rats receiving 30 or 
60 pmol were impaired on all days of training, while rats receiving the 7.5 pmol dose did 
not differ from controls (Figure 2.6). On the final day of training controls and 7.5 pmol 
rats were finding the platform in 7.5 +/-1.2 seconds and 6.9 +/- 0.8 seconds respectively, 
while 30 and 60 pmol rats were taking 16.2 +/-1.4 seconds and 25.7 +/- 2.5 seconds 
respectively, to find the platform location. A two-way mixed ANOVA with Group 
(Control versus 7.5 pmol versus 30 pmol versus 60 pmol) as the between subjects 
variable and Training Day (four levels) as the repeated measure revealed a significant 
effect of group [F(3,25)=49.69, /K0.001], of day [F(3,75)=53.72,/?<0.001] and an 
interaction [F(9,75)=3.69,/?<0.001]. The interaction was further broken down using 
planned comparisons that found no difference between control and 7.5 pmol rats on any 
of the training days (p<0.05). Rats receiving 30 pmol took longer than 7.5 pmol rats on 
days three and four (p<0.05), while 60 pmol rats took significantly longer than all other 
groups on all days {p<0.05). There were no differences in swim speed between the 
groups. A two-way mixed ANOVA with Group as the between subjects variable and 
Training Day (four levels) as the two-way mixed found no effect of group [F(3,25)=1.43, 
p=0.26], of day [F(3,75)=0.66,/>=0.58] or interaction [F(9,75)=1.15,/?=0.34].
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HIDDEN PLATFORM LOCATION TRAINING
Figure 2.6: The lowest dose of ET-1 (7.5 pmol) did not impair acquisition training in the 
water maze while the medium (30 pmol) and high (60 pmol) doses resulted in 
significantly longer latencies to find the hidden platform compared to the low dose or 
control rats. Data are given as means +/- SEM.
4.3. Discussion
Here, I demonstrate a dose dependent effect of a hippocampal infusion of ET-1 on 
spatial memory as assessed during acquisition training in a hidden platform version of the 
Morris water maze. All groups were able to swim well and actively searched for the 
hidden platform, but the 60 pmol and 30 pmol groups were severely impaired in their 
ability to learn the platform location. In contrast, rats receiving 7.5 pmol were 
indistinguishable from controls and rapidly learnt the location of the hidden platform.
This is the first study looking at the behavioural effects of using ET-1 to damage 
the hippocampus. Previous studies have used ET-1 to damage motor or sensorimotor 
cortex and have reported region specific impairment in sensation and forelimb use 
(Adkins et ah, 1993; Gilmour et ah, 2004). Moreover, Fuxe et al. (1992) has reported a 
dose dependent effect on lesion size with greater damage resulting from higher doses, 
which would explain the results in the current study. The acquisition deficit observed in 
the groups receiving the two largest doses of ET-1 is comparable to previous research on 
stroke and spatial memory. Middle cerebral artery occlusion causes damage to the
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hippocampus and select cortical areas and can produce impairment on both acquisition 
and retention of platform location in the water maze task (Markgraf et al., 1992; 
Yonemori et al., 1996; Luo et al., 2007, but see Karhunen et al. 2006). This deficit on the 
water maze task following stroke can be improved by treatment with anti-inflammatory 
drugs (Liu et al., 2006), voluntary wheel running (Luo et al., 2007) or enriched 
environment (Dahlquist et al., 2004).
Cerebral hypoperfusion is another model of stroke that reduces blood flow to the 
cortex and hippocampus. This model does not cause extensive damage to the brain, save 
for a gradual loss of CA1 neurons in the hippocampus (Farkas and Luiten, 2001). 
Following chronic hypoperfusion, spatial memory is impaired in rats tested on the water 
maze (de la Torre et al., 1992; Pappas et al., 1996; de Jong et al., 1999). The cognitive 
effects of mild or sub-threshold stroke have not been extensively studied, but due to the 
sensitivity of CA1 neurons of the hippocampus, any observed impairment would likely 
be revealed in tests of hippocampal processing. Auer et al. (1989) briefly induced low 
level ischemia in rats that resulted in a 50% loss of CA1 neurons, and found no effect on 
the standard version of the water maze; however, rats were impaired in a more difficult 
moving platform version.
I was unable to conduct a histological analysis of lesion size in the current study, 
so a correlation between lesion size and performance could not be determined. I predict 
that I would have found minimal damage to the hippocampus in the low dose group and 
extensive cell death in groups receiving the higher doses. Additional experiments in our 
laboratory confirmed this prediction by finding minimal damage surrounding the infusion 
site (Driscoll et al., 2007; McDonald et al., 2008), or a moderate amount of neuronal cell
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death throughout the hippocampus (Craig et al. submitted). Further experiments testing 
this model on water maze performance have suggested a relationship between lesion size 
and performance. McDonald et al. (2008) and Driscoll et al. (2007) reported minimal 
hippocampal damage and no impairment in spatial memory following sub-threshold 
stroke, and Craig et al. (submitted) reported a mild impairment in the water maze task in 
rats with moderate hippocampal damage.
The lowest dose (7.5 pmol) of ET-1 used in the current study did not impair 
acquisition of the water maze task. I chose this dose for future studies to better model the 
‘silent’ infarcts commonly observed in the elderly (Snowden et al., 1997; Vermeer et al., 
2007). Although the design of this pilot study was unable to demonstrate a lack of 
impairment on all stages of the water maze task, additional experiments using this model 
have since confirmed that while there is some inherent variability to this model, overall 
spatial memory remains at or near control levels allowing this model to be behaviourally 
defined as a sub-threshold risk factor.
Conclusion
I have presented three animals models of sub-threshold risk factors (stress stroke 
and seizures) that do not impair hippocampal learning and memory as tested on the water 
maze task. I have discussed a role for these risk factors in the development of AD, and 
more importantly the potential consequences of behaviourally sub-threshold levels of 
these risk factors. These models will prove useful in continuing research designed to 
further understand the etiology of AD. Future studies will explore the effects of 
combining these risk factors with each other, and others to identify unique “sub-types” of 
AD that would respond optimally to individualized treatments.
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Chapter 3
Chronic circadian disruption impairs hippocampal memory in the rat
Modified from a paper published in Brain Research Bulletin. 16 (1 -2): 141 -151 
by Laura A. Craig and Robert J. McDonald in 2008
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Abstract
Circadian related disorders and alterations in sleep-wake patterns are common complaints 
in the elderly, especially those diagnosed with Alzheimer’s disease. The negative 
physical and psychological effects resulting from chronic circadian disruption are 
numerous and appear to be positively correlated with the length of time an individual has 
suffered from a circadian disorder. In the current paper, I explore the effects of acute and 
chronic disruption of circadian rhythms on memory using a phase shifting schedule that 
can continually challenge the rats’ circadian system by using repeated phase shifts and 
recovery sessions. I demonstrate a significant learning and memory deficit on a spatial 
version of the water maze task in the chronically phase shifted, but not in the acutely 
phase shifted animals. Moreover, I find no impairment in fear conditioning suggesting 
that chronic phase shifting predominantly affects hippocampal memory. I propose that 
chronic circadian disruption may play a role in the development of age related cognitive 
deficits and dementia in the elderly.
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1. Introduction
Changes in circadian rhythms and deterioration of sleep-wake patterns are some 
of the most common complaints in the elderly population, especially those patients 
suffering from dementia or Alzheimer’s disease (AD). Indeed, this is the number one 
cause of institutionalization for demented patients as caretakers at home find it 
increasingly difficult to manage their patients’ frequent night time awakenings (Poliak 
and Perlick, 1991; Hatfield et al., 2004). An interesting link between circadian disruption 
and cognitive impairment has previously been reported in both human (Bonnet, 1989) 
and non-human animals (Fekete et ah, 1985; Stone et al., 1997; Antoniadis et al., 2000). 
Changes in rhythmicity, such as increased night time activity, combined with frequent 
day time napping, and ‘sundowning’ (a tendency for patients to become increasingly 
agitated in the late aftemoon/evening) have been consistently reported in AD patients 
(Witting et al., 1990; van Someren et al., 1996).These disruptions of the circadian system 
could play a role in the cognitive deficits observed in AD.
Circadian rhythms are controlled largely by the suprachiasmatic nucleus (SCN) in 
the brain. The SCN acts as an internal pacemaker, driving a daily rhythm with a period of 
near twenty four hours although input from light, meals, and social contacts act as cues to 
set the clock to a precise twenty four hour period (Antle and Mistleberger, 2005).
Damage to the SCN in rodents completely abolish these daily rhythms, but rodents can 
recover normal rhythmicity following the transplantation of healthy SCN tissue 
confirming the importance of this nucleus as a circadian clock (Ralph et ah, 1990; Hurd 
et al., 1998). Considering the importance of the SCN to the maintenance of circadian 
rhythms, it is no surprise that individuals suffering from chronic circadian disturbances,
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such as the aged population, and especially patients with AD, show dramatic changes in 
the structure and function of this region. These changes include reduction in volume and 
cell number in the SCN and changes in the rhythmicity and expression of vasopressin 
producing neurons, suggesting a neuroanatomical basis for the decline in circadian 
rhythmicity in the aged population (Swaab et al., 1985; Frankland et al., 1998).
The aged non-human animal population also tends to show impairments in their 
circadian rhythms. In fact, Antoniadis et al. (2000) have demonstrated that in hamsters, 
the extent of circadian disruption in aged animals is a better predictor of age related 
cognitive decline than age alone. A wide variety of cognitive processes can also be 
affected by phase shifting. Phase shifting is a procedure that actively changes one of the 
external time cues (e.g., advancing the time of lights off by a set number of hours) in 
order to reset the SCN, causing a healthy animal to modify its behaviour and adapt to the 
novel schedule. Devan et al. (2001) have shown that phase shifting for six days during 
acquisition of the water maze task, interferes with long term memory recall for the 
platform location two weeks later. Other researchers have found impairments in passive 
and active avoidance following phase shifting (Tapp and Holloway, 1981; Fekete et al., 
1985). These studies suggest a link between cognitive impairments and circadian 
disruption, especially in the area of memory recall, but much more work is required in 
this area to fully understand the nature of this relationship.
There have been several controlled studies in humans and non-human animals 
reporting that an acute disruption to circadian rhythmicity can result in memory deficits, 
specifically those involved in recall. However, the evidence supporting impairments in 
individuals suffering from chronic circadian disruption tends to predominantly focus on
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human populations, either individuals working shift work [who are specifically selected 
to be healthier, and more fit to handle the rigors of shift work (Knutsson, 2004)], or aged 
patients with chronic circadian disorders who often have pre-existing mental health 
complaints [making it difficult to separate cognitive impairments caused by circadian 
disruption and those caused by Alzheimer’s disease, or dementia (van Someren et al., 
2000)]. Exploration into the effects of chronic circadian disruption on learning and 
memory in both young and aged populations is required to begin to understand the nature 
of the relationship between circadian disruption and memory. Here I use a phase shifting 
procedure that allows me to maintain rats in a state of circadian disruption for varying 
amounts of time in a controlled environment. This will help me to explore the 
consequences of chronic circadian disruption on cognitive processes and its potential 
links to physiological, psychological and neurodegenerative disorders. In the current 
study I demonstrate the effects of acute and chronic circadian disruption on learning and 
memory in the rat.
2. Materials and Methods 
Animals
Thirty seven male Long Evans hooded rats (300-400g) obtained from Charles 
River (Saint-Constant, PQ) were used for all studies. They were divided into three 
groups: Acutely phase shifted rats (Acute; n=8), chronically phase shifted rats (Chronic; 
n=8) and control rats for water maze testing (Control; n=7) and control rats for fear 
conditioning (Control; «=14). Both groups of phase shifted rats (n=16) were housed 
individually in polypropylene cages equipped with a 42.5 cm diameter running wheel, 
with food and water ad libitum, on a 12 hour light/dark cycle, with variable times of light
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offset. Control rats (n=21) were pair housed in standard shoebox housing with food and 
water ad libitum, on a 12 hour light/dark cycle with lights off at 19:30. All animals were 
handled in accordance to guidelines set out by the Canadian Council for Animal Care.
Circadian rhythms
In order to create a state of circadian disruption I used a two stage phase shifting 
session which lasted 16 days. Acutely phase shifted rats underwent a single session (16 
days), while chronically phase shifted rats underwent four consecutive sessions (64 days). 
Control rats remained on a constant 12 hour light/dark schedule for the duration of the 
experiment with lights off at 19:30.
Phase Shifting
Each phase shifting session was made up of two distinct stages: phase shifting and 
recovery. Animals were initially phased advanced by three hours a day for six 
consecutive days. This phase advancement was followed by ten days of re-entrainment to 
allow the animals a partial recovery [ten days is half the normal re-entrainment time 
required in this paradigm (Deven et al., 2001)]. After this partial re-entrainment, animals 
were phase advanced, a second time, for three hours a day for another six days, then 
allowed a second recovery (Table 3.1 shows the time the lights were turned off during the 
phase shifting procedure). This design allowed me to continually challenge the circadian 
system for the duration of my experiment.
Data Collection: Phase shifted animals were housed individually in polypropylene cages 
equipped with a 42.5 cm diameter running wheel attached via a microswitch to a 
computer. Activity (wheel running) was monitored continuously using a ClockLab data
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analysis and collection system for circadian rhythms (ActiMetrics Software, Wilmette, 
IL). Actograms for each animal were double plotted to clearly show general patterns of 
activity. Daily onsets of activity and total activity for each animal were obtained using 
the ClockLab analysis program (ActiMetrics Software). The activity onsets were 
determined for the six days prior to the start of phase shifting session (baseline) and for 
the six days following each phase shifting session (post 1-4; post 1 refers to the six days 
following the first phase shifting session, post 2 refers to the six days following the 
second phase shifting session, etc.). The difference between the actual time of lights off 
and the onset of activity was calculated, averaged over the six days and used to describe 
the phase angle of entrainment. A delayed phase angle was negative, and referred to 
activity onsets occurring after the time of lights off, while an advanced phase angle was 
positive, and referred to activity onsets proceeding the time of lights off. Activity was 
recorded in wheel revolutions per minute, and determined for the light phase (light 
activity) and the dark phase (dark activity). To control for inter-rat variability in total 
activity, light activity was expressed as a percentage of total activity and used as a 
measure of rhythm fragmentation. This proportion of light activity was averaged for the 
six days prior to the start of phase shifting session (baseline) and for the six days 
following each phase shifting session (post 1-4).
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Table 3.1: Schedule of phase shifting to induce chronic circadian disruption
DAY
1 Lights off at 16:30
2 Lights off at 13:30
3 Lights off at 10:30
4 Lights off at 07:30
5 Lights off at 04:30
6 Lights off at 01:30
7-16 Re-entrainment: Lights off at 22:30
17 Lights off at 19:30
18 Lights off at 16:30
19 Lights off at 13:30
20 Lights off at 10:30
21 Lights off at 07:30
22 Lights off at 04:30
23-32 Re-entrainment: Lights off at 01:30
33 Lights off at 22:30
34 Lights off at 19:30
35 Lights off at 16:30
36 Lights off at 13:30
37 Lights off at 10:30
38 Lights off at 07:30
39-48 Re-entrainment: Lights off at 04:30
49 Lights off at 01:30
50 Lights off at 22:30
51 Lights off at 19:30
52 Lights off at 16:30
53 Lights off at 13:30
54 Lights off at 10:30
55-64 Re-entrainment: Lights off at 07:30
70
Behavioural testing
Behavioural testing occurred following the final ten day re-entrainment of the 
phase shifting procedure at the equivalent circadian phase for each group. Rats were 
tested on a six day version of the water maze task, followed by three days of testing on a 
fear conditioning task. The acutely phase shifted group of rats began behavioural testing 
after one session (16 days) at 13:30 (three hours after lights on), and the chronically 
phase shifted group of rats were tested after four consecutive sessions (64 days) at 22:30 
(three hours after lights on). The control group of rats were tested at 10:30 (three hours 
after lights on).
Water maze: Rapid Acquisition Task
I used a three stage variant of the spatial version of the water maze task
(McDonald et al., 2005). A white plastic circular pool 1.4 m in diameter and 40 cm deep
was filled to within 20 cm of the top of the wall with water (20-22°C) made opaque by
adding skim milk powder. The invisible platform was 12 cm in diameter and made of
white Plexiglas with holes drilled into the top of it to provide grip for the animals.
During training the platform was submerged 2 cm under water. Extra-maze cues in the
training room included five posters of different sizes and orientations mounted on three
of the four walls, a computer rack, a door, an animal rack and the experimenter. Four
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different start points were used [N, S, E, W (not true compass headings)], equally spaced 
around the pool. The order was randomly selected for each day and each start point was 
used twice for day one to four and day six. On day five only the three start points farthest 
from the platform were used (N, E, S) with each start point repeated five times and the 
initial start point repeated at the end for a total of 16 trials.
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In the first stage (Original location training) rats were trained over four days for 
eight trials a day, to swim to a fixed, spatial location. Twenty-four hours after completion 
of stage 1, the second stage (New location training) began. This stage consisted of new 
spatial location training as animals were re-trained to swim to the new platform location 
over sixteen trials within two hours on a single day. Stage 2 allowed me to ask if rats 
could learn to go to a new location, during a single intensive training session. The third 
stage (Re-training to original location) occurred twenty four hours after stage 2 with the 
platform returned to its original (stage 1) location and each animal was given eight trials. 
This stage allowed me to ask how the massed new location training during stage 2 
affected relearning to the original location. The platform locations for each stage of this 
task are depicted in Figure 2.1.
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the hippocampus to rapidly form a novel representation in a familiar 
context. The third stage tested the strength of each representation, as an unimpaired rat 
would clearly demonstrate a memory for both locations with a preference for the most 
recent (McDonald et al., 2005).
Data collection: A computer based rat tracker (VP118,'HVS Image) was used to collect 
and analyze data obtained from an overhead video camera. The measures of performance 
were swim time, defined as the latency between release and escape onto the platform and 
path length to the platform. If a rat did not reach the platform 60 seconds after release, a 
latency of 60 seconds was assigned, and the rat was guided manually to the platform and
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allowed to remain on the platform for 10 seconds before being removed to a holding cage 
until the next trial. An additional analysis was conducted on the first swim of re-training 
to determine the first quadrant entered, which was used as a measure of platform 
preference (new versus original).
Fear conditioning to tone and context
The three day fear conditioning procedure used here was designed to test 
hippocampal independent learning and memory on two related tasks: fear conditioning to 
tone (cue) and to context. Animals were placed into Context A (an operant chamber, 
metal walls, bars on floor, scented with Quatsyl®-D Plus disinfectant) and allowed to 
habituate for two minutes. They were presented with a 10 second tone (80 db), followed 
by a two second shock (1.0 mA). This tone-shock pairing was repeated every 70 seconds 
for five repetitions. Sixty seconds following the final shock, the animals were removed 
from the chamber, and returned to their home cage. Twenty four hours later the animals 
were placed in a novel context, Context B (Plexiglas walls, bedding on the floor, 
unscented), and after two minutes of habituation, were presented with an eight minute 
tone (80 db), with no shock and scored for freezing behaviour, as a measure of fear. 
Freezing behaviour is a reliable measure of fear, and was defined as a period of complete 
immobility except for breathing movements in the animal (Blanchard and Blanchard, 
1969). Forty eight hours later animals were returned to Context A for a five minute trial 
(no shock, no tone) to assess freezing behaviour in response to the original conditioning 
context.
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3. Results
One Acute rat died for unknown reasons prior to phase shifting and behavioural 
testing; the following analyses include data from seven rats in this group.
Circadian rhythms
Circadian rhythms were continuously recorded throughout the study using a 
running wheel connected to a computerized data collection system (due to minor 
technical difficulties with equipment used in the data collection process some data for 
individual rats was lost. On that day the rat would be removed from the corresponding 
circadian rhythm analysis; one Acute rat was removed from the entire analysis due to 
multiple missed days). A representative actogram is shown from each group illustrating 
the initial entrainment, phase shifting session(s) and recovery session(s) for an Acute rat 
(Figure 3.1 A) and a Chronic rat (3.IB).
Figure 3.1: Representative actogram from an Acute (A) and a Chronic animal (B). 
Actograms are double plotted over forty eight hours for clarity. Each horizontal line 
represents two days, and the vertical bands represent wheel running. The shaded portions 
refer to when the lights were off.
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Phase angle o f entrainment
During the initial entrainment the rats predictably began running shortly after 
lights off. This initial entrainment is a good measure of normal circadian rhythms and as 
such, served as a control for the effects of phase shifting. However, following the first 
phase shifting session, the phase angle of both groups was significantly delayed, (-1.55 
+/- 0.25 hours and -1.47 +/- 0.31 hours, for Acute and Chronic rats respectively). There 
were no inherent differences between the Acute and Chronic groups before or after the 
first phase shifting session and both groups showed a significantly delayed phase angle 
following the initial phase shift. A two-way mixed ANOVA with Group (Acute versus 
Chronic) as the between subjects variable, and Phase Shift (baseline versus post 1) as the 
repeated measure found a significant effect of phase shift [F(l,10)=22.51,p<0.01], but no 
effect of group [F(l,10)=0.08,p=0.78], or interaction [F(l,10)=0.00,;?=0.98] (the 
baseline data from one Acute rat and the post 1 data from one Chronic animal were 
excluded from the analysis). Tukey post hoes showed the phase angle following the phase 
shift to be significantly delayed compared to baseline (p’s<0.05).
To look at the effect of multiple phase shifts and recovery sessions on phase 
angle, I further examined the activity onsets of the Chronic group. Following the first 
phase shift the phase angle was delayed, with the activity onset occurring 1.5 hours after 
lights off (compared to the baseline phase angle of -11.4 minutes). The phase angle was 
delayed further after the second phase shift (-3.4 hours), and reduced following the third 
phase shift (-1.4 hours), where it stabilized for the duration of the experiment (Figure 
3.2A). A two-way mixed ANOVA with Group as the between subjects variable and 
Phase Shift (five levels) as the repeated measure revealed a significant main effect of
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phase shifting [F(4,24)= 5.70,/?<0.05] (the post 4 data from one rat was excluded).
Tukey post hoes revealed that the phase angle following the second phase shift was 
significantly delayed compared to baseline or post 1 (p’s<0.05).
Rhythm fragmentation
Normal rats will confine the majority of their activity to the dark phase of the 
light cycle, while spending the light phase resting. Therefore, the proportion of activity 
during the light phase (light activity) is a good measure of rhythm fragmentation. 
Interestingly, I found a similar pattern of results as observed with the phase angle of 
entrainment. During the initial entrainment the rats predictably confined their activity to 
the dark phase with only 4.3 +/- 0.57% and 9.4 +/- 2.99% light activity for acute and 
chronic rats respectively. Following the first phase shift, there was an increased 
proportion of light activity in both groups (11.5 +/- 3.55% and 13.0 +/- 2.48%). There 
were no differences between the Acute and Chronic groups before or after the first phase 
shifting session. A two-way mixed ANOVA with Group as the between subjects variable, 
and Phase Shift (two levels) as the repeated measure, revealed no effect of phase shift 
[F(l,10)=4.57,/>=0.058], group [F(l,10)=1.40,/>=0.26] or interaction [F(l,10)=0.54, 
/>=0.48] (the baseline data from one Acute rat and the post 1 data from one Chronic 
animal were excluded from the analysis). However, there was a trend towards increased 
activity when the lights were turned on in both groups following the phase shift 
(p=0.058).
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Figure 3.2: Activity onsets and number of wheel rotations were recorded and averaged 
over the six days prior to phase shifting (baseline), and for the six days following each 
phase shifting session (post 1-4). The phase angle of entrainment for Acute and Chronic 
rats shows initial entrainment, then a delayed phase angle peaking after the second phase 
shift (A). The proportion of total activity occurring during light phase for Acute and 
Chronic rats shows initial low levels of light activity, followed by a significant peak in 
light activity following the second phase shift (B). Data are given as means +/- SEM.
To look at the effect of multiple phase shifts and recovery sessions on rhythm 
fragmentation, I further examined the light activity of the Chronic group. Following the 
first phase shifting session the proportion of light activity was increased, with 13.0% of 
activity occurring during the light phase (compared to the baseline light activity of 9.4%). 
The proportion of light activity was increased further after the second phase shift 
(29.5%), and then decreased following the third phase shift (15.2%), where it stabilized 
for the duration of the experiment (Figure 3.2B). A two-way mixed ANOVA with Group
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as the between subjects variable and Phase Shift (five levels) as the repeated measure 
revealed no effect of phase shift [F(4,16)=2.74,p=0.06] (the post 4 data from one rat was 
excluded), however, there was a trend towards increased activity when the lights were 
turned on following the second phase shift (p=0.06).
Water maze: Rapid Acquisition Task
Original location training
The chronic group had significantly longer latencies to find the platform on all 
days during original location training (Figure 3.3A). The latency (in seconds) to find the 
platform was recorded and averaged over the eight daily trials to obtain a single daily 
latency score for each animal. The daily scores for all four days of original location 
training were subjected to a two-way mixed ANOVA with Group (Control versus Acute 
versus Chronic) as the between subjects variable, and Training Day (four levels) as a 
repeated measure, and revealed a significant effect of group [F (2,19)=4.70,p<0.05] and 
of day [F(3,57)=97.74,p<0.01], but no interaction [F(6,57)=l. 16, p=0.34]. By the final 
day of training, the daily latency score for Chronic rats was more than twice as long as 
the averaged score for the other two groups (13.13 +/- 3.11 sec versus 5.70 +/- 0.76 sec). 
Tukey post hoes revealed that Chronic rats were impaired compared to the other groups 
(p5s<0.05).
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Figure 3.3: Chronic rats are impaired on the spatial water maze task when compared to 
Acute and Control rats. Both latency to platform and path length data is shown for 
Chronic, Acute and Control rats on original location training (A,B), new location training 
(C,D) and re-training to the original platform location (D,E). Data are given as means +/-
SEM.
I also measured the length of the path taken to find the hidden platform and found 
that while the chronically phase shifted rats appeared to have longer path lengths than 
Acute or Control rats this was not significant (3.3B). A two-way mixed ANOVA with 
Group as the between subjects variable and Training Day (four levels) as a repeated 
measure revealed a significant effect of day [F(3,57)=70.63,/><0.001], but no effect of 
group [F(2,19)=1.98,/?=0.17] or interaction [F(6,57)=0.81,/?=0.56]. My inability to find 
a difference in path length between groups was likely due to the slightly faster swim 
speeds of Acute (0.24 +/- 0.01 m/s) and Chronic rats (0.21 +/- 0.01 m/s) compared to 
Control rats (0.19 +/- 0.01 m/s) during original location training. A one way ANOVA
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with Group as the between subjects variable was used to assess swim speed and revealed 
a significant effect of group [ir(2,19)=5.46, j><0.05]. Tukey post hoes revealed that 
Control rats were significantly slower than both Acute and Chronic rats (p’s<0.05).
New location training
The platform was moved to the opposite quadrant of the pool and the latency and 
path length to find the new platform location was recorded and averaged into eight 
discrete trial blocks (two trials per block). The Chronic group was impaired in their 
ability to rapidly acquire a new platform location during this stage of this task when 
compared to the other groups (Figure 3.3C). By the final trial block, Chronic rats were 
still taking longer to find the platform (8.44 +/- 1.24 sec) than the averaged latency of the 
Control and Acute rats (4.31 +/-1.18 sec). A two-way mixed ANOVA with Group as a 
between subjects variable and Trial Block (eight levels) as a repeated measure, was used 
to assess the mass training and showed significant effects of group [F(2,19)=10.88, 
p<0.01], and of trial block [i7(7,133)=17.92,/?<0.01], but no interaction [F(14,133)=0.49, 
p=0.93]. Tukey post hoes revealed that Chronic rats were impaired compared to both 
Control and Acute rats (p’s<0.05).
The Chronic rats also had significantly longer path lengths than both Acute and 
Control rats on this stage of the water maze task (3.3D). A two-way mixed ANOVA with 
Group as the between subjects variable and Trial Block (eight levels) as the repeated 
measure revealed a significant effect of group [F(2,19)=6.09,/?<0.01] and of trial block 
[F(7,133)=16.31,/?<0.001], but no interaction [F(14,133)=0.66,/?=0.80]. Tukey post hoes 
showed that Chronic rats had significantly longer path lengths than Acute or Control rats
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(p’s<0.05). A one way ANOVA found no difference in swim speed on this day of 
training [A(2,19)=0.87, p=0.43].
Re-training to original location
The platform was returned to the original location (from stage 1) and the latency 
and path length to find this location was recorded over eight trials on the final day of 
testing. The results of the competition test are displayed in Figure 3.3E showing that the 
Chronic rats were still unable to learn the original platform location. By the final trial 
Chronic rats were taking more than twice as long as the averaged latencies of the Control 
and Acute rats (8.91 +/-1.36 sec versus 2.97 +/- 0.92 sec). A two-way mixed ANOVA, 
with Group as the between subjects variable, and Trial (eight levels) as a repeated 
measure revealed a significant effect of group [F(2,19)=6.22, p<0.01], and of trial 
[F(7,133)=5.35,/?<0.01], but no interaction [i7(14,133)=1.38,p=0.17]. Tukey post hoes 
revealed that Chronic rats were impaired compared to both other groups (p’s<0.05).
Chronic rats also had significantly longer path lengths during reversal training 
(3.3F). A two-way mixed ANOVA with Group as the between subjects variable and Trial 
(eight levels) as the repeated measure revealed a significant effect of group 
[F(2,19)=4.99,/?<0.05] and of trial [F(7,133)=4.26,p<0.001], but no interaction 
[A(14,133)=l .24, p=0.25]. Tukey post hoes found that Chronic rats had significantly
s
longer path lengths compared to both other groups (p’s<0.05). I assessed swim speed on 
this day and found that Chronic rats swam slightly faster than Control rats (0.24 +/- 0.01 
m/s versus 0.19 +/- 0.02 m/s), but were no different from Acute rats (0.22 +/- 0.02 m/s). 
A one way ANOVA was used to assess swim speed and revealed a significant effect of
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group [F(2,19)=3.65, p<0.05. Tukey post hoes showed Chronic rats to be significantly 
faster than Control rats, but no different from Acute rats (p’s<0.05).
To further assess the competition data, individual swim paths on the first trial 
were then analyzed to obtain a measure of the animal’s memory for the platform 
locations. The swim paths differed markedly between groups, with the Control and Acute 
animals swimming first to the new location, and then after failing to find the platform, 
swimming to the original location (Figure 3.4A, B). In contrast, the Chronic animals
appeared to have no clear representation of either location and either swam randomly 
throughout the pool before finding the platform, or swam to the new or original locations 
at chance levels (3.4C). In order to quantify this data, I chose to use quadrant entry as a 
categorical measure of platform memory. Each swim path was classed as new, original, 
or middle depending on which quadrant the rat first entered upon leaving the starting 
quadrant. These data were then subjected to a binomial test with the categories set as 
new or other (combined choice of original and middle), with a 0.33 expected probability 
of entering the new quadrant. The Control and Acute groups showed a clear preference 
for the new quadrant as 6 out of 7 Control rats (p<0.01), and 5 out of 7 Acute rats 
(p<0.05) entered the new quadrant first, whereas only 3 out of 8 Chronic animals entered 
the new quadrant first (p-0.524) (3.4D).
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Figure 3.4: Representative swim paths from each group show that Control (A) and Acute 
(B) rats swam first to the new platform, then headed towards the original platform 
location and escaped from the water, whilst Chronic (C) rats swam to the new platform at 
chance levels. The initial swim on the competition day of the spatial water maze was 
analyzed to determine platform preference (D). Data are given as means +/- SEM.
Fear Conditioning
Conditioning to tone
All groups were able to learn the tone-shock association, and showed an increase 
in freezing behaviour in the presence of the tone. The percentage of freezing during the 
first four minutes exposed to the tone was calculated and compared to the Context B 
habituation period. This percentage of freezing for all groups was significantly greater in 
the presence of the tone (76.37% +/- 4.72% versus 25.10% +/- 4.84%; Figure 3.5A). A 
two-way mixed ANOVA with Group as a between subjects variable, and Tone 
(habituation versus tone presentation) as a within subjects variable, revealed a significant 
effect of tone [F(l,26)=96.84,/?<0.01], but no group effect [F(2,26)=1.52,p=0.24] or 
interaction [F(2,26)=0.22, p=0.81 ].
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Conditioning to context
All groups were able to learn the context-shock association, and showed an 
increase in freezing behaviour when returned to Context A on day three. I measured a 
percentage freezing for the total time exposed to Context A on day three and compared it 
to the Context A habituation on day one. The percentage of freezing to context for all 
groups was significantly greater on day three compared to day one (74.57% +/- 3.52% 
versus 4.07% +/- 0.74%; Figure 3.5B). A two-way mixed ANOVA with Group as a 
between subjects variable, and Context (day one versus day three) as a within subjects 
variable, revealed a significant effect of context [F(l,26)=316.61,/?<0.01], but no group 
effect [F(2,26)=1.75,/?=0.19], or interaction [F(2,26)=1.87, p=0.17].
FEAR CONDITIONING TO TONE
100S
CONTROL ACUTE
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Figure 3.5: Performance on the fear conditioning task. There were no impairments in any 
of the groups on either fear conditioning to tone (A) or to context (B). Data are given as 
means +/- SEM.
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4. Discussion
Here I show the effects of acute versus chronic circadian disruption on measures 
of circadian rhythmicity and learning and memory in the rat. Following both acute and 
chronic phase shifting, the circadian rhythmicity of the animals was disrupted; however 
this disruption had differential effects on learning and memory dependent on how long 
the animal was subjected to phase shifting. Chronically phase shifted rats were severely 
impaired on both acquisition and retention of a platform location in the water maze, while 
the acutely phase shifted rats performed at control levels. There were some minor 
differences in swim speed, as the control rats were slightly slower than the acutely phase 
shifted group during acquisition, and slower than the chronically phase shifted group 
during the competition test. However, I do not believe these differences affected the 
overall pattern of results as both phase shifted groups had similar swim speeds overall.
No deficit was observed in the fear conditioning task, either to tone or to context, 
suggesting that the observed deficit was specific to hippocampal memory. These forms of 
fear conditioning (cued and contextual) are both dependent on the amygdala for 
successful learning (Fanselow et al., 1999; Ponnusamy et al., 2007). Contextual fear 
conditioning does have a hippocampal component, but when distinctly different contexts 
and multiple context-shock pairings are used (as was In the current study) the amygdala is 
able to successfully form an association without hippocampal involvement (Frankland et 
al., 1998; Wiltgen et al., 2006).
The ability of these animals to successfully learn the fear conditioning task also 
demonstrates that the observed impairment on the water maze was not simply a
85
performance deficit. The formation of a tone-shock and context-shock association 
requires motivation to learn, as well as intact motor and sensory skills. The impairment in 
spatial learning could not be explained by changes in measures of circadian health (phase 
angle of entrainment and rhythm fragmentation), as these measures were similar for both 
the unimpaired acute group and the impaired chronic group immediately prior to 
behavioural testing.
Circadian rhythms and phase shifting
I found that during the phase shifting procedure, animals dramatically changed 
their behaviour over the course of multiple phase-shifts. Non-phase shifted rats on a 
constant light/dark (L:D) schedule reliably begin wheel running at the same time each 
day, just after lights off (Turek et al., 1995; Antle and Mistlberger, 2005). This pattern of 
wheel running activity was observed in my animals prior to phase shifting demonstrating 
entrainment to the existing L:D schedule. However, following phase shifting, the changes 
in phase angle, and proportion of activity during the light phase in my animals suggests 
that their ability to maintain circadian rhythmicity had become compromised.
One powerful measure of the presence of the clock and circadian entrainment to 
an external zeitgeber is to look at an animal’s daily onset of activity. Responsiveness to 
zeitgebers, such as light, decreases with age and is a reliable indicator of an intact healthy 
clock (Turek et al., 1995). In young healthy animals, the phase angle of entrainment is 
extremely stable. However, changes in phase angle can be induced by both photic (e.g., 
phase shifting, light pulse) and non-photic (e.g., novel running wheel, food, receptive 
mate) stimuli (Janik et al., 1994, Turek et al., 1995). Re-entrainment following photic 
stimuli is variable and is dependent on the timing of the pulse or the size and direction of
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the phase shift. Tapp and Holloway (1981) reported that within five days, rats can re­
entrain following a single twelve hour phase shift. Devan et al. (2001) used a similar 
phase shifting paradigm to the one used in the current study, and found with this more 
extreme challenge to the circadian system, rats required eighteen days to fully re-entrain. 
By rapidly repeating phase shifts and recovery sessions, I was able to create a state of 
chronic circadian disruption where for sixty four days (Chronic group) rats were not 
given the opportunity to re-entrain. Even twenty six days following the final phase shift, 
my rats still demonstrated a delayed phase angle (data not shown).
Another reliable sign of circadian health is the presence of distinct activity-rest 
cycles that correspond with light and dark phases. In nocturnal animals the proportion of 
total activity occurring during the light phase is a good measure of rhythm fragmentation. 
Young healthy rats will show little or no activity during the light phase, restricting the 
majority of their activity to the dark phase. Aged animals, especially those with cognitive 
impairments, demonstrate fragmented rhythms, with activity spread throughout the 
twenty four hour period (Antoniadis et al., 2000; Pang et al., 2004). The most common 
complaints of AD patients are increased night time awakenings, and day time napping 
which are indicative of rhythm fragmentation. The connection between rhythm 
fragmentation and the severity of dementia tends to follow an inverted U curve with the 
most fragmented rhythms found in moderately demented patients (van Someren et al., 
1996). It remains to be seen whether the observed cognitive deficits lead to the disruption 
of circadian rhythms in these patients, or whether the long-term disruption of rhythms 
plays a role in the degeneration of memory processes in the elderly.
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Circadian rhythms and cognitive impairment
The idea that circadian disruption leads to cognitive impairment has been 
supported by a number of animal studies. Devan et al. (2001) demonstrated a deficit in 
long-term memory following six days of phase shifting in rats. Animals that were trained 
on the water maze task during the phase shifting session, and tested seven days later 
showed impaired retention for the platform location. This appeared to be a deficit in 
consolidation as opposed to impairment in retrieval as the result of being trained and 
tested at different circadian times. McDonald et al. (2002) subsequently confirmed this 
and showed no effect of circadian time on the performance of rats on multiple different 
memory tasks. In the current study, I have shown that when acutely phase shifted rats, 
after the same six days of circadian disruption, were trained and tested following ten days 
of recovery they were not impaired on this task. This suggests that ten days was sufficient 
time for cognitive processes to recover, even though the animals were not fully re­
entrained. I further demonstrated that the negative effects of long-term circadian 
disruption were present in my chronically phase shifted group, resulting in a severe 
deficit in both acquisition and retention of platform location in the water maze implying 
specific impairment in hippocampal function, as this group was able to successfully learn 
a hippocampal independent task (fear conditioning) immediately following water maze 
testing.
Other studies have shown cognitive impairments in both passive and active 
avoidance following a single phase shift. Tapp and Holloway (1981) found that this 
impairment was present both in rats with disrupted circadian rhythms (tested twenty four 
hours after the phase shift) and in rats that had been allowed to fully re-entrain (tested
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seven days after the phase shift). Fekete et al. (1985) phase shifted rats for varying 
lengths of time prior to training and found that three days was sufficient for rats to 
recover from the phase shift on measures of memory and task performance, however, re­
entrainment of circadian rhythms took longer. It seems that immediately phase shifting 
post training or a phase shift just prior to testing interferes with memory. The 
performance of my acutely phase shifted group agrees with these results as their training 
began ten days post phase shift, more than enough time for memory processes to recover, 
although re-entrainment was not complete.
The presence of recovery time after an acute challenge to the circadian system is 
enough to protect the animal from phase shift-induced memory deficits. However, even 
after ten days of recovery, chronic circadian disruption led to both an acquisition and a 
retention deficit as observed in chronically phase shifted rats. One weakness of the 
current study is the difference in housing conditions between the phase shifted groups 
(individually housed with a wheel) and the non-phase shifted controls (pair housed 
without a wheel). Voluntary wheel running has been shown to enhance performance on 
the water maze in both young and aged rats (Adlard et al., 2004; Vaynmann et al., 2004; 
Alaei et al., 2007). However, I do not believe that using control rats that were housed 
without a wheel has altered my main finding of a learning and memory deficit following 
chronic phase shifting. As there were no differences observed between control and acute 
animals, I focused on comparing acute and chronically phase shifted animals directly as 
both groups were housed with wheels. The memory deficits reported here in the chronic, 
but not the acute, group suggest that the longer an individual (human or non-human 
animal) suffers from circadian disruption, the greater the likelihood is that signs of
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dementia or cognitive impairments will develop. Taken together, these studies point 
towards a link between circadian disruption and impairments in learning and memory 
tasks.
Possible mechanisms for the negative effects of circadian disruption
Here I show that chronic, but not acute disruption of circadian rhythms severely 
impairs both acquisition and retention on a spatial memory task in the rat. Neither group 
demonstrated complete re-entrainment at the time of behavioural training and testing, and 
showed similar delays in activity onset, and increased proportion of light activity. 
Therefore, it is unlikely that differences in circadian phase or rhythm fragmentation are 
responsible for the impairments observed following chronic phase shifting. Instead, it is 
likely that long-term exposure to the negative effects of circadian dysfunction can result 
in impairment. These effects include chronic stress, changes in sleep quality and quantity, 
and changes in hormone levels such as melatonin, amongst others.
Chronic stress is a commonly proposed mechanism to explain the negative effects
of shift work and circadian disruption. High levels of stress have been reported by
individuals employed in shift work and Cho et al. (2000, 2001) found a correlation
between elevated cortisol levels, increased cognitive impairment and reduced right
medial temporal lobe volume in airline crews who had suffered from chronic circadian
* .disruption in the form of continual jet lag for over four years. Increases m stress and 
levels of stress hormones (cortisol in humans and corticosterone (CORT) in rats) have 
been linked to cognitive impairments and neuronal damage in both human and non­
human animals (McEwen and Sapolsky, 1995). Interestingly, elevated cortisol has also 
been observed in AD patients and has been hypothesized to play a role in the progression
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of this disorder and aid in the degeneration of the hippocampus (Davis et al., 1986;
Lupien etal., 1998).
Luine et al. (1996) examined the effects of stress on learning and memory in rats, 
using repeated daily sessions of restraint stress and then testing performance on a spatial 
radial maze task. They demonstrate that seven days of restraint stress had no effect, but 
fourteen days of restraint stress enhanced performance in the maze. However, twenty one 
days of stress resulted in a reversible impairment (requiring an eighteen day recovery 
period) (Luine et a l, 1994). McLay et al. (1998) then showed that following eighty days 
of daily CORT treatment, rats were impaired on the Barnes circular platform task, and 
this impairment persisted for at least two months. Although no CORT analysis was 
performed in this study, it is likely that an increase would be observed in my animals due 
to stresses resulting from the unpredictability of the L:D schedule and the animals’ 
inability to fully re-entrain. Future studies are required to perform a time course of blood 
sampling to determine CORT levels in my acutely and chronically phase shifted groups.
It would be interesting to discover whether a peak in CORT levels will correspond with 
the peak in delayed phase angle and light activity observed after the second phase shift.
A second possible way chronic circadian disruption could affect cognition is 
through associated sleep disturbances. Sleep disturbances have been shown to produce 
cognitive deficits (Rasch and Gais, 2006) and AD patients in particular tend to show 
reductions in both REM and non REM sleep, particularly Stage 4 slow wave sleep when 
memory consolidation is purported to occur (van Someren et al., 1993; Backhaus et al, 
2007). If this is the cause of the cognitive impairments observed in this study, similar 
results might be expected to be noted in both the acutely and the chronically phase shifted
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groups. Cognitive deficits that have been linked to sleep disturbances are associated with 
a lack of memory consolidation during slow wave and REM sleep, and can appear after 
as little as one night of disturbed sleep, making it unlikely that sleep loss alone is 
interfering with hippocampal processing in my study (Rasch and Gais, 2006). 
Alternatively, my results could be explained by the theory that over time, changes in the 
patterning of sleep, due to circadian disruption, could elicit abnormal firing in the 
hippocampus (Buzsaki, 1989; Stone, 1989) leading to interference with memory 
consolidation and possible epileptic activity which could further lead to tissue damage 
and memory loss (Sutherland et al., 1997; McDonald, 2002).
A third consequence of chronic circadian disruption is change in the level of, and 
secretion patterns of the hormone melatonin. Melatonin is crucial to the proper 
modulation of the SCN and plays an important anti-oxidant and neuroprotective role in 
the brain (McArthur et al., 1991; Antle and Mistlberger, 2005). Decreased levels of 
melatonin have been observed in the aged population, and more so in both pre-clinical 
and clinical Alzheimer’s patients, suggesting a potential link (Liu et ah, 1999; Wu et al., 
2003). In addition, this hormone has been shown to enhance behavioural recovery and to 
reduce damage resulting from stroke, Alzheimer’s disease and other neurodegenerative 
diseases in animals (Pei et al., 2003; Feng et al., 2004). Although the loss of melatonin 
may not directly cause cognitive deficits, with decreasing level of this hormone, 
individuals suffering from chronic circadian disruption may become more vulnerable to 
brain damage leading to memory loss or dementia.
These are only a few of the many contributors to the negative effects of circadian 
disruption and the most likely explanation will be a combination of these factors. While
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there have been no reports, to my knowledge, describing a causal link between circadian 
disruption and the appearance of AD pathology, many animal models of AD exhibit 
circadian disruption prior to the appearance of plaques and tangles (Vloeberghs et ah, 
2001; Pang et ah, 2004; Ambree et ah, 2006). The many side effects of circadian 
disruption are stress, decreases in melatonin secretion and sleep deprivation. While sleep 
deprivation has not been linked to the development of AD pathology, chronic stress has 
been found to increase both plaques and tangles in transgenic mouse models of AD 
(Green et ah, 2006; Jeong et ah, 2006; Rissman et ah, 2007). In addition, melatonin 
treatment can reduce the deposition of (3-amyloid in transgenic mouse models of AD and 
protect against oxidative stress (Matsubara et ah, 2003; Feng et ah, 2004). Further work 
using animal models should allow me to intensively study these alternative explanations. 
Conclusion
In conclusion, I have demonstrated a significant cognitive impairment in rats 
following chronic phase shifting. I propose that this deficit is partly the result of chronic 
stress due to the inherent unpredictability of phase shifting and an inability of the rat to 
fully re-entrain following each phase shift. However, the stress response is not the sole 
cause of this impairment. It is likely acting in combination with other negative effects 
resulting from chronic circadian disruption, such as alterations in sleep patterns and 
neuronal firing in the hippocampus, and decreases indie neuroprotective hormone 
melatonin. Future studies will explore these possible mechanisms, and begin to describe 
the brains’ unique response to circadian disruption. I believe that following more 
extensive phase shifting, this cognitive impairment will gradually increase in type and 
severity. These deficits may become more global over time, affecting attention, executive
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functioning and habit formation in addition to the spatial memory deficit reported here. 
The current findings describe a model that will allow me to further study the role chronic 
circadian disruption has in the development of cognitive deficits in the elderly.
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Chapter 4
Reduced cholinergic status in hippocampus produces spatial memory deficits when 
combined with kainic acid induced seizures
Modified from a paper published in Hivvocamvus. July 23, Epub ahead of print 
by Laura A. Craig, Nancy S. Hong, Joelle Kopp and Robert J. McDonald in 2008
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Abstract
Many risk factors have been suggested to increase the likelihood of developing 
Alzheimer’s disease (AD), but apart from rare cases of familial AD, no single factor has 
been shown to be causative on its own. One of these risk factors most commonly 
associated with Alzheimer’s disease is a loss of cholinergic activity in medial temporal 
structures such as the hippocampus. While the role played by this cholinergic depletion in 
the development of AD is unclear, one possibility is that it may increase hippocampal 
vulnerability to subsequent risk factors. One secondary risk factor that has been 
associated with AD is the presence of seizures, which can damage the hippocampus 
through excitotoxic cell death. To examine the interaction between these two common 
risk factors on hippocampal function and integrity, I gave rats a focal cholinergic lesion 
of the medial septum using the specific immunotoxin 192-IgG Saporin, followed two 
weeks later by a non-convulsive dose of kainic acid. I then assessed rats for seizure 
severity, hippocampal damage and performance on a spatial memory task. The 
combination of the two factors resulted in a trend towards increased seizure severity in 
the cholinergic depleted rats, but more importantly, following cholinergic depletion, rats 
that displayed non-convulsive seizure behaviour were significantly impaired on a spatial 
version of the water maze, but not on a cued version of this task suggesting impairment in 
hippocampal processing. Rats receiving either factor alone had no difficulty learning the 
spatial memory task. This result could not be explained by seizure severity or gross 
hippocampal damage, suggesting a more subtle interaction between these two risk factors 
is responsible for the development of a hippocampal based memory impairment.
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1. Introduction
There are several plausible hypotheses describing causative factors for 
Alzheimer’s disease (AD), but to date, no accurate etiology has been established. A 
model has been proposed by McDonald (2002) that places risk factors for AD into two 
groups; passive factors, such as cholinergic depletion, which can increase the 
vulnerability of hippocampal neurons, and active factors, such as seizures, that have the 
ability to directly disrupt learning and memory, through the death or dysfunction of 
hippocampal neurons. The interaction between these various factors should produce 
specific sub-types of the disorder depending on which factors are present, consequently 
affecting the diagnosis and future treatment choices for each group of patients.
A significant decline in acetylcholine in the brains of patients with AD was first 
reported in 1976 (Davies and Maloney, 1976) and this finding led to the cholinergic 
hypothesis of AD (Bartus et al., 1982; Gallagher and Comlombo, 1995; Mesulam, 2004). 
However, due to the variable success treating patients with cholinergic agonists, the focus 
of AD research has shifted away from this theory. However, the consistency of this 
depletion in AD patients suggests that, while not causative, levels of acetylcholine may 
have an important role to play in the development of this disorder, especially in the early 
stages (Bowen et al., 1992; Perry et al., 1992; Schliebs and Arendt, 2006). In addition to 
human AD patients, many of the transgenic mice developed to model AD, exhibit 
significantly reduced levels of acetylcholine in the brain, particularly in the hippocampus 
further strengthening the link between AD and cholinergic depletion (Morley, 2002; 
Belluci et al., 2006).
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A relationship between AD and late onset unprovoked seizures, has been 
suggested in both human and animal studies. A few studies have shown that individuals 
with epilepsy have a greater risk of developing AD (Breteler et al., 1995; Thompson and 
Duncan, 2005) and several clinical studies have found increases in the occurrence of 
seizures in patients suffering from AD when compared to non-demented age matched 
controls (Hauser et ah, 1986; Romanelli et al., 1990; Hesdorffer et al., 1996). In addition, 
several descriptions of transgenic mouse models of AD have reported increased 
susceptibility to seizures and lowered seizure thresholds, as well as increased 
hippocampal damage in response to kainic acid induced seizures (Guo et al., 1999; Del 
Vecchio et al., 2004). This increased susceptibility may be partially due to decreased 
levels of acetylcholine in these mice, as enhanced sensitivity to both hippocampal 
kindling (Kokaia et al., 1996; Ferencz et al., 1997; Ferencz et al., 2001) and generalized 
seizures (Silveira et al., 2000) have been demonstrated in rats following cholinergic 
depletion.
Due to the potential relationship between seizures, cholinergic depletion and 
individuals diagnosed with Alzheimer’s, I chose to look at the effects of a non-convulsive 
seizure induced by a systemic dose of kainic acid in rats following cholinergic depletion, 
on their ability to successfully leam a spatial version of the water maze. Non-convulsive 
seizures were used here as a risk factor instead of convulsive seizures due to the finding 
that animals that suffer convulsive seizures consistently display learning and memory 
impairment as well as significant hippocampal damage. I predict that following 
cholinergic depletion, animals will be more susceptible to seizures and that the
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combination of cholinergic depletion and seizures will impair performance in the water 
maze task.
2. Materials and Methods 
Animals
Forty seven male Long Evans hooded rats (300-400g; CCBN breeding colony) 
were pair housed in standard shoebox housing on a 12 hour light/dark cycle with food 
and water ad libitum. The rats were divided into four groups; rats receiving cholinergic 
depletion and kainic acid (AC-kainic; n=15), rats receiving sham surgery and kainic acid 
(Kainic; n=16), rats receiving cholinergic depletion only (AC; n=8) and untreated rats 
used as controls for behavioural testing (Control; n=8). All animals were cared for and 
handled in accordance to guidelines set forth by the Canadian Council for Animal Care. 
Surgery
Surgery was performed under Isoflurane anaesthesia (4% with 2.0 L/min of 
oxygen for induction and 2% after surgical plane was established) in a standard 
stereotaxic apparatus. An incision was made in the scalp and periosteum down the 
midline. The fascia was pushed to the edges of the skull with a sterile gauze swab and 
the skin retracted to expose the skull surface. Holes were drilled into the skull using a 1 
mm drill bit attached to a high speed drill. Following surgery all animals were given a 
single dose of buprenorphine (Temgesic; 0.1 mg/kg subcutaneously) as an analgesic. 
Cholinergic depletion
The specific neurotoxin 192 IgG Saporin (IgG SAP; Chemicon) has been 
commonly used to induce selective cholinergic lesions in rats depending on the site of 
infusion. I chose to damage cholinergic neurons in the medial septum and vertical limb of
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the diagonal band of Broca (MS/VDB) which leads to a reduction in levels of 
hippocampal acetylcholinesterase (AChE). I lowered a 30 gauge cannula, through holes 
drilled in the skull, into the MS/VDB (AP +0.45; ML +/-0.6; DV -6.6 and -8.0 mm from 
bregma and the skull) and bilaterally infused IgG SAP [0.15 pg/pl dissolved in sterile lx 
phosphate buffer saline (PBS; pH 7.4)] at a rate of 0.05 pl/min using a Harvard mini­
pump. Each animal received a total volume of 0.3 pi per side at the first injection site 
(DV -8.0), and 0.2 pi per side at the second site (DV -6.6). The cannula was left in place 
for six and four minutes after the first and second injection respectively to ensure 
diffusion of the toxin. Sham operated rats underwent the identical procedure, but were 
infused with lx sterile PBS instead of IgG SAP.
Seizures
Two weeks following surgery AC-kainic and Kainic animals were injected 
intraperitoneally with 6 mg/kg i.p. of kainic acid (Ocean Produce International) dissolved 
in sterile lx PBS and observed in clear Plexiglas boxes. This dose is considered to be 
non-convulsive in normal adult rats (Mikulecka et al., 1999; Gobbo and O’Mara, 2004). 
Video was recorded of the first ninety minutes and scored for seizure severity using a 
four point ranking scale based on Lothman and Collins (1981): 0-nothing, sleeping; 1- 
immobility, hunched posture, ‘staring’; 2-wet dog shakes; 3-mild limbic convulsions, 
automatisms; 4-severe limbic convulsions, rearing, bilateral clonus, salivation, loss of 
postural control. The highest seizure stage reached was recorded for each animal. 
Behavioural Testing
Behavioural testing began one week following injection with kainic acid and 
consisted of a six day version of the water maze task to test for deficits in hippocampal
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processing. A subset of AC-kainic and Kainic rats were also tested on a visible platform 
version of the water maze to test for general performance deficits.
Water maze: Rapid Acquisition Task
I used a three stage variant of the spatial version of the water maze task 
(McDonald et al., 2005). A white plastic circular pool 1.4 m in diameter and 40 cm deep 
was filled to within 20 cm of the top of the wall with water (20-22° C) made opaque by 
adding skim milk powder. The invisible platform was 12 cm in diameter and made of 
white Plexiglas with holes drilled into the top of it to provide grip for the animals.
During training the platform was submerged 2 cm under water. Extra-maze cues in the 
training room included five posters of different sizes and orientations mounted on three 
of the four walls, a computer rack, a door, an animal rack and the experimenter. Four 
different start points were used [N, S, E, W (not true compass headings)], equally spaced 
around the pool. The order was randomly selected for each day and each start point was 
used twice for day one to four and day six. On day five only the three start points farthest 
from the platform were used (N, E, S) with each start point used five times and the initial 
start point repeated at the end for a total of 16 trials.
In the first stage (Original location training) rats were trained over four days for
eight trials a day, to swim to a fixed, spatial location. Twenty four hours after completion
■*
of stage one; the second stage (New location training) began. This stage consisted of new 
spatial location training. The platform was moved to the opposite quadrant of the pool 
and animals were trained for sixteen trials within two hours on a single day to swim to 
the new platform location. Stage two allowed me to ask if rats could learn to go to a new 
location, during a single intensive training session. The third stage (Re-training to
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original location) occurred twenty four hours after stage two with the platform returned to 
its original (stage one) location and each animal was given eight trials. This stage allowed 
me to ask how the massed new location training during stage two affected relearning to 
the original location. The platform location for each stage is depicted in Figure 2.1.
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the rat to rapidly form a novel representation in a familiar context. For 
the third stage, the subjects’ are required to re-leam the original location (McDonald et 
al., 2005).
Data collection: A computer based rat tracker (VP118, HVS Image) was used to collect 
and analyze data obtained from an overhead video camera. If a rat did not reach the 
platform 60 seconds after release, the rat was guided manually to the platform (aided 
placement) and allowed to remain on the platform for 10 seconds before being removed 
to a holding cage until the next trial. For all three stages the measures of performance 
were latency to platform and path length to platform. Path length is a sensitive measure 
that can control for potential differences in swim speed.
Water maze: Visible platform
The visible platform version of the water maze task was used as a test of general 
performance, controlling for sensory, motor and motivation deficits. The same pool and 
room used for the spatial water maze task was used, except that the platform was made 
visible by attaching a 6 cm high black block to the top of the hidden platform. This block 
was raised 2 cm out of the water, allowing rats to easily see the platform. The visible
102
platform task was carried out on day 7 and consisted of two training sessions in a single 
day. Each session consisted of four trials (lasting 30 seconds) using each start point (N, 
W, E, S) once. The platform was placed in a novel location at the start of each training 
session to discourage the use of a spatial strategy in the second session.
Histology
Following behavioural testing all animals were sacrificed with an overdose of 
Euthanol and transcardially perfused with lx PBS followed by 4% (w/v) 
paraformaldehyde (PFA). The brains were carefully extracted and placed in 4% (w/v) 
PFA at 4°C for 24 hours. Brains were then transferred to a 30% (w/v) sucrose solution 
(sucrose was dissolved in lx PBS), containing 0.02% (w/v) sodium azide at 4°C for at 
least three days. Brains were sectioned on a freezing cryostat at 40 pm in a series of five. 
The first two sections of each series were mounted onto 1% (w/v) gelatin/0.2% (w/v) 
chromalum coated slides, while the third, fourth, and fifth series were stored in lx PBS 
containing 0.02% (w/v) sodium azide at 4°C until being processed for 
immunohistochemistry. The fifth series was not used in this experiment and was stored 
for future analyses.
Cresyl violet staining and volumetries
The first series was stained with Cresyl violet and analyzed to determine the 
extent of damage to the hippocampus. Working in a rostral-caudal direction, coronal 
sections were examined and at the first sign of hippocampal damage pictures were taken 
under a lOx objective to document the extent of the lesion. I continued to take pictures of 
every fifth section leaving approximately 200 pm between sections sampled to ensure no 
cell, or hippocampal region was counted twice. After all documentation of the damage
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for each subject in all of the sections was obtained (usually three to four sections),
t ;
volumetric analysis was completed manually using an AxioVision microscope with 
associated Axio Imager analysis software (version 4.3). Briefly, the extent of damage in 
the CA fields and dentate gyrus of the hippocampus were traced and a calculation of the 
volume of the lesion within the traced areas was obtained. The values from the traced 
areas were calculated by the computer software in millimetres squared. The total volume 
of damage for each animal was calculated and used to obtain an average for each group.
AChE staining
The second series was stained for AChE to get a qualitative image of cholinergic 
depletion in the hippocampus. I treated the slides for 30 minutes with 6.24 mg 
tetraisopropylpyrophosphoramide dissolved in 200 mL of distilled water, then rinsed the 
slides twice with distilled water and incubated them on a shaker table for four hours in a 
reaction mixture containing 5.72 g Trizma maleate, 2.04 g Trizma base, 100 mg 
acetylthiocholine iodide, 294 mg dihydrous tri-sodium citrate, 150 mg anhydrous cupric 
sulphate and 32.8 mg potassium ferricyanide dissolved in 200 mL distilled water (all 
chemicals were obtained from Sigma). Slides were rinsed twice with distilled water, and 
left to dry overnight, then cleared with HemoDe (Sigma) and coverslipped with Permount 
(Sigma) the next day.
Immunohistochemistry
The third and fourth series were processed for immunohistochemistry to 
determine the completeness and specificity of the cholinergic depletion. An antibody 
raised against parvalbumin was used to label y-aminobutyric acid (GABA)-ergic neurons, 
and one against choline acetyltransferase (ChAT) was used to label cholinergic neurons.
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Free floating sections were rinsed in lx PBS (pH 7.4), and then placed in a 3% (v/v)
H2O2 solution for four minutes to block endogenous peroxidases. After three washes in 
lx PBS, sections were blocked for 30 minutes in 15% (v/v) normal horse serum (for anti- 
parvalbumin; Vector Labs) or 15% (v/v) normal rabbit serum (for anti-ChAT; Vector 
Labs). Sections were incubated overnight in primary antibody [anti-ChAT polyclonal, 
1:1000 (Chemicon) or anti-parvalbumin monoclonal, 1:5000 (Sigma)] diluted in lx PBS 
with 7.5% (v/v) serum (horse for anti-parvalbumin; rabbit for anti-ChAT). Sections were 
then washed three times in lx PBS and incubated for 30 minutes in a biotinylated 
secondary antibody (ABC Elite Kit, Vector Labs), washed three times in lx PBS, 
incubated for 30 minutes with AB reagent (ABC Elite Kits, Vector Labs), washed three 
times in lx PBS then developed with 3,3’-diaminobenzidine (DAB) substrate according 
to the manufacturer’s instructions (Vector Labs). Sections were then mounted onto 1% 
(w/v) gelatin/0.2% (w/v) chromalum coated slides, air dried overnight, then dehydrated in 
alcohol, cleared in HemoDe (Sigma) and coverslipped with Permount (Sigma).
Cell counts: Under light microscopy (AxioVision) ChAT positive neurons were counted 
in both hemispheres of the MS/VDB. I chose two sections to quantify; the first, at the site 
of injection and the second, in a section 200 pm caudal to the injection site. This 
quantification was not used as an accurate count of MS/VDB neurons, but instead to 
estimate the completeness of the cholinergic depletion. Each hemisphere was counted 
separately to confirm lesion symmetry, after which counts for both hemispheres were 
then totaled for a representative cell count over the two sections.
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3. Results
Two rats assigned to the AC-kainic group were removed from this experiment due 
to incomplete cholinergic lesions (<40% depletion) leaving a total of 13 rats in this 
group.
Seizures
Following the injection of kainic acid (6 mg/kg i.p.), most rats had mild non- 
convulsive (stage 1 or 2) seizures consisting of freezing, and wet dog shakes which are 
common observations during kainic acid induced seizures in rats. A few animals in each 
group (4 out of 16 Kainic (25%) and 6 out of 13 AC-kainic rats (46.2%) displayed 
convulsive (stage 4) seizures characterized by bilateral forelimb clonus and rearing, 
followed by loss of postural control and hindlimb clonus. One AC-kainic and one Kainic 
rat died following two hours of continual convulsions and were not used for further 
analysis. Animals were divided by seizure type (convulsive or non-convulsive) and I 
found that although it appeared that rats were more likely to have a convulsive seizure in 
response to kainic acid following cholinergic depletion, compared to those having a sham 
surgery, this was not significant. An independent samples t-test was performed and found 
no difference in seizure severity between groups [t (27) = 1.21,/?=0.236; Figure 4.1].
Water maze: Rapid Acquisition Task
•»
Because of the small number of surviving rats that had convulsive seizures and to 
control for the effect of seizure severity on behavioural testing, I decided to exclude all 
rats that had a convulsive seizure from subsequent analysis. Convulsive seizures induced 
by systemic kainic acid have been previously shown to cause hippocampal damage as 
well as cognitive and performance deficits on hippocampal memory tasks (Milgram et
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al., 1988; Gayoso et al., 1994). The following histological and behavioural analyses 
included seven AC-kainic rats, twelve Kainic rats, eight AC rats and eight Control rats.
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Figure 4.1: Following injection with a non-convulsive dose of kainic acid, 46.2% of AC- 
kainic rats and 25.0 % of Kainic rats had fully convulsive seizures. The remainder of the 
rats displayed behavioural signs indicative of non-convulsive seizures. Though there was 
a trend towards greater seizure severity in the AC-kainic group, there was no significant 
difference between groups. Data are given as means +/- SEM.
Original location training
The results of the original platform location training are depicted in Figure 4.2A. 
The AC-kainic group was significantly impaired on all days in their ability to learn the 
platform location during original location training when compared to the AC, Kainic and 
Control groups. The latency (in seconds) to find the platform was recorded and averaged 
over the eight daily trials to obtain a single daily latency score for each animal. The daily 
scores for all four days of acquisition were subjected to a two-way mixed analysis of 
variance (ANOVA) with Group (AC-kainic versus AC versus Kainic versus Control) as 
the between subjects variable, and Training Day (four levels) as a repeated measure, and 
revealed a significant effect of group [,F(3,31)=17.53,/><0.01] and of day 
[F(3,93)=l 03.96,/K0.01], but no interaction [F(9,93)=l .89, p=0.06]. By the final day of 
training, the daily latency score for AC-kainic rats was almost twice as long as the
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averaged score for the other three groups (15.23 +/- 3.25 seconds versus 6.79 +/-1.00 
seconds). Tukey post hoes revealed that AC-kainic rats were impaired compared to all 
other groups (p’s<0.01).
I also measured the length of the path taken to find the hidden platform and found 
that AC-kainic rats had significantly longer path lengths than Kainic, AC or Control rats 
(4.2B). A two-way mixed ANOVA with Group as the between subjects variable and 
Training Day (four levels) as a repeated measure revealed a significant effect of group 
[F(3,31)=8.80,/?<0.01] and day [F(3,93)=89.37,p<0.001], but no interaction 
[F(9,93)=1.06,/?=0.40]. Tukey post hoes revealed that AC-kainic rats had significantly 
longer path lengths than any of the other groups (p’s<0.05). A one way ANOVA found 
no difference in swim speed on this stage of training [F(3,31)=1.00,/>=0.40].
New location training
The platform was moved to the opposite quadrant of the pool and the latency (in 
seconds) to find the new platform location was recorded and averaged into eight discrete 
trial blocks (two trials per block). The AC-kainic group was impaired in their ability to 
rapidly acquire a new platform location on this stage of this task when compared to all 
other groups (Figure 4.2C). By the final trial block, AC-kainic rats were still taking 
longer to find the platform (15.75 +/- 7.65 seconds) than the averaged latency of the other 
three groups (4.38 +/- 0.44 seconds). A two-way mixed ANOVA with Group as a 
between subject variable and Trial Block (eight levels) as a repeated measure, was used 
to assess new location training and found a significant effect of group [F(3,31)=7.54, 
p<0.01] and of trial block [F(7,217)=45.12,/?<0.01], but no interaction [F(21,217)=1.32,
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p=0.17]. Tukey post hoes revealed that AC-kainic rats were impaired compared to all 
other groups (p’s<0.01).
ORIGINAL LOCATION TRAINING ORIGINAL LOCATION TRAINING
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Figure 4.2: AC-kainic rats have longer latencies and path lengths to find the hidden 
platform on all stages of the spatial water maze task. AC-kainic rats are significantly 
impaired compared to AC, Kainic and Control rats during original location training (A, 
B), new location training (C, D) and re-training to the original location (E, F). Data are 
given as means +/- SEM.
The AC-kainic rats also had significantly longer path lengths than Kainic, AC and 
Control rats on this stage of the water maze task (4.2D). A two-way mixed ANOVA with 
Group as the between subjects variable and Trial Block (eight levels) as the repeated 
measure revealed a significant effect of group [F(3,31)=9.77,/?<0.001], of trial block 
[F(7,217)=32.07,p<0.001], but no interaction [F(21,217)=1.01,p=0.46]. Tukey post hoes
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showed AC-kainic rats to have longer path lengths than all other groups (p’sO.05). A 
one way ANOVA found no difference in swim speed on this day of training 
[F(3,31)=2.43,/>=0.08].
Re-training to original location
The platform was returned to the original location (from stage one) and the 
latency and path length to find this location was recorded over eight trials on the final day 
of testing. The results of the re-training to original location trials are displayed in Figure 
4.2E showing that the AC-kainic rats were impaired in their ability to re-leam the original 
platform location. A two-way mixed ANOVA, with Group as the between subjects 
variable, and Trial (eight levels) as a repeated measure revealed a significant effect of 
group [F(3,30)=3.04, ;?<0.05], and of trial [F(7,210)=14.27,p<0.01], but no interaction 
[F(21,210)=0.97, j9=0.50]. Holm-Bonferroni post hoes revealed that AC-kainic rats were 
impaired compared to all other groups (p’s<0.05).
There was a trend towards longer path lengths in the AC-kainic rats during re­
training but this did not reach significance (4.2F). A two-way mixed ANOVA with 
Group as the between subjects variable and Trial (eight levels) as the repeated measure 
revealed a significant effect of trial [F(7,210)=T 1.02,/><0.001], a nearly significant effect 
of group [F(3,30)=2.83,/?=0.06], but no interaction [F(21,210)=0.85,jp=0.65]. I assessed 
swim speed on this day and found no difference in swim speed on this day of training 
[F(3,31)=1.66, p=0.20].
To further assess the competition data, individual swim paths on the first trial 
were analyzed to obtain a measure of the animal’s memory for the platform locations.
The swim paths differed markedly between groups, with the Control, AC and Kainic
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animals swimming first to the new location, and then after failing to find the platform, 
swimming to the original location (Figure 4.3A-C). In contrast, the AC-kainic animals 
appeared to have no clear preference, and swam to either the original or the new location 
at chance levels (4.3D). In order to quantify these data, I chose to use quadrant entry as a 
categorical measure of platform memory. Each swim path was classed as new, original, 
or middle depending on which quadrant the rat first entered upon leaving the starting 
quadrant. These data were then subjected to a binomial test with the categories set as 
new or other (combined choice of original and middle), with a 0.33 expected probability 
of entering the new quadrant. The Control, AC and Kainic groups showed a clear 
preference for the new quadrant as seven out of eight Control, seven out of eight AC, and 
ten out of twelve Kainic rats (p<0.05) entered the new quadrant first. The AC-kainic 
animals appear to have no clear preference and swim to either the new or original 
quadrant at chance levels as only four out of seven rats entered the new quadrant first 
(p=0.17; 4E).
The performance of rats on this hippocampal dependent task following cholinergic 
depletion combined with non-convulsive seizures was significantly compromised. All 
three stages of this task were affected. AC-kainic rats were delayed during original 
location training and in their ability to learn a new location in a single day. An analysis of 
swim paths on the final day of testing revealed no clear memory for either of the 
locations, in contrast to the performance of Control, AC and Kainic groups that showed a 
clear preference for the most recently learnt location.
I l l
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Figure 4.3: Representative swim paths from each group show that Control (A), AC (B) 
and Kainic (C) rats swam first to the new platform, then headed towards the original 
platform location and escaped from the water, while AC-kainic rats swam to either 
location at chance levels (D). The initial swim on the competition day of the spatial water 
maze was analyzed to determine platform preference (E). Data are given as means +/-
SEM.
Water maze: Visible Platform Task
■*
I tested a subset of AC-kainic and Kainic rats on the visible platform task to determine 
whether changes in motivation or sensory and motor deficits were responsible for the 
observed impairment in the spatial water maze. No difference between groups was 
observed (Figure 4.4) and the latencies were comparable to those previously reported for 
AC and Control rats tested on a similar paradigm (Craig et al. submitted). A two-way
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mixed ANOVA with Group (AC-kainic versus Kainic) as the between suhjects variable 
and Session (two levels) as the repeated measure revealed a significant effect of session 
[F(l ,9)=9.63, /><0.05], but no effect of group [F(l,9)=0.54,/>=0.48] or interaction 
[F(l,9)=1.44,/>=0.26]. Follow up Tukey post hoes showed both groups had significantly 
shorter latencies during the second training session (p’s<0.05).
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Figure 4.4: There were no differences between Kainic and AC-kainic rats on a visible 
platform version of the water maze, suggesting the observed impairment in the spatial 
water maze was due to a hippocampal specific deficit. Data are given as means +/- SEM.
Histology
Quantification o f the cholinergic lesion in the medial septum
I confirmed the completeness and specificity of the cholinergic lesion in the 
medial septum of both AC and AC-kainic groups through AChE staining and 
immunohistochemistry for ChAT and parvalbumin. Following cholinergic depletion, 
animals had very few ChAT positive cholinergic neurons (Figure 4.5A-C) combined with 
intact parvalbumin labeled GABA-ergic neurons (4.5D-F) confirming the specificity of 
the cholinergic lesion. The AChE staining clearly showed a depletion of cholinergic 
activity in the hippocampus of all lesioned animals compared to the sham operated group
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(4.5G-I).
Figure 4.5: Photomicrographs of anti-ChAT labeling in the MS/vDB from a Kainic rat 
(A), an AC rat (B) and an AC-kainic rat (C) confirm the near total loss of cholinergic 
neurons in this area following infusion of IgG SAP. Anti-parvalbumin labeling in the 
MS/vDB from a Kainic rat (D), an AC rat (E) and an AC-kainic rat (F) confirm the 
specificity of this lesion to cholinergic neurons, while sparing GABA-ergic neurons. The 
normal AChE staining apparent in the dorsal hippocampus of a Kainic rat (G) is 
dramatically reduced following cholinergic depletion in the hippocampus of an AC rat
(H) and an AC-kainic rat (I). Scale bars, 0.1 mm (A-F) and 1.0 mm (G-I).
■»
I quantified the extent of the cholinergic lesion by comparing the ChAT positive 
cell counts between groups. To control for any possible effects of systemic kainic acid on 
the number of cholinergic neurons in the medial septum, I used the ChAT positive cell 
counts from the Kainic group to determine a percent depletion for the AC-kainic group 
and used the cell counts from the Control group to determine the percent depletion for the
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AC group. I found 90.11 +/- 7.26 % depletion in the AC-kainic group and 96.81 +/- 
1.75% depletion in the AC group (Two AC-kainic rats had incomplete lesions with less 
then 40% depletion and were removed from the study). There were significantly fewer 
cholinergic neurons in the AC and AC-kainic groups compared to the Kainic and Control 
groups (Table 4.1). A one way ANOVA revealed a significant effect of group 
[F(3,30)=72.09,/><0.01]. Tukey post hoes showed that there were no differences between 
the extent of the depletion in AC and AC-kainic groups, and both groups had 
significantly fewer ChAT positive cells than either the Kainic or Control groups 
(p’s<0.05; Figure 4.6)
Table 4.1: The number of cholinergic neurons in the medial septum totaled over two 
sections in both lesioned and sham operated rats.
Group Number of ChAT positive neurons
Section 1 Section 2 Total
Control 125.00 +/- 12.29 129.71 +/-19.06 254.71 +/- 25.99
Kainic 160.17 +/-14.34 169.17 +/-12.60 329.33 +/- 18.03
AC 8.13+/-4.45 0.00 +/- 0.00 8.13+/-4.45
AC-kainic 10.29 +/- 4.55 22.29+/-21.30 32.57 +/- 23.91
Data are given as means +/- SEM. Control rats are from a separate experiment and 
included only as a general comparison.
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Figure 4.6: Choline acetyltransferase (ChAT) positive cell counts show a clear depletion 
in AC (97%) and AC-kainic (89%) rats compare to Kainic and Control rats. Control rats 
are from a separate experiment and included only as a general comparison. Data are 
given as means +/- SEM.
Lesioned animals had areas of necrotic cell death in the MS/VDB surrounding the 
injection site. This non-specific damage has been reported previously (Heckers et al., 
1994; Frick et al., 2004) and work in our laboratory has shown no correlation between 
lesion size (due to focal necrosis following infusion of the toxin) and water maze 
performance (data not shown).
Analysis o f hippocampal damage
The hippocampus was visually inspected under light microscopy in the Cresyl 
violet stained sections, and revealed damage related to seizure severity. Both AC-kainic 
and Kainic rats having non-convulsive seizures had little or no damage to CA1, CA2, 
CA3 or the dentate gyrus. There was some minor thiqning of CA1 in a small number of 
animals in both groups but the majority of the animals had no apparent damage (Figure 
4.7A-B). A volumetric analysis was performed to quantify lesion damage and found no 
difference in hippocampal damage between AC-kainic or Kainic rats without convulsions 
(AC-kainic: 4.48 +/- 4.16 mm2 and kainic: 0.00 +/- 0.00 mm2). A one way ANOVA was
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performed and found no effect of group [F(l,15)=2.83,/?=0.11]. Both AC-kainic and 
Kainic rats that had convulsions showed the characteristic damage to CA1 and CA3 that 
results from systemic kainic acid injection (data not shown). AC-kainic rats appeared to 
have greater amounts of damage than sham operated Kainic rats; however, the small 
number of surviving rats with convulsions did not allow for a quantitative comparison of 
hippocampal damage between groups.
Figure 4.7: Photomicrographs (5x) of Cresyl Violet stained hippocampal sections from a 
Kainic rat without convulsions (A) and a AC-kainic rat without convulsions (B). Both 
groups show no damage or disruption to the hippocampal cell layers. Scale bars, 0.1 mm.
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4. Discussion
The results of the present study show an interesting interaction between the 
cholinergic system and seizure activity on learning and memory. Previous work in our 
laboratory has shown no functional impairment on this task following cholinergic lesions 
alone (Craig and McDonald, 2006; Craig et al., 2008) which is consistent with the 
literature (Baxter and Gallagher, 1996; Frielingsdorf et al., 2005). The present study 
reports no deficit following the low dose of kainic acid used in sham operated animals, 
which confirms previous behavioural studies of rats injected with non-convulsive doses 
of kainic acid (Gobbo and O’Mara, 2004). Interestingly, in the present study, the 
combination of these two factors results in a significant impairment on the spatial water 
maze. The lesioned animals with convulsions performed at a level consistent with reports 
on rats following convulsive doses of kainic acid (data not shown). Gayoso et al. (1994) 
showed that while animals treated with a convulsive dose of kainic acid were initially 
severely impaired they were able to learn the task after intensive training. This is 
supported in my study, where the shortened original location training stage revealed the 
greatest difference between groups, but during new location training (massed training in a 
single session), both subgroups of the AC-kainic group performed at a similar level likely 
due to the extensive training period (data not shown). Nonetheless, all AC-kainic rats 
were impaired compared to Control, AC and Kainic rats. The novel finding here is the 
deficit observed in my non-convulsive lesioned rats. The combination of these two 
factors (cholinergic depletion and seizures) significantly impairs performance, while 
either factor alone has no effect.
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It is important to note that the behavioural deficit observed here was not due to 
seizure severity. Gobbo and O’Mara (2004) showed that following a low dose of kainic 
acid, which causes non-convulsive seizures, there were no impairments when rats were 
trained and tested in the water maze, whilst in animals exhibiting convulsive seizures 
there were distinct impairments. Although, the animals having convulsive seizures in my 
study performed worse than those having non-convulsive seizures, there was still a 
significant difference between the AC-kainic and Kainic groups on all aspects of the 
water maze task. This lends support to McDonald’s co-factors theory (McDonald, 2002) 
that defines risk factors for AD as either passive factors that can increase the vulnerability 
of hippocampal neurons, yet have no noticeable effect on hippocampal memory, or active 
factors that have the potential to directly damage neurons and impair memory.
Here, the cholinergic depletion is acting as a passive factor by increasing the 
vulnerability of hippocampal neurons to an active factor (kainic acid induced seizures). I 
used a non-convulsive dose of kainic acid that does not affect spatial memory, to allow 
for the appearance of impairment in the cholinergic depleted rats, without the risk of 
masking by a previously existing deficit. My finding suggests that depleted rats were 
more vulnerable than sham operated rats to the effects of kainic acid on learning and 
memory. There was little gross neuronal damage observed in the hippocampus of 
depleted rats that could explain the observed impairment; however, the presence of this 
spatial memory deficit suggests a more subtle mechanism is being affected by these two 
co-factors leading to the disruption of hippocampal processing in rats following 
cholinergic depletion and kainic acid. While there are many studies that have correlated 
the amount of brain damage with the extent of behavioural impairment (Kiyota et al.,
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1991; Nedelmann et al., 2007), there have also been a significant number of studies 
reporting a behavioural deficit in the absence of increased damage (Jaspers et al., 1990; 
Walh et al., 1991; Yamaguchi et al., 1995). The observation that performance is not 
always correlated with the amount of damage stresses the importance of using both 
histological and behavioural measures when assessing impairment and the value of future 
studies designed to detect subtle changes in hippocampal processing.
Cholinergic depletion and seizure severity
Several researchers have found an enhancement of hippocampal seizure activity 
or increased vulnerability to seizures following cholinergic depletion (Kokaia et al.,
1996; Ferencz et al., 1997; Silveira et al, 2000; Ferencz et al., 2001).The mechanism by 
which cholinergic depletion is thought to influence seizure activity is via the cholinergic 
projections from the medial septum to the hippocampus. These projections play an 
important role in hippocampal excitability. Jouvenceau et al. (1996, 1997) demonstrated 
that removal of the cholinergic projections to the hippocampus resulted in an enhanced 
response to glutamate in a slice preparation, even though GABA-ergic and inhibitory 
responses remained normal. This agrees with the increased susceptibility to kindled, 
pentylenetetrazole- or flurothyl- induced seizures in animals lesioned with IgG SAP 
where the GABA-ergic projections remain intact (Kokaia et al., 1996; Silveira et al., 
2000). Furthermore, the finding that the progression of kindling is unaltered in rats 
following cholinergic depletion suggests a quantitative change in excitability, rather than 
a qualitative change in connectivity (Kokaia et al., 1996; Ferencz et al., 2001). Taken 
together these findings would have predicted an increased susceptibility to kainic acid (a 
glutamate agonist) in the lesioned animals used in the current study, but this was not the
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case. Although there was a trend towards increased seizure severity in rats following 
cholinergic depletion in my study, this was not significant.
There are a few possible explanations for not observing increased seizure severity 
in my lesioned rats. First, I specifically damaged cholinergic neurons of the medial 
septum and this may not have been sufficient to lower the seizure threshold to systemic 
kainic acid. While a specific lesion of medial septal cholinergic neurons accelerates 
hippocampal kindling (Ferencz et al., 2001), reports examining generalized seizures 
induced by treatment with flurothyl or pentylenetetrazole have only been carried out in 
rats with complete lesions of the basal forebrain cholinergic neurons that project to the 
cortex as well as the hippocampus (Silveira et al., 2000). It is possible that the additional 
cortical depletion may create a more permissive environment for the spread of seizure 
activity leading to an increased response to seizures induced by systemic administration 
of epileptogenic chemicals. Alternatively, this is the first study to examine the effects of a 
non-convulsive dose of kainic acid in cholinergic depleted rats. The low dose used may 
not have been close enough to the convulsive threshold to allow me to see any effect of 
cholinergic depletion.
I have chosen to look at the interaction between cholinergic depletion and seizures 
because of the clinical observation of increased occurrences of seizures in patients 
suffering from AD, and increased risk of AD in individuals with epilepsy. The increased 
incidence of seizures in AD patients is likely due to a number of co-existing risk factors, 
not only cholinergic depletion of the medial septum as was modeled here. However, I 
was interested to see whether there was an interaction between these two factors in the 
development of cognitive impairment. While I did not observe increased seizure
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susceptibility in my model, I did see a deficit in spatial memory suggesting that 
hippocampal impairment was a result of the interaction between these risk factors. It is 
possible that additional doses of kainic acid would accelerate epileptogenesis in 
cholinergic depleted rats and lead to increased neuronal damage, but fixture studies are 
required to fully understand the relationship between cholinergic neurons of the medial 
septum and the response to kainic acid.
The excitotoxicity theory of neurodegenerative diseases
The excitoxicity theory of neurodengerative diseases has received a lot of 
attention. Essentially, this theory suggests that increases in glutamate leads to cell death, 
which releases more glutamate in a continual cycle. The detrimental effects of 
cholinergic depletion and seizures fit in nicely with this theory. Cholinergic depletion 
enhances the release of hippocampal glutamate, while simultaneously increasing the 
response to glutamate. This combined with seizure activity, will further increase the 
amount of glutamate, leading to more extensive hippocampal damage than either factor 
alone. Lothman and Collins (1981) have reported that it is the convulsive nature of the 
seizures that is required for neuronal cell death, rather than the absolute dose of kainic 
acid. The low dose of kainic acid used in the current study did not produce hippocampal 
damage in the absence of a convulsive seizure, but in combination with cholinergic 
depletion of the medial septum, does lead to behavioural deficits on a task reliant on the 
hippocampus. In addition, I have observed a trend towards increased hippocampal 
damage in lesioned rats that had a convulsive seizure compared to non-lesioned rats (data 
not shown). Over time seizures may become more frequent and would increase the 
amount of damage to other areas of the brain, negatively affecting different memory
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systems located in anatomically distinct areas. Geddes and Cotman, (1986) reported that 
AD patients had an expanded distribution of the kainate receptor field in the dentate 
gyrus, making them more sensitive to the excitotoxic effects of glutamate. The recent 
effectiveness of the non competitive glutamate antagonist, memantine, in treating 
moderate to severe cases of AD lends further support to this theory (Reisberg et al., 2003; 
Tariot et al., 2004).
Support for the multiple combinations of co-factor theory of aging
This study provides support for the co-factor theory proposed by McDonald 
(2002). By combining two distinct factors at a dosage that have no effect on performance 
on their own, I observe a deficit on hippocampal specific behaviour in the absence of any 
gross neuronal damage. Additional support for this model has been provided combining 
a number of other risk factors for AD such as aging and mild ischemia (Driscoll et al., 
2007), stress and mild ischemia (McDonald et al., 2008) as well as cholinergic depletion 
and stress (Craig et al, 2008). While the effect of these combinations on hippocampal 
pathology can vary between dramatically ramping up lesion size (Driscoll et al., 2007; 
McDonald et al., 2008), to no obvious damage (Craig et al., 2008), the appearance of a 
deficit on hippocampal based tasks remains constant. Taken together, these studies 
suggest that although the many risk factors for AD are all capable of producing cognitive 
impairment, the underlying mechanism or extent of neuronal damage varies depending on 
the risk factors present. This has important implication for designing both preventative 
and reactive treatment plans for individuals at risk for, or suffering from AD.
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Conclusion
Here I show that the combination of two risk factors for AD (cholinergic 
depletion and non-convulsive seizures) can lead to cognitive deficits on a task designed 
to test hippocampal function. I believe that the loss of cholinergic projections to the 
hippocampus have rendered this region increasingly vulnerable to the effects of seizure 
activity on learning and memory. While I am not arguing that seizures ‘cause’ AD, or 
dementia, I am proposing that the presence of late onset seizures are contributing to the 
memory deficit and eventual hippocampal damage of an individual who may be in the 
early stages of AD, or simply, due to a depletion of acetylcholine, be more vulnerable to 
the effects of excitotoxic activity in the brain. For example an individual may present as 
non- or mildly demented for years with a depleted cholinergic system; then, following the 
occurrence of an unprovoked spontaneous seizure, would likely have an exaggerated 
response in terms of cognitive impairment, seizure severity and/or hippocampal damage. 
This could lead to the expression of early signs of a subtype of AD. This individual 
would require a different treatment program from an individual with a preponderance of 
genetic factors even though both patients ultimately are diagnosed with AD.
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Chapter 5
Selective lesion of medial septal cholinergic neurons followed by a mini-stroke impairs
spatial learning in rats
Modified from a paper submitted to Experimental Brian Research 
by Laura A. Craig, Nancy S. Hong, Joelle Kopp and Robert J. McDonald in 2008
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Abstract
Reduced levels of hippocampal acetylcholine are a common finding in patients diagnosed 
with Alzheimer’s disease, but it remains unclear what role this depletion plays in the 
development of dementia. It is possible that reduced levels of acetylcholine increases the 
vulnerability of hippocampal neurons to future insults, which could lead to neuronal 
death and cognitive impairment. One insult that is commonly observed in the demented 
elderly and often co-exists with Alzheimer’s disease is stroke. In the current experiment,
I used the immunotoxin 192 IgG Saporin to specifically lesion the cholinergic neurons of 
the medial septum that project to the hippocampus. I then explored the effects of small, 
localized strokes in the hippocampus on a spatial learning task. The combination of 
cholinergic depletion and stroke resulted in significant impairment on the spatial water 
maze compared to the performance of rats receiving either factor alone. Volumetric 
analysis of the hippocampus revealed no difference in the overall lesion size of stroke- 
only or combined (cholinergic depletion and stroke) rats, suggesting that a more subtle 
mechanism is responsible for the observed impairment. I propose that healthy 
hippocampal neurons may normally be able to withstand, and compensate for a small 
ischemic insult. However, in the absence of cholinergic projections from the medial 
septum, these compensatory processes in the hippocampus may be compromised 
resulting in the spatial learning impairment reported here. This suggests an association 
between the cholinergic depletion observed during aging and the potential for functional 
recovery following stroke.
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1. Introduction
The characteristic pathology of Alzheimer’s disease (AD) (amyloid plaques, 
neuritic tangles and reduction in acetylcholine levels) has been well described over the 
past 30 years; yet the etiology of this disorder remains a mystery. Several single factor 
theories of causation have been proposed but the most plausible theories describe a 
combination of multiple factors that can produce specific sub-types of this disorder. The 
combination of factors present will consequently affect the diagnosis and future treatment 
choices for each group of patients (McDonald, 2002).
One of the risk factors for AD is a loss of cholinergic neurons of the basal 
forebrain and there is a significant decline in acetylcholine (ACh) in the brains of patients 
with AD (Davies and Maloney, 1976; Gallagher and Colombo, 1995; Mesulam, 2004). 
Unfortunately, treating AD patients with cholinergic agonists has had varying success at 
slowing the progression of this disorder, suggesting that the loss of ACh is not causative 
on its own. Nevertheless, the consistency of this depletion in AD patients suggests that 
levels of ACh may have an important role to play in the development of this disorder, 
especially in the early stages. In addition to human AD patients, many transgenic mice 
developed to model AD, exhibit significantly reduced levels of ACh in the brain, 
particularly in the hippocampus further strengthening the link between AD and 
cholinergic depletion (Morley, 2002; Belluci et al., 2006).
Another risk factor that has been consistently linked with dementia is stroke. 
Cortical and subcortical infarcts resulting from “silent” stroke have become increasingly 
common in the elderly population (Shi et al., 2000). While current diagnoses of AD 
specifically exclude cases with co-existing vascular disease, it is impossible to ignore the
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significance of the finding that mixed dementia (both vascular and AD pathology in an 
individual) is the most common form of dementia (Scheinder et al., 2007), and that the 
presence of vascular disease, or stroke increases the chances of developing AD and the 
eventual severity of the disorder (Snowden et al., 1997). Global ischemia and lacunar 
stroke have been found to preferentially target the hippocampus resulting in increased 
levels of apoptosis and hippocampal atrophy (Kirino and Sano, 1984; Honkaniemi et al., 
1996; Back et al., 2004; Grau-Olivares et al., 2007). Song et al. (2007) found that a large 
percentage of AD patients with infarcts exhibited more rapid decline of cognitive abilities 
than those without infarcts. Taken together these studies suggest that hippocampal 
damage resulting from stroke could accelerate the appearance of dementia in preclinical 
AD patients.
Here I examined the behavioural effects of two common risk factors, cholinergic 
depletion and stroke that both target the hippocampus, on spatial and non-spatial versions 
of the water maze task. I predicted that either the stroke or cholinergic depletion alone 
would have little or no effect on behaviour, while the combination of the two factors 
(cholinergic depletion and stroke) would result in increased hippocampal damage in 
response to stroke and a corresponding impairment on the spatial version of the water 
maze task.
■c
2. Materials and Methods 
Animals
Twenty four male Long Evans hooded rats (300-400g) were obtained from 
Charles River (Saint-Constant, QC) and used for this experiment. Rats were divided into 
four groups: AC (n=9) received a cholinergic depletion followed two weeks later by a
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sham stroke; Stroke (n=8) received a sham depletion followed by stroke; AC-stroke 
(m=8) received a cholinergic depletion followed by stroke; and Control (n=7) received a 
sham depletion followed by a sham stroke. Animals were pair housed with food and 
water ad libitum, on a 12 hour light/dark cycle with lights off at 19:30. All animals were 
handled in accordance to guidelines set out by the Canadian Council for Animal Care.
Surgery
Surgery was performed under Isoflurane anaesthesia (4% with 2.0 L/min of 
oxygen for induction and 2% after surgical plane was established) in a standard 
stereotaxic apparatus. An incision was made in the scalp and periosteum down the 
midline. The fascia was pushed to the edges of the skull with a sterile gauze swab and 
the skin retracted to expose the skull surface. Holes were drilled into the skull using a 1 
mm drill bit attached to a high speed drill. Following surgery all animals were given a 
single dose of buprenorphine (Temgesic; 0.1 mg/kg subcutaneously) as an analgesic. 
Cholinergic depletion
The specific neurotoxin 192 IgG Saporin (IgG SAP; Chemicon) has been 
commonly used to induce selective cholinergic lesions in rats depending on the site of 
infusion. I chose to damage cholinergic neurons in the medial septum and vertical limb of 
the diagonal band of Broca (MS/VDB) which leads to a reduction in levels of 
hippocampal acetylcholinesterase (AChE). I lowered a 30 gauge cannula, through holes 
drilled in the skull, into the MS/VDB (AP +0.45; ML +/-0.6; DV -6.6 and -8.0 mm from 
bregma and the skull) and bilaterally infused IgG SAP [0.15 pg/pl dissolved in sterile lx 
phosphate buffer saline (PBS; pH 7.4)] at a rate of 0.05 pl/min using a Harvard mini­
pump. Each animal received a total volume of 0.3 pi per side at the first injection site
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(DV -8.0), and 0.2 pi per side at the second site (DV -6.6). The cannula was left in place 
for six and four minutes after the first and second injection respectively to ensure 
diffusion of the toxin. Sham operated animals underwent an identical procedure, but were 
infused with sterile lx PBS instead of IgG SAP.
Stroke
The vasoconstrictor Endothelin-l(ET-l; human, porcine; Sigma) was used to 
create a small, localized stroke in the hippocampus. A prior, unpublished, experiment was 
carried out to test different groups of rats on the hidden platform version of the Morris 
water maze following different concentrations of ET-1 stroke. The lowest concentration 
(7.5 pmol used here) was chosen because it did not result in functional impairments on 
the standard, spatial version of the water task. I lowered a 30 gauge cannula, through 
holes drilled in the skull in to the dorsal (AP -4.1; ML +/-3.0; DV -3.7 mm from bregma 
and the skull respectively) and ventral hippocampus (AP -5.2; ML +/-5.3; DV -7.0 mm 
from bregma and the skull respectively) and bilaterally infused ET-1 (7.5 pmol dissolved 
in sterile saline) at a rate of 0.1 pl/min using a Harvard mini-pump. Each animal received 
a total volume of 5 pi to each site. The cannula was then left in place for 10 minutes after 
each infusion to ensure diffusion of the toxin. Sham operated animals underwent an 
identical procedure, but were infused with sterile saline instead of ET-1. Following 
surgery animals were given buprenorphine (Temgesic; 0.1 mg/kg subcutaneously) as an 
analgesic.
Behavioural Testing
Behavioural testing began one week following the second surgery (stroke or sham 
stroke) and consisted of six days on the Rapid Acquisition Task to test for deficits in
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hippocampal processing, followed by two days on a visual platform task to, control for 
sensory, motor or motivational deficits.
Water maze: Rapid Acquisition Task
I used a three stage spatial version of the water maze task (McDonald et al., 
2005). A white plastic circular pool 1.4 m in diameter and 40 cm deep was filled to 
within 20 cm of the top of the wall with water (20-22°C) made opaque by adding skim 
milk powder. The invisible platform was 12 cm in diameter and made of white Plexiglas 
with holes drilled into the top of it to provide grip for the animals. During training the 
platform was submerged 2 cm under water. Extra-maze cues in the training room 
included five posters of different sizes and orientations mounted on three of the four 
walls, a computer rack, a door, an animal rack and the experimenter. Four different start 
points were used [N, S, E, W (not true compass headings)], equally spaced around the 
pool. The order was randomly selected for each day and each start point was used twice 
for days one to four and days six to eight. On day five only the three start points farthest 
from the platform were used (N, E, S) with the initial start point repeated at the end for a 
total of 16 trials.
In the first stage (Original location training) rats were trained over four days for 
eight trials a day, to swim to a fixed, spatial location. Twenty four hours after completion
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of stage one the second stage (New location training) began. This stage consisted of new 
spatial location training as animals were re-trained to swim to the new platform location 
over sixteen trials within two hours on a single day. The third stage consisted of two 
parts: a probe test and re-training to original location, both of which occurred 24 hours 
after mass training and each animal was given a 60 second trial with the platform
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removed from the pool. The platform was then returned to the pool in its qriginal (stage 
one) location and each animal was given seven additional trials in which to re-leam the 
original location.
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the hippocampus to rapidly form a novel representation in a familiar 
context. The third stage allowed me to test spatial memory for the previously learnt 
locations and determine which of these locations the subject had formed the strongest 
representation. The second part of stage three allowed me to ask how the massed new 
location training during stage two affected re-training to the original location (McDonald 
et al., 2005).
Water maze: Visible platform
The visible platform version of the water maze task was used as a test of general
performance that could control for potential sensory, motor and/or motivation deficits.
The same pool and room used for the spatial water maze task was used for this task,
except that the platform was made visible by attaching a 6 cm high black block to the top
of the hidden platform. This block was raised 2 cm out of the water, allowing rats to
■»
easily see the platform. The visible platform task was carried out on days seven and eight 
and consisted of one training session each day. Each session consisted of four trials 
(lasting 30 seconds) using each start point (N, W, E, S) once. The platform was placed in 
a novel location at the start of each training session to discourage the use of a spatial 
strategy in the second session.
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Data collection: A computer based rat tracker (Ethovision) was used to collect and 
analyze water maze data obtained from an overhead video camera. For the training trials, 
the measures of performance were swim time, defined as the latency between release and 
escape onto the platform and length of the path taken to find the platform. Path length is a 
sensitive measure that can control for potential differences in swim speed. If a rat did not 
reach the platform 60 seconds after release, a latency of 60 seconds was assigned, and the 
rat was guided manually to the platform and allowed to remain on the platform for 10 
seconds before being removed to a holding cage until the next trial. For the probe test, 
platform preference was used as a measure of performance. The percentage of time the 
rat spent in each quadrant, as well as the number of times the rat crossed each of the 
platform locations was recorded. During the visible platform task, latency to platform, 
path length and swim speed were assessed and compared from day one to day two.
Histology
Following behavioural testing all animals were sacrificed with an overdose of 
Euthanol and transcardially perfused with lx PBS (pH 7.4) followed by 4% (w/v) 
paraformaldehyde (PFA). The brains were carefully extracted and placed in 4% (w/v) 
PFA at 4°C for 24 hours. Brains were then transferred to a 30% (w/v) sucrose solution, 
containing 0.02% (w/v) sodium azide at 4°C for at least three days. Brains were sectioned 
on a freezing cryostat at 40 pm in a series of five. The first two sections of each series 
were mounted onto 1% (w/v) gelatin/0.2% (w/v) chromalum coated slides, while the 
third, fourth, and fifth series were stored in lx PBS containing 0.02% (w/v) sodium azide 
at 4°C until being processed for immunohistochemistry. The fifth series was not used in 
this experiment and was stored for future analyses.
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Cresyl violet staining and volumetries
The first series was stained with Cresyl violet and volumetric analysis was used to 
determine the extent of damage to the hippocampus. Working in a rostral-caudal 
direction, coronal sections were examined and at the first sign of hippocampal damage 
pictures were taken under a lOx objective to document the extent of the lesion. I 
continued to take pictures of every fifth section leaving approximately 200 pm between 
sections sampled to ensure no cell, or hippocampal region was counted twice. After all 
documentation of the damage for each subject in all of the sections was obtained (usually 
three to four sections), volumetric analysis was completed manually using an AxioVision 
microscope with associated Axio Imager analysis software (version 4.3). The extent of 
damage in the CA fields and dentate gyrus of the hippocampus were traced and a 
calculation of the volume of the lesion within the traced areas was obtained. The values 
from the traced areas were calculated by the computer software in millimetres squared. 
The total volume of damage for each animal was calculated and used to obtain an average 
for each group. This method of analysis has been used previously and produces an 
accurate estimate of hippocampal damage following focal stroke in the rat (Driscoll et al., 
2007; McDonald et al., 2008).
AChE staining
The second series was stained for AChE to get a qualitative image of cholinergic 
depletion in the hippocampus. I treated the slides for 30 minutes with 6.24 mg 
tetraisopropylpyrophosphoramide (Sigma) dissolved in 200 mL of distilled water, then 
rinsed the slides twice with distilled water and incubated them on a shaker table for four 
hours in a reaction mixture containing 5.72 g Trizma maleate, 2.04 g Trizma base, 100
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mg acetylthiocholine iodide, 294 mg dihydrous trisodium citrate, 150 mg anhydrous 
cupric sulphate, 32.8 mg potassium ferricyanide dissolved in 200 mL distilled water (all 
chemicals were obtained from Sigma). Slides were rinsed twice with distilled water, and 
left to dry overnight, then cleared with HemoDe (Sigma) and coverslipped with Permount 
(Sigma) the next day.
Immunohistochemistry
The third and fourth series were processed for immunohistochemistry to 
determine the completeness and specificity of the cholinergic lesion in the medial 
septum. An antibody raised against parvalbumin was used to label y-aminobutyric acid 
(GABA)-ergic neurons, and one against choline acetyltransferase (ChAT) was used to 
label cholinergic neurons. Free floating sections were rinsed in lx PBS, and then placed 
in a 3% (v/v) H2O2 solution for four minutes to block endogenous peroxidases. After 
three washes in lx PBS, sections were blocked for 30 minutes in 15% (v/v) normal horse 
serum (for anti-parvalbumin; Vector Labs) or 15% (v/v) normal rabbit serum (for anti- 
ChAT; Vector Labs). Sections were incubated overnight in primary antibody [anti-ChAT 
polyclonal, 1:1000 (Chemicon) or anti-parvalbumin monoclonal, 1:5000 (Sigma)] diluted 
in lx PBS with 7.5% (v/v) serum (horse for anti-parvalbumin; rabbit for anti-ChAT). 
Sections were then washed three times in lx PBS and incubated for 30 minutes in a 
biotinylated secondary antibody [ABC Elite Kit (mouse for parvalbumin and goat for 
ChAT), Vector Labs], washed three times, incubated for 30 minutes with AB reagent 
(ABC Elite Kit, Vector Labs), washed three times then developed with diaminobenzidine 
(DAB) substrate (Vector Labs) according to the manufacturer’s instructions. Sections 
were then mounted onto 1% (w/v) gelatin/0.2% (w/v) chromalum coated slides, air dried
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overnight, dehydrated in alcohol, cleared in HemoDe (Sigma) and coverslipped with 
Permount (Sigma).
Cell counts: Under light microscopy (AxioVision) ChAT positive neurons were counted 
in both hemispheres of the MS/VDB. I chose two sections to quantify; the first, at the site 
of injection and the second, in a section 200 pm caudal to the injection site. This 
quantification was not used as an accurate count of MS/VDB neurons, but instead to 
estimate the completeness of the lesion. Each hemisphere was counted separately to 
confirm lesion symmetry, after which counts for both hemispheres were then totaled for a 
representative cell count over the two sections. I combined the ChAT positive cell counts 
from the stroke and control groups, and used this average to determine the percentage of 
cell loss in the lesioned groups. Any animal with less than 35% cell loss was excluded 
from the experiment.
3. Results
Five rats assigned to the AC and AC-stroke groups were removed from this 
experiment due to incomplete cholinergic lesions (<35% cell loss). The following 
histological and behavioural analyses include five animals in the AC group and seven rats 
in the AC-stroke group.
Water maze: Rapid Acquisition Task
Original location training
The AC-stroke group was significantly impaired on all days in their ability to 
learn the platform location during original location training when compared to the AC, 
Stroke and Control groups (Figure 5.1 A). However, the Stroke rats had slower latencies
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to find the platform on the final day of training suggesting impairment in these rats on 
this stage of training. The latency (in seconds) to find the platform was recorded and 
averaged over the eight daily trials to obtain a single daily latency score for each animal. 
The daily scores for all four days of original location training were subjected to a two- 
way mixed analysis of variance (ANOVA) with Group (AC-stroke versus AC versus 
Stroke versus Control) as the between subjects variable, and Training Day (four levels) as 
a repeated measure, and revealed significant effects of group [F(3,23)=14.29,/7<0.01], of 
day [F(3,69)=75.17,/><0.01] and an interaction [F(9,69)=2.19,p<0.05]. By the final day 
of training AC-stroke rats were taking four times longer to find the platform (23.98 +/- 
3.99 sec) and Stroke rats were taking almost three times longer (16.55 +/- 0.99 sec) than 
the averaged latency for AC and Control rats (5.87 +/- 0.39 sec). Planned comparisons 
revealed that AC-stroke rats had significantly longer latencies on days two to four when 
compared to all other groups (p’sO.05). I also found that Stroke rats had significantly 
longer latencies than either AC or Control rats on day four (p<0.05), but there was still a 
significant difference between the latencies of Stroke rats and AC-stroke rats on this day 
(pO.OS).
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Figure 5.1: AC-stroke rats were impaired on all stages of the spatial water maze task as 
measured using latency to platform and path length as dependent variables. AC-stroke 
rats take longer to find the platform during original location training (A,B), new location 
training (C,D) and re-training to the original location (E,F). Data are given as means +/- 
SEM.
To control for potential differences in swim speed that could account for this 
difference, I also analyzed path length and found a similar pattern of results. AC-stroke 
rats had significantly longer path lengths than all other groups; however, no impairment 
was observed in Stroke rats using this measure (5. IB). A two-way mixed ANOVA with 
Group as the between subjects variable and Training Day (four levels) as the repeated 
measure revealed a significant effect of group [F(3,23)=10.23,p<0.001] and of day 
[F(3,69)=69.49,/?<0.001], but no interaction [F(9,69)=l. 16, /?=0.34], Holm-Bonferroni 
post hoes showed that the path lengths of AC-stroke rats were significantly longer than 
the path lengths of all other groups (p’s<0.05).
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New location training
The AC-stroke group was impaired in their ability to rapidly acquire a new 
platform location on this stage of the task when compared to all other groups (Figure 
5.1C). By the final trial block, AC-stroke rats were still taking longer to find the platform 
(20.08 +/- 5.00 seconds) than the averaged latency of AC and Control rats (6.35 +/- 0.53 
seconds). Stroke rats performed at control levels during new location training (8.35 +/- 
1.48 seconds). A two-way mixed ANOVA with Group as a between subjects variable and 
Trial Block (eight levels) as a repeated measure, was used to assess new location training 
and showed a significant effect of group [F(3,23)=5.81,/?<0.01] and of trial block 
[F’(7,161)=23.96,/><0.01], but no interaction [F(21,161)=1.28,/?=0.19]. Holm-Bonferroni 
post hoes showed that the latencies of AC-stroke rats were significantly longer compared 
to the latencies of all other groups on this stage of the task (p’s<0.05).
I also assessed path length on this day and found AC-stroke rats had longer path 
lengths compared to Control, AC or Stroke rats (5. ID). A two-way mixed ANOVA with 
Group as the between subjects variable and Trial Block (eight levels) as the two-way 
mixed found a significant effect of group [i?(3,23)=5.03, p<0.01] and of trial block 
[ir(7,161)=23.55,/?<0.001], but no interaction [F{21,161 )=1.17, /?=0.29]. Holm- 
Bonferroni post hoes showed that the path lengths of AC-stroke rats were significantly 
longer than the path lengths of all other groups (p’s<0.05).
Probe test
I found no differences between the groups on measures of quadrant preference or 
platform crossings. A two-way mixed ANOVA with Group as the between subjects 
variable and Quadrant Preference (new, original or other) as the repeated measure found
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no effect of group [F(3,23)=0.18,p=0.91], quadrant [F(2,46)=2.61,/?=0.08] or interaction 
[F(6,46)=0.125,/>=0.30]. The number of platform crossings was subjected to an ANOVA 
with Group as the between subjects variable and Crossing (new or original) as the 
dependent variable. This analysis found no effect of group [F(3,23)=0.73,/>=0.54]> 
crossing [F(l ,23)=0.17, p=0.69] or interaction [F(3,23)=0.64,/?=0.60] (data not shown).
Re-training to original location
The results of the re-training to original location stage are displayed in Figure 
5.IE and show that the AC-stroke group was impaired in their ability to re-leam the 
original location on this stage of the task when compared to all other groups. A two-way 
mixed ANOVA, with Group as the between subjects variable, and Trial (seven levels) as 
a repeated measure revealed significant effects of group [F(3,23)=6.57,/?<0.01], and of 
trial [F(6,138)=2.48,/?<0.05], but no interaction [F(18,138)=0.96,/j=0.50]. By the final 
trial AC-stroke rats were taking almost four times as long to find the platform (28.79 +/- 
8.06 seconds) as the averaged latency for AC and Control groups (7.16 +/- 0.99 seconds). 
Stroke rats were performing at control levels (6.47 +/- 1.70 seconds). Holm-Bonferroni 
post hoes showed that the latency to platform of AC-stroke rats was significantly longer 
than the latencies of all other groups on this stage of the task (p’s<0.05).
Path lengths were assessed during re-training to the original location and found 
AC-stroke rats to be impaired compared to all other groups (5.IF). A two-way mixed 
ANOVA with Group as the between subjects variable and Trial (seven levels) as the 
repeated measure revealed a significant effect of group [F(3,23)=4.92, p<0.01] and of 
trial [F(6,138)=2.75,p<0.05], but no interaction [F(18,138)=0.84,/?=0.65]. Holm-
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Visible platform
The results of this task are depicted in Figure 5.2. AC-stroke rats took longer than 
the AC and Stroke groups to locate the platform on day one, but were no different from 
Control rats (Control: 9.02 +/- 2.15 seconds; AC: 6.03 +/- 0.36 seconds; Stroke: 7.48 +/- 
0.99 seconds; AC-stroke: 11.67 +/- 1.77 seconds). All groups showed improved 
performance from day one to day two, but AC and Stroke rats still escaped from the pool 
faster than control or AC-stroke rats (5.2A). The latency (in seconds) to find the platform 
and escape from the pool were averaged over the four daily trials, and a two-way mixed 
ANOVA, with Group as the between subjects variable and Training Day (two levels) as 
the repeated measure, revealed significant effects of group [F(3,23)=3.42,/?<0.05], and of 
day [F(1,23)=T0.10,/?<0.01], but no interaction [F(3,23)=0.81,p=0.50]. Holm- 
Bonferroni post hoes showed that the latency to platform of AC-stroke rats was 
significantly longer than AC and Stroke rats (p’s<0.05), but was not different from 
Control rats.
Analysis of path length showed a similar pattern of results as AC-stroke rats took 
a longer path to reach the visible platform, but once again showed a significant 
improvement by day two suggesting that they were able to learn the task and were 
motivated to escape from the pool (5.2B). A two-way mixed ANOVA with Group as the 
between subjects variable and Training Day (two levels) as the repeated measure revealed 
a significant effect of group [F(3,23)=3.97, j9<0.05] and of day [F(l,23)=10.59,/?<0.01] 
but no interaction [.F(3,23)=0.81,p=0.50]. Holm-Bonferroni post hoes found that the path
Bonferroni post hoes showed the path lengths of AC-stroke rats were significantly longer
than the path lengths of Control, AC or Stroke rats (/?’s<0.05).
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lengths of AC-stroke rats were significantly longer than the path lengths of Control, AC
and Stroke rats (p’sO.05).
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Figure 5.2: AC-stroke rats took longer to reach the platform during visible platform 
training, but they did show improvement by day two suggesting they were motivated to 
escape the pool (A,B). Data are given as means +/- SEM.
An analysis of swim speed during visible platform training found AC rats were 
significantly faster than Control and Stroke rats, but all other groups had similar swim 
speeds (control: 0.20 +/- 0.01 m/s; AC: 0.26 +/- 0.281n/s; stroke: 0.20 +/- 0.01 m/s; AC- 
stroke: 0.23 +/- 0.12 m/s). A one way ANOVA revealed a significant effect of group 
[A(3,23)=4.12,/K0.05]. Holm-Bonferroni post hoes found that the swim speed of AC rats 
was significantly faster than Control and Stroke rats (p’sO.05), but there were no 
differences in swim speed between the other groups.
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Histology
Quantification o f cholinergic lesion
I confirmed the completeness and specificity of the cholinergic lesion in the 
medial septum of both AC and AC-stroke groups through AChE staining and 
immunohistochemistry for ChAT and parvalbumin. Lesioned animals had very few 
ChAT positive cholinergic neurons (Figure 5.3A-C) combined with intact parvalbumin 
labeled GABA-ergic neurons (5.3D-F) confirming the specificity of the cholinergic 
lesion. The AChE staining clearly showed a depletion of cholinergic activity in the 
hippocampus in all lesioned animals compared to the sham operated groups (5.3G-I).
I quantified the extent of the cholinergic lesion by comparing the ChAT positive 
cell counts between groups. To control for any possible effects of stroke on the number of 
cholinergic neurons in the medial septum, I used the ChAT positive cell counts from the 
Stroke group to determine a percentage of cell loss for the AC-stroke group, and used the 
ChAT positive cell counts from the Control group to determine a percentage of cell loss 
for AC group. I found 80.31 +/- 0.47% cell loss in the AC-stroke group and 67.49 +/- 
29.14 % cell loss in the AC group (One AC-stroke rat and four AC rats had incomplete 
lesions with less than 35% depletion and were removed from the study). There were 
significantly fewer cholinergic neurons in the AC and AC-stroke groups compared to the 
Stroke and Control groups (Table 5.1). A one way ANOVA revealed a significant effect 
of group [F(3,23)=17.66,/?<0.01]. Holm-Bonferroni post hoes showed that there was no 
significant difference in the extent of the depletion for AC and AC-stroke groups, and 
that both groups had significantly fewer ChAT positive cells than either the Stroke or 
Control groups (p’s<0.05).
143
Figure 5.3: Photomicrographs of anti-ChAT labeling in the MS/vDB from a Control rat 
(A), an AC rat (B) and an AC-stroke rat (C) confirm the near total loss of cholinergic 
neurons in this area following infusion of IgG SAP. Anti-parvalbumin labeling in the 
MS/vDB from a Control rat (D), an AC rat (E) and an AC-stroke rat (F) confirm the 
specificity of this lesion to cholinergic neurons, while sparing GABA-ergic neurons. The 
normal AChE staining apparent in the dorsal hippocampus of a Control rat (G) is 
dramatically reduced following cholinergic depletion in the hippocampus of an AC rat 
(H) and an AC-stroke rat (I). Scale bars, 0.1 mm (A-F) and 0.5 mm (G-I).
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Table 5.1: The number of cholinergic neurons counted in two sections through the 
medial septum
Group Number of ChAT positive neurons
Section 1 Section 2 Total
Control 125.00 +/- 12.29 129.71 +/-19.06 254.71.+/- 25.99
AC 54.33+/- 18.53 44.67 +/- 22.58 99.00+/-31.58
Stroke 150.125 +/- 17.76 158.25 +/- 24.43 308.38 +/- 37.27
AC-stroke 42.43 +/- 8.74 18.29+/-6.69 60.71 +/-14.52
Data are given as means +/- SEM.
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Figure 5.4: Choline acetyltransferase (ChAT) positive cell counts show a clear depletion 
in AC (67%) and AC-stroke (80%) rats compared to Stroke and Control rats. Data are 
given as means +/- SEM.
I did notice that lesioned animals had areas of necrotic cell death in the MS/VDB 
surrounding the injection site. This non-specific damage has been reported previously 
(Heckers et al., 1994; Frick et al., 2004) and work in our laboratory has shown no 
correlation between lesion size (due to focal necrosis following infusion of the toxin) and 
water maze performance (data not shown). In the current study, a researcher, blinded to
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group conditions, subjectively described the non-specific damage as none, small, medium 
or large. There was slightly more necrotic damage in AC-stroke (4 large and 3 medium) 
compared to AC (1 large and 5 medium). I re-analyzed the water maze data with the 
groups divided by lesion size (AC-stroke-medium, AC-stroke-large and AC-medium; 
AC-large was not included in the analysis as there was only one rat in this group) to 
determine whether the larger lesion was responsible for the effect. AC-stroke rats were 
still impaired on all stages of the water maze task regardless of the amount of non­
specific damage (data not shown).
Quantification o f stroke damage in the hippocampus
Both AC-stroke and Stroke rats had significantly more hippocampal damage 
compared to Control and AC rats. Damage was localized around the infusion sites in both 
dorsal (Figure 5.5A-C) and ventral hippocampus (5.5D-F). This damage affected all 
regions of the hippocampus (CA1, CA2, CA3 and dentate gyrus) and included thinning 
of cell layers, reactive gliosis and a complete loss of tissue in some regions especially 
surrounding the needle tract. Some of the Control and AC rats had minimal disruption of 
cell layers surrounding the needle tract from the sham infusion procedure, but little 
damage. In addition to the hippocampal damage, both groups that received the intra- 
hippocampal strokes had some collateral damage in adjacent thalamic nuclei immediately 
below the dorsal hippocampus. In the Stroke group 7 of the 8 subjects had some bilateral 
damage to the lateral dorsal thalamic or the medial dorsal nuclei. The other subject in this 
group had unilateral damage to the lateral dorsal site. In the AC-stroke group, 3 of the 8 
subjects had bilateral damage to either the lateral dorsal thalamic or medial dorsal nuclei. 
Four of the subjects from this group had unilateral damage to the same site and one
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subject had no thalamic damage. Since the damage to these areas was similar or larger in 
the Stroke group it is very unlikely that this extrahippocampal damage accounts for the 
enhanced deficit in the AC-stroke group.
Figure 5.5: Photomicrographs (5x) of Cresyl violet stained hippocampal sections from a 
Control rat (A,D), a Stroke rat (B,E) and an AC-stroke rat (C,F). Damage is apparent in 
both dorsal (A-C) and ventral (D-F) hippocampal sections in the area surrounding the 
injection site as a result of stroke. Scale bars, 0.5 mm.
The amount of damage was quantified using volumetric analysis (Figure 5.6).
Both Stroke rats and AC-stroke rats had similar amounts of damage (2919.08 +/- 845.81
mm2 versus 3156.61 +/- 981.33 mm2). A one way ANOVA was performed on Lesion
size, with Group (AC-stroke versus AC versus Stroke versus Control) as the between
%
subjects variable and revealed a significant effect of group (F(3,24)=7.00, /K0.01). 
Holm-Bonferroni post hoes found that the size of the AC-stroke and Stroke lesions were 
not significantly different, while the lesion size for both these groups was significantly 
greater than either AC or Control rats (p’s<0.05).
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Figure 5.6: Volumetric analysis of damage throughout the entire hippocampal revealed 
significantly more damage in Stroke and AC-stroke rats compared to Control or AC rats. 
Data are given as means +/- SEM.
4. Discussion
In this study, I have found that a reduction in hippocampal cholinergic activity 
prior to a small focal stroke resulted in significant impairment in spatial learning. 
Although stroke on its own did cause mild impairment on a single measure (latency to 
platform) during original location training on the water maze task, the performance of 
rats following the combination of cholinergic depletion with stroke was significantly 
worse on all stages of the water maze task. The volume of hippocampal damage as a 
result of the stroke was comparable in both groups suggesting it was an interaction 
between the factors rather than an increase in lesion size that led to the observed 
behavioural impairment.
There have been a number of studies describing a role for cholinergic agonists in 
promoting recovery from ischemic or excitotoxic neuronal damage (Yamaguchi et al., 
1995; Akaike et al., 2003; Takada et al., 2003; Fujiki et al., 2005; Gonzales et al., 2006). 
However, damaging basal forebrain cholinergic neurons can lead to reductions in cerebral 
blood flow (Waite et al., 1999), and cerebral hypoperfusion has been found to be
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protective against focal ischemia (Choi et al., 2007; Kim et al., 2008). These findings 
suggest a role for the cholinergic system in mediating the brain’s response to ischemia 
and stroke, although a detailed understanding of the underlying mechanism remains 
unknown. To the best of my knowledge, I am the first to examine the behavioural and 
gross histological effects of stroke following cholinergic depletion in the rat. The 
observed impairment of the combined group on all stages of the hidden platform version 
of the water maze task revealed an interaction between these two factors suggesting a 
deficit in hippocampal processing. The combined group was able to learn the visible 
platform version of the water maze (a form of learning that does not require hippocampal 
function) at control levels demonstrating that they were motivated to escape from the 
water and that there were no general performance deficits that could explain the impaired 
learning of the hidden platform task. The enhanced performance of the stroke and 
depleted only rats on this task was surprising, but hippocampal damage has been shown 
to bias the selection of a cue strategy over a place strategy (McDonald and White, 1994) 
which could explain the enhanced performance of my stroke rats. Janis et al. (1998) 
reported that following cholinergic depletion rats preferred an egocentric cue based 
strategy, but this finding has been challenged by Bizon et al. (2003) who found that 
cholinergic depletion of the hippocampus actually biased the rats towards a spatial 
strategy. My results appear to support Janis et al. (1998), but the enhanced performance 
of the cholinergic depleted rats in the current study could also be due to their faster swim 
speeds during visible platform training.
I predicted that in the absence of cholinergic projections to the hippocampus I 
would see an increase in the amount of damage resulting from stroke. Surprisingly, I
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found no difference in lesion size due to stroke when I compared my sham operated rats 
to my cholinergic depleted rats. My results are comparable to a previous study in gerbils 
where Gabriel et al. (1998) electrolytically damaged the medial septum prior to inducing 
transient global ischemia and reported no change in the extent of hippocampal damage in 
sham compared to lesioned animals. The appearance of a behavioural deficit in the 
absence of an increase in lesion size suggests that a more subtle mechanism is responsible 
for the cognitive impairment in my rats. While there are many studies that have 
correlated the amount of brain damage with the extent of behavioural impairment (Kiyota 
et al., 1991; Nedelmann et al., 2007), there have also been a significant number of studies 
reporting a behavioural effect in the absence of increased damage (Jaspers et al., 1990; 
Walh et al., 1991; Yamaguchi et al., 1995). The observation that performance is not 
always correlated with the amount of damage stresses the importance of using both 
histological and behavioural measures when assessing impairments arising from stroke.
Caveats
I believe that my overall conclusions are valid and that these findings set the stage 
for further research into this area; however, there were a few minor caveats associated 
with this study. Firstly, the amount of non-specific damage to the medial septum 
following the cholinergic lesion was unexpected; however, this has been reported 
previously by other groups using interparenchymal infusions of IgG SAP (Heckers et al., 
1994; Frick et al., 2004). Moreover, I did not notice any correlation between the extent of 
the medial septal damage and performance on the water maze task in the lesion only or 
combined groups (L.Craig, unpublished observations). Previous studies, using less 
specific methods to damage the medial septum, reported extensive memory impairments
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on spatial memory tasks, similar to the water maze task used here (Marston et al., 1993; 
Waite and Thai, 1996). In the current study, lesioned rats were unimpaired on both 
versions of the water maze task confirming that the non-specific damage observed here 
was not functionally relevant. Rather, it was the additive effect of the stroke combined 
with the depletion that resulted in the spatial learning impairment in my combined group. 
Secondly, the extent of the cholinergic cell loss was less than expected. Previous studies 
have reported a 90-100% loss of cholinergic neurons of the medial septum (Baxter et al., 
1995; Frick et al., 2004; Craig et al., 2008). Nevertheless, the cell loss seen here is 
greater than the loss of cholinergic neurons observed during natural aging in humans 
(Perry et al., 1992) or in rats (Fischer et al., 1991).
Potential mechanisms of functional impairment in subjects following cholinergic 
depletion and stroke
The cholinergic system plays an important role in many forms of neuronal 
plasticity such as functional recovery following injury (Gonzales et al., 2006), 
neurogenesis (Mohapel et al., 2004; Cooper-Kuhn et al., 2005), and regulating the 
secretion of neurotrophins such as nerve growth factor (NGF) and brain derived 
neurotrophic factor (BDNF) (Knipper et al., 1994; French et al., 1999). In the absence of 
sufficient levels of ACh any one of these mechanisms could potentially have detrimental
H
effects on the hippocampus over time. In combination with a secondary insult such as 
stroke, low levels of ACh would leave the hippocampus with a reduced ability to 
compensate for the damage. I have previously suggested that a cholinergic lesion of the 
medial septum renders hippocampal neurons increasingly vulnerable to secondary insults. 
This has been supported in our laboratory in the current study, and by experiments
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demonstrating impairment in spatial memory following a medial septal cholinergic lesion 
combined with chronic stress (Craig et al., 2008) or when combined with non-convulsive 
seizures (Craig et al., 2008). I believe that the reduction in ACh does not directly damage 
hippocampal neurons, but instead acts to increase hippocampal vulnerability to future 
insults by reducing the brain’s ability to compensate for damage.
Potential mechanisms: alterations in plasticity related to reorganization of neuronal 
tissue
One possible mechanism to explain my results is the cholinergic system’s role in 
mediating functional recovery following injury. This form of plasticity refers to the 
reorganization of neuronal tissue in order to compensate for damaged areas. Cholinergic 
agonists such as nicotine have been found to promote these plastic changes and enhance 
functional recovery following stroke (Gonzales et al., 2006). Zenardi et al. (2007) 
reported that transgenic mice lacking high affinity nicotinic receptors are more 
susceptible to excitotoxic damage, and do not benefit from enriched environment. The 
neuroprotective role of the cholinergic system is further supported by reports showing the 
cholinergic agonists, nicotine and donepezil are effective at enhancing recovery and 
reducing infarct size following stroke in rats (Fujiki et al., 2005; Gonzalez et al., 2006), 
as well as protecting hippocampal neurons following systemic kainic acid (Borlongan et 
al., 1995). In addition, pre-treatment with either nicotine jar donepezil have been found to 
protect both cortical and hippocampal neurons from excitotoxic damage in vitro (Akaike 
et al., 1994; Dajas-Bailador et al., 2000; Takada et al., 2003). Taken together these 
studies suggest a role for the cholinergic system in mediating recovery from ischemic 
damage. In the absence of a functional cholinergic system the hippocampus would be less
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able to recover from injury. Cholinergic projections can mediate hippocampal plasticity 
in two ways: through changes in rates of neurogenesis and in levels of neurotrophin 
factors essential for neuronal plasticity.
Potential mechanisms: neurogenesis and growth factors
Stroke has been shown to increase levels of neurogenesis (Arvidsson et al., 2001; 
Jin et al., 2001) and Nakatomi et al. (2002) has found that infusing growth factors 
[epidermal growth factor (EGF) and fibroblast growth factor (FGF)] intraventricularly 
following ischemia can enhance the production of new neurons in the rat hippocampus 
leading to functional recovery. This implies a role for neurogenesis in the recovery from 
stroke, and stresses the importance of endogenous growth factors. The cholinergic system 
plays an important role in both neurogenesis and the production of these trophic factors. 
Following specific cholinergic lesions of the basal forebrain, levels of hippocampal 
neurogenesis are reduced (Mohepel et al., 2004; Cooper-Kuhn et al., 2005). Moreover, 
there are reductions in the levels of brain derived neurotrophic factor (BDNF) and nerve 
growth factor (NGF) available to the hippocampus (Rnipper et al., 1994; French et al., 
1999). Cholinergic agonists have been shown to increase the production of FGF-2, NGF 
and BDNF in cortex and hippocampus which could play a role in enhancing neuronal 
proliferation and/or survival (Belluardo et al., 1998; Maggio et al., 1998; Kenny et al., 
2000; Martinez-Rodriguez et al., 2003; Mudo et al., 2007).
Multiple combinations of co-factors
By understanding the risk factors that have been linked to AD and the role they 
play in the development of this disorder, the chances of developing effective treatment 
strategies are increased. I have begun to look at the effects of multiple risk factors on
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hippocampal damage and measures of learning and memory. Driscoll et al. (2007) 
subjected aged rats to a mini-stroke and found increased lesion size as well as 
significantly worse performance on the spatial water maze. McDonald et al. (2007) 
reported that when a mini-stroke was given to chronically stressed rats, there was a 
similar increase in lesion size, but a milder behavioural deficit was observed. I have also 
shown that by specifically damaging the cholinergic input to the hippocampus, rats are 
more sensitive to the effects of low doses of kainic acid and to chronic stress, 
demonstrating impaired water maze performance (Craig et al., 2008; L.Craig, 
unpublished observations). Taken together, these studies show that the presence of two 
risk factors that on their own have little effect on memory, when combined can result in 
significant impairment. Interestingly the extent of the behavioural impairments vary, 
from mild to severe, depending on which risk factors are present, lending further support 
to this theory as an accurate model of the differences observed between individuals in the 
quality of their cognitive aging.
Conclusion
In conclusion, I have shown that the interaction of these two risk factors 
(cholinergic depletion and stroke) can lead to impairment in hippocampal processing in 
the absence of any noticeable changes in the amount of observed damage. I believe this is 
the result of a reduced plasticity and inability of the hippocampus (in the absence of 
sufficient ACh) to compensate for the damage resulting from an active factor such as 
stroke. Future studies will look at the possible mechanisms behind this effect in order to 
open up potential treatment or prevention strategies tailored to those at risk for AD 
combined with vascular changes.
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Chapter 6
Emergence of spatial impairment in rats following specific cholinergic depletion of the 
medial septum combined with chronic stress
Modified from a paper published in European Journal o f Neuroscience. 27, 2262-2271 
by Laura A. Craig, Nancy S. Hong, Joelle Kopp and Robert J. McDonald in 2008
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Abstract
A consistent finding in patients suffering from Alzheimer’s disease is a loss of the
cholinergic neurons of the basal forebrain that project to the hippocampus. However, the
role this depletion plays in the development of Alzheimer’s disease remains unclear. The
loss of this ascending neurotransmitter system could potentially render hippocampal
neurons more susceptible to further insult, such as chronic stress, ultimately resulting in
neuronal death and memory loss. I explored this possibility by using the highly specific
toxin 192 IgG Saporin to destroy the majority of cholinergic activity in the septo-
hippocampal pathway in rats. Following depletion, rats were subjected to two weeks of
restraint stress. Rats were divided into two groups and were tested either on a
hippocampus dependent (water maze) task or on a hippocampus independent task (fear
conditioning to tone and context). I showed that cholinergic depletion or stress alone had
no effect on the successful performance of either of the tasks. However, rats with a
combination of cholinergic depletion and stress were significantly impaired on the water
maze task. No deficits were apparent in the combined group that was tested on fear
conditioning to tone or context, suggesting that this impairment is specific to spatial
working memory. These rats had no obvious hippocampal neuronal loss or damage;
however there were likely subtle changes in hippocampal processing that led to the
observed deficit on the hippocampal dependent task. These findings support my theory
■*
that cholinergic depletion of the medial septum increases hippocampal vulnerability to 
further insults such as stress.
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1. Introduction
Alzheimer’s disease (AD) is the leading cause of dementia in the elderly 
population today (Mesulam, 2004). While the exact cause of AD is unknown, there have 
been a number of factors identified as potentially increasing the risk of developing this 
disorder. McDonald (2002) proposed an etiological model based on the theory that AD 
pathology originates in the hippocampus (Hyman et al., 1984; Ball et a l, 1985). This 
model classifies risk factors for AD as either passive factors, which can increase the 
vulnerability of hippocampal neurons, or active factors, that can directly disrupt learning 
and memory, through the death or dysfunction of hippocampal neurons.
One of the passive risk factors most often found in AD patients is a loss of the 
cholinergic neurons of the basal forebrain that project to the cortex and hippocampus 
(Davies and Maloney, 1976; Mesulam, 2004). A moderate decline in cholinergic activity 
is commonly found during the natural aging process of both rats and humans (McGeer et 
al., 1984; Fischer et al., 1991; Baskerville et al., 2006). This natural cholinergic depletion 
may affect elderly individuals by increasing hippocampal vulnerability to future insults 
such as stress, stroke or seizures that could lead to cognitive decline.
Another common passive risk factor that has been linked to AD is chronic stress
(Wilson et al., 2006). Elevated levels of glucocorticoids (corticosterone (CORT) in rats
and cortisol in humans) can impair learning and memory in both aged rats (Montaron et
■*
al., 2006) and humans (Lupien et al., 1998). Furthermore, prolonged exposure to elevated 
glucocorticoids can result in hippocampal atrophy and cell death (Magarinos and 
McEwen, 1995; Sapolsky, 2000). Interestingly, elevated cortisol levels have been found 
in AD patients; with higher levels correlating with more severe dementia and increased
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hippocampal atrophy (Davis et al., 1986; Csemansky et al., 2006). This suggests a role 
for chronic stress and prolonged exposure to glucocorticoids in determining the quality of 
cognitive aging.
Both cholinergic depletion of the medial septum and stress specifically target the 
hippocampus. Following a lesion of cholinergic neurons, there are no changes in baseline 
CORT levels or habituation to chronic stress (Helm et al., 2004); however, there are 
reductions in hippocampal glucocorticoid receptors (Han et al., 2002) and a heightened 
CORT response to acute stress (Helm et al., 2004). These alterations suggest a 
compromised ability to respond appropriately to stress in the absence of a functional 
cholinergic system. This could lead to increases in hippocampal damage and/or 
impairment over that which is observed with comparable levels of stress alone.
In the current study, I chose to explore the behavioural consequences of 
combining cholinergic depletion of the medial septum with a stress procedure designed to 
chronically elevate CORT levels. I tested rats on either a hippocampal dependent task or 
on a hippocampal independent task. I predicted that rats receiving either factor alone 
would perform at control levels on both tasks, while the combination of factors would 
produce a hippocampal specific deficit, based on my hypothesis that passive factors (such 
as cholinergic depletion) can increase the vulnerability of hippocampal neurons.
Experiment 1: The effects of cholinergic depletion and chronic stress on levels of 
blood borne CORT
My first experiment was designed to ensure that my chronic stress procedure was 
able to effectively raise CORT levels. I was also interested in whether cholinergic
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depletion of the medial septum would have any effect on overall CORT levels measured 
following two weeks of chronic stress.
2.1. Materials and Methods 
Animals
Twenty four male Long Evans hooded rats (300-400g; CCBN breeding colony) 
were used for this experiment. They were divided into three groups: AC-stress (w=8) 
received a cholinergic depletion followed by 14 days of stress (these rats were also used 
in Experiment 3 for behavioural testing), Stress («=7) received 14 days of stress and 
Control («=8) were handled only (Stress and Control rats were from the previous pilot 
experiment and included for comparison purposes only). Animals were pair housed with 
food and water ad libitum, on a 12 hour light/dark cycle with lights off at 19:30. All 
animals were handled in accordance to guidelines set out by the Canadian Council for 
Animal Care.
Surgery
Surgery was performed under Isoflurane anaesthesia (4% with 2.0 L/min of 
oxygen for induction and 2% after surgical plane was established) in a standard 
stereotaxic apparatus. An incision was made in the scalp and periosteum down the 
midline. The fascia was pushed to the edges of the skull with a sterile gauze swab and 
the skin retracted to expose the skull surface. Holes \yere drilled into the skull using a 1 
mm drill bit attached to a high speed drill. Following surgery all animals were given 
buprenorphine (Temgesic; 0.1 mg/kg subcutaneously) as an analgesic.
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Cholinergic depletion .
The specific neurotoxin 192 IgG Saporin (IgG SAP; Chemicon) has been 
commonly used to induce selective cholinergic lesions in rats depending on the site of 
infusion. I chose to damage cholinergic neurons in the medial septum and vertical limb of 
the diagonal band of Broca (MS/VDB) which leads to a reduction in levels of 
hippocampal acetylcholinesterase (AChE). I lowered a 30 gauge cannula, through holes 
drilled in the skull, into the MS/VDB (AP +0.45; ML +/-0.6; DV -6.6 and -8.0 mm from 
bregma and the skull) and bilaterally infused IgG SAP [0.15 pg/pl dissolved in sterile lx 
phosphate buffer saline (PBS; pH 7.4)] at a rate of 0.05 pl/min using a Harvard mini­
pump. Each animal received a total volume of 0.3 pi per side at the first injection site 
(DV -8.0), and 0.2 pi per side at the second site (DV -6.6). The cannula was left in place 
for six and four minutes after the first and second injection respectively to ensure 
diffusion of the toxin.
Variable restraint stress
I used a variable restraint stress schedule to increase CORT levels over a two 
week period. This schedule was designed to decrease the rats’ ability to acclimatize to the 
stress duration and minimize habituation. To induce stress, rats were taken in their home 
cages to a testing room between 11:30 - 13:30 each day and restrained in Plexiglas 
cylinders (diameter 6.5 cm, length 15 cm) for a variable amount of time each day (20, 5, 
60, 15, 10, 30 or 40 minutes). This cycle was repeated twice for a total of 14 days of 
stress.
Blood collection and analysis of CORT levels: To assess levels of circulating CORT, rats 
were placed in a restraint tube and blood samples were obtained by tail nick with a
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scalpel blade on the final day of stress. Blood was collected from AC-stress and Stress 
rats 30 minutes after being placed in the restraint tube to obtain a peak level of CORT in 
response to the stressor. Blood was collected from Control rats within the first three 
minutes of being placed in the restraint tube to ensure CORT levels did not have time to 
significantly increase in response to the brief stress of the procedure. All blood samples 
(0.2 - 0.5 ml) were collected into tubes containing 100 pi of 10% (v/v) 
ethylenediaminetetraacetic acid (EDTA), placed on ice, centrifuged (7500 rpms for 10 
minutes) and the plasma was immediately frozen at -20°C. A commercially available 125I 
radioimmunoassay kit (Coat-A-Count Rat Corticosterone, DPC, California) was used for 
quantifying levels of plasma CORT for each animal.
3.1. Results
Analysis of blood borne CORT levels
To confirm that my stress procedure produced elevated glucocorticoid levels, I 
took blood samples on the final day of stress and analyzed them for levels of blood borne 
CORT. Both AC-stress and Stress rats showed a significant elevation in CORT levels 
following 14 days of variable restraint stress when compared to Control rats (Figure 6.1). 
There was no difference between AC-stress and Stress rats in overall CORT levels 
(308.73 +/- 38.75 ng/ml and 279.18 +/- 29.62 ng/ml respectively). Data was analyzed 
using a one way analysis of variance (ANOVA) that found an effect of group 
[F’(2,21)=32.99,/?<0.01]. Tukey post hoes revealed that AC-stress and Stress rats both 
had increased levels of CORT compared to Control rats (p<0.01).
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CORTICOSTERONE LEVELS
Figure 6.1: AC-stress and Stress rats have elevated levels of CORT compared to Control 
rats on the final day of the 14 day variable stress procedure. Data are given as means +/-
SEM.
Experiment 2: The effects of cholinergic depletion and chronic stress on the 
performance of a hippocampal dependent task.
My second experiment was designed to determine the effects of cholinergic 
depletion of the medial septum followed by chronic stress on the ability of the rat to 
complete a hippocampal dependent task (water maze).
2.2. Materials and Methods 
Animals
Thirty two male Long Evans hooded rats (300-400g; CCBN breeding colony) 
were used for this experiment. They were divided into four groups: AC-stress («=8) 
received a cholinergic depletion followed by 14 days of stress, AC (n=8) received a 
cholinergic depletion followed by 14 days of handling'only, Stress (w=8) received a sham 
depletion followed by 14 days of stress and Control (n=8) were handled only. All animals 
were housed identically to conditions described in Experiment 1.
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Surgery
The surgical procedures were identical to those described in Experiment 1. Sham 
operated animals underwent the same procedure, but were infused with sterile lx PBS 
instead of IgG SAP.
Variable restraint stress
The variable stress procedure was identical to the one described in Experiment 1. 
Behavioural testing
Behavioural testing began 24 hours following the final day of stress.
Water maze: Rapid Acquisition Task
I used a three stage variant of the spatial version of the water maze task 
(McDonald et al., 2005). A white plastic circular pool 1.4 m in diameter and 40 cm deep 
was filled to within 20 cm of the top of the wall with water (20-22°C) made opaque by 
adding skim milk powder. The invisible platform was 12 cm in diameter and made of 
white Plexiglas with holes drilled into the top of it to provide grip for the animals.
During training the platform was submerged 2 cm under water. Extra-maze cues in the 
training room included five posters of different sizes and orientations mounted on three 
of the four walls, a computer rack, a door, an animal rack and the experimenter. Four
• i
different start points were used [N, S, E, W (not true compass headings)], equally spaced 
around the pool. The order was randomly selected for each day and each start point was 
used twice for day one to four and day six. On day five only the three start points farthest 
from the platform were used (N, E, S) with the initial start point repeated at the end for a 
total of 16 trials.
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In the first stage (Original location training) rats were trained over four days for 
eight trials a day, to swim to a fixed, spatial location. Twenty four hours after completion 
of stage one; the second stage (New location training) began. This stage consisted of new 
spatial location training as animals were re-trained to swim to the new platform location 
over sixteen trials within two hours on a single day. Stage two allowed me to ask if rats 
could learn to go to a new location, during a single intensive training session. The third 
stage (Re-training to original location) occurred twenty four hours after stage two with 
the platform returned to its original (stage one) location and each animal was given eight 
trials. This stage allowed me to ask how the massed new location training during stage 
two affected relearning to the original location.
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the rat to rapidly form a novel representation in a familiar context. For 
the third stage, the subjects’ are required to re-leam the original location (McDonald et 
al„ 2005).
Data collection: A computer based rat tracker (VP118, HVS Image) was used to collect
and analyze data obtained from an overhead video camera. If a rat did not reach the
■*
platform 60 seconds after release, the rat was guided manually to the platform (aided 
placement) and allowed to remain on the platform for 10 seconds before being removed 
to a holding cage until the next trial. For all three stages the measures of performance 
were latency to platform and path length to platform. Path length is a sensitive measure 
that can control for potential differences in swim speed. I also recorded the number of
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aided placements for each animal and used this measure to confirm that rats were actively 
searching for the platform as opposed to ‘floating’ or being excessively thigmotaxic.
3.2. Results
One rat assigned to the Stress group died post surgery; the following analysis 
includes data from seven rats in this group.
Water maze: Rapid Acquisition Task
Original location training
The latency (in seconds) to find the platform was recorded and averaged over the 
eight daily trials to obtain a single daily path length for each animal (Figure 6.2A). The 
AC-stress group was impaired in their ability to learn the platform location during 
original location training. The daily latencies for all four days were subjected to a two- 
way mixed ANOVA with Group as the between subjects variable, and Training Day (four 
levels) as a repeated measure, and revealed a significant effect of group [F(3,27)=5.47, 
/><0.01] and of day [F(3,81)=94.76,p<0.01], but no interaction [F(9,81)=1.32,p=0.24], 
By the final day of training, the daily latency score for AC-stress rats was almost twice as 
long as the averaged score for the other three groups (12.00 +/- 1.80 seconds versus 6.07 
+/-1.06 seconds). Holm-Bonferroni post hoes revealed that AC-stress rats were impaired 
compared to all other groups (p’s<0.05).
■*
I also measured the path length (in meters) to find the platform and found a 
similar pattern of results. The AC-stress group appeared to be impaired in their ability to 
learn the platform location during original location training, with a path length of 2.17+/- 
0.43 meters on the final day of training, compared to the averaged path length of AC, 
Stress and Control groups (1.32 +/- 0.27 meters); however, this trend was not significant
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(6.2B). The daily path lengths for original location training were subjected to a two-way 
mixed ANOVA with Group (AC-stress versus AC versus Stress versus Control) as the 
between subjects variable, and Training Day (four levels) as a repeated measure, and 
revealed a significant effect of day [F(3,81)=103.91,p<0.01], but not of group 
[F(3,27)=2.32,/?=0.10] and no interaction [F(9,81)=0.87,/?=0.55]. Tukey post hoes 
revealed that all groups exhibited shorter path lengths from day one (6.84 +/- 0.76 
meters) to day four (1.53 +/- 0.31 meters; p 's<0.05).
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Figure 6.2: AC-stress rats are impaired on all stages of the spatial water maze task. 
Measures of latency and path length of platform revealed that AC-stress rats were 
impaired compared to AC, Stress and Control rats on original location training (A,B), 
new location training (C,D) and re-training to the original location (E,F). Data are given 
as means +/- SEM.
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New location training
The platform was moved to the opposite quadrant of the pool and the path length 
to find the new platform location was recorded and averaged into eight discrete trial 
blocks (two trials per block). The AC-stress group was impaired in their ability to rapidly 
acquire a new platform location on this stage of this task when compared to all other 
groups (6.2D). By the final trial block, AC-stress rats were still taking longer to find the 
platform (12.96 +/- 2.94 seconds) than the averaged latency of the other three groups 
(4.63 +/- 0.49 seconds). A two-way mixed ANOVA with Group as a between subject 
variable and Trial Block (eight levels) as a repeated measure, was used to assess the mass 
training and found a significant effect of group [F(3,27)=22.71,/><0.01], of trial block 
[F(7,189)=36.65,/?<0.01], and an interaction [F(21,189)=5.39,/?<0.01]. The interaction 
was further broken down using planned comparisons that showed significantly longer 
latencies for AC-stress rats on trial blocks one to four, and seven to eight, compared to all 
other groups (p’s<0.05).
I also used path length as a measure of performance and found the same pattern of 
results. The AC-stress group was impaired in their ability to rapidly acquire a new 
platform location on the mass training stage of this task when compared to all other 
groups (Figure 6.2D). By the final trial block, AC-Stress rats were taking longer to find
a*
the platform (4.35 +/- 0.63 meters) than the averaged path length of the other three 
groups (1.82 +/- 0.01 meters). A two-way mixed ANOVA with Group as a between 
subject variable and Trial Block (eight levels) as a repeated measure, was used to assess 
the mass training and found a significant effect of group [A(3,27)=16.31,/?<0.01], of trial 
block [F(7,189)=20.47, j^<0.01], and an interaction [F(21,189)=3.44,p<0.01]. The
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interaction was further broken down using planned comparisons that showed significantly 
longer path lengths for AC-Stress rats on trial blocks one to four, and seven to eight, 
compared to all other groups (p’s<0.05).
Re-training to original location
The platform was returned to the original location (from stage 1) and the latency 
to platform was recorded over eight trials on the final day of testing. Surprisingly, there 
were no differences in latency to platform for any of the groups. AC-stress rats were able 
to learn the original location on this stage of training (6.2E). All groups showed a 
significant decrease in latency to find the platform from trial one (22.41 +/- 6.43 seconds) 
to trial eight (4.19 +/-1.19 seconds). A two-way mixed ANOVA, with Group as the 
between subjects variable, and Trial (eight levels) as a repeated measure revealed a 
significant effect of trial [F(7,189)=16.62,/K0.01], but no effect of group [F(3,27)=2.49, 
p=0.08] or interaction [F(21,189)=T.26, p=0.21].
I also measured the path length to find this location and using this measure found 
that the AC-stress group was impaired in their ability to learn the original platform 
location (6.2F). By the final trial AC-stress rats were taking twice as long (1.40 +/- 0.38 
meters) as the averaged path length for the other three groups (0.66 +/- 0.26 meters). A 
two-way mixed ANOVA, with Group as the between subjects variable, and Trial (eight
a*
levels) as a repeated measure revealed a significant effect of group [F(3,27)=3.95, 
p<0.05] and of trial [F(7,189)=12.87,p<0.01], but no interaction [F(21,189)=1.17,
0.28]. Holm-Bonferroni post hoes showed AC-stress rats were significantly impaired 
compared to all other groups (p’s<0.05).
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To further assess the competition data, individual swim paths on the first trial 
were then analyzed to obtain a measure of the animal’s memory for the platform 
locations. The swim paths differed markedly between groups, with the AC, stress and 
control animals swimming first to the new location, and then after failing to find the 
platform, swimming to the original location (Figure 6.3A - C). In contrast, the AC-stress 
animals appeared to have no clear preference, and swam randomly throughout the pool 
(6.3D). In order to quantify these data, I chose to use quadrant entry as a categorical 
measure of platform memory. Each swim path was classed as new, original, or middle 
depending on which quadrant the rat first entered upon leaving the starting quadrant. 
These data were then subjected to a binomial test with the categories set as new or other 
(combined choice of original and middle), with a 0.33 expected probability of entering 
the new quadrant. The AC, Stress and Control groups showed a clear preference for the 
new quadrant as seven out of eight AC, and seven out of eight Control and six out of 
seven Stress rats (p<0.05) entered the new quadrant first (Figure 6.3E). None of the AC- 
stress animals entered the new quadrant first, but six out of eight rats swam directly to the 
original quadrant (p<0.05). However, a closer inspection of their swim paths revealed 
that although these rats entered the original quadrant first, suggesting a memory for this 
location, they were unable to find the platform. Instead, these rats swam randomly 
throughout the pool until they bumped into the platfoijn and escaped.
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Figure 6.3: The initial swim on the competition day of the spatial water maze was 
analyzed to determine platform preference. Representative swim paths from each group 
[Control (A), AC (B), Stress (C) and AC-stress (D)] show that AC-stress rats swam 
randomly throughout the pool, while all other groups swam first to the new platform, then 
headed towards the original platform location and escaped from the water (E). Data are 
given as means +/- SEM.
Aided Placements
A potential confound when conducting behavioural testing with stressed animals 
is the possibility of learned helplessness or anxiety related behaviours. In the water maze, 
learned helplessness is often expressed as ‘floating’ defined as immobility of the rat with 
just enough movement to stay afloat (Porsolt et al., 1978), while excessive thigmotaxic
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behaviour is a sign of heightened anxiety (Barnett, 1963; Devan et al., 1999). These 
behaviours are not conducive to an effective search strategy and often necessitate the 
experimenter guiding the rat to the platform at the cessation of the trial (aided 
placement). I predicted that if my stressed rats (AC-stress or Stress) were engaging in 
these behaviours they would have more aided placements throughout each day of training 
than Control or AC rats.
The number of aided placements during original location training were subjected 
to a two-way mixed ANOVA with Group as the between subjects variable and Training 
Day (four levels) as the repeated measure. This analysis revealed a significant effect of 
group [F(3,27)=3.63, /?<0.05], day [F(3,81)=88.92,/?<0.001] and an interaction 
[F(9,81)=2.60,p<0.01]. The interaction was broken down further using planned 
comparisons that showed that AC-stress rats had significantly more aided placements 
(42% of all trials were aided placements) on day one than AC or Stress rats (31% and 
23% aided placements respectively; /?’s<0.05). While AC-stress rats did not differ 
significantly from Control rats (26% aided placements; p=0.08) on day one, there was a 
trend for more aided placements in the combined group. By days three and four there 
were no differences between any of the groups showing all rats were exploring 
sufficiently to find the platform within the 60 second time limit (Figure 6.4A).
■»
The number of aided placements during new location training were subjected to a 
one-way ANOVA and found a significant effect of group [F(3,27)=l 1.98,/?<0.001]. 
Tukey post hoes found that AC-stress rats had more aided placements than the other 
groups (p’sO.05). However, the increased number of aided placements occurred during 
the first four trial blocks of mass training where AC-stress rats had 14 aided placements
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compared to Control, AC and Stress groups (two, one and no aided placements
respectively). By the last four trial blocks there was only one aided placement in the AC-
stress group demonstrating these rats were actively searching for the platform, even if
their strategy was less efficient (6.4B).
c
- o -  CONTROL 
- • —AC  
-a-STRESS  
- • —AC-STRESS
Figure 6.4: To ensure AC-stress rats were actively searching for the platform, I analyzed 
the number of aided placements. AC-stress rats had a few more aided placements on the 
initial day of original location training and on the first few trial blocks of new location 
training, but overall were actively searching for the platform during all three stages of 
training and had a similar number of placements to all other groups (A-C). Data are given 
as means +/- SEM.
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There were no differences in the number of aided placements during the re­
training to original location stage. A one way ANOVA with fixed effects was performed 
to detect differences in the total number of aided placements and found no differences 
between groups [F(3,27)=0.49, p=0.69] (6.4C).
The performance of rats on a hippocampal dependent task (water maze) following 
cholinergic depletion combined with chronic stress was significantly compromised. All 
three stages of this task were affected. AC-stress rats had more difficulty locating the 
platform during original location training and were significantly impaired in their ability 
to learn a new location in a single day. This group was also impaired during re-training to 
the original location.
Experiment 3: The effects of cholinergic depletion and chronic stress on a 
hippocampal independent task.
My third experiment was designed to determine the effects of cholinergic 
depletion of the medial septum followed by chronic stress on the ability of the rat to 
complete a hippocampal independent task (fear conditioning).
2.3. Materials and Methods
Animals
*9
Thirty two male Long Evans hooded rats (300-400g) were used for Experiment 3. 
They were divided into four groups: AC-stress («=8) received a cholinergic depletion 
followed by 14 days of stress, AC (n=8) received a cholinergic depletion followed by 14 
days of handling only, Stress («=8) received a sham depletion followed by 14 days of
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stress and Control («=8) were handled only. All animals were housed identically to 
conditions described in Experiment 1.
Surgery
The surgical procedures were identical to those described in Experiment 2. 
Variable restraint stress
The variable stress procedure was identical to the one described in Experiment 1. 
Behavioural testing
Behavioural testing began 24 hours after the final day of stress.
Fear conditioning to tone and context
The three day fear conditioning procedure used here was designed to test 
hippocampal independent learning and memory on two related tasks: fear conditioning to 
tone (cue) and to context. Both cued and contextual fear conditioning are dependent on 
the amygdala for successful learning (Fanselow and LeDoux, 1999; Ponnusamy et al., 
2007). Contextual fear conditioning does have a hippocampal component, but when 
distinctly different contexts and multiple context-shock pairings are used (as was in the 
current study) the amygdala is able to successfully form an association without 
hippocampal involvement (Frankland et al., 1998; Wiltgen et al., 2006).•i
Animals were placed into Context A (an operant chamber, metal walls, bars on 
floor, scented with Quatsyl®-D Plus disinfectant) and allowed to habituate for two 
minutes. They were presented with a 10 second tone (80 db), followed by a two second 
shock (1.0 mA). This tone-shock pairing was repeated every 70 seconds for five 
repetitions. Sixty seconds following the final shock, the animals were removed from the
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chamber, and returned to their home cage. Twenty four hours later the animals were 
placed in a novel context, Context B (Plexiglas walls, bedding on the floor, unscented), 
and after two minutes of habituation, were presented with an eight minute tone (80 db), 
with no shock and scored for freezing behaviour, as a measure of fear. Freezing 
behaviour is a reliable measure of fear, and was defined as a period of complete 
immobility except for breathing movements in the animal (Blanchard and Blanchard, 
1969). Forty eight hours later animals were returned to Context A for a five minute trial 
(no shock, no tone) to assess freezing behaviour in response to the original conditioning 
context.
3.3. Results
Due to a malfunction of the shock boxes, two AC-stress rats were excluded from 
this analysis.
Fear conditioning
Conditioning to tone
All groups were able to learn the tone-shock association, and showed an increase
in freezing behaviour in the presence of the tone. The percentage of freezing during the
first four minutes exposed to the tone was calculated and compared to the Context B
habituation period. This percentage of freezing for all groups was significantly greater in■*
the presence of the tone (48.17% +/-12.55% versus 20.48% +/-12.55%; Figure 6.5A). A 
two-way mixed ANOVA with Group as a between subjects variable, and Tone 
(habituation versus tone presentation) as a within subjects variable, revealed a significant 
effect of tone [F(l,24)=29.61,/?<0.001], but no group effect [F(3,24)=1.02,/?=0.40] or 
interaction [F(3,24)=0.77,p=0.51\.
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Conditioning to context
All groups were able to learn the context-shock association, and showed an 
increase in freezing behaviour when returned to Context A on day three. I measured a 
percentage freezing for the total time exposed to Context A on day three and compared it 
to the Context A habituation on day one. The percentage of freezing to context for all 
groups was significantly greater on day three compared to day one (46.55% +/-11.96% 
versus 2.46% +/- 0.96%; Figure 6.5B). A two-way mixed ANOVA with Group as a 
between subjects variable, and Context (day one versus day three) as a within subjects 
variable, revealed a significant effect of context [F(l,24)=48.16, /?<0.01], but no group 
effect [F(3,24)=0.47, p=0.70] or interaction [F(3,24)=0.65,/?=0.59].
Following the combination of cholinergic depletion and chronic stress, rats 
retained their ability to successfully learn a hippocampal independent task (fear 
conditioning to tone and context) at a level comparable to that seen in all three control 
groups.
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Figure 6.5: Performance on the fear conditioning task. There were no impairments in any 
of the groups on either fear conditioning to tone (A) or to context (B). Data are given as 
means +/- SEM.
Histology
Following behavioural testing all animals were sacrificed with an overdose of
Euthanol and transcardially perfused with lx PBS followed by 4% (w/v)
paraformaldehyde (PFA). The brains were carefully extracted and placed in 4% PFA at
4°C for 24 hours. Brains were then transferred to a 30% (w/v) sucrose solution,
■*
containing 0.02% (w/v) sodium azide at 4°C for at least three days. Brains were sectioned 
on a freezing cryostat at 40 pm in a series of five. The first two sections of each series 
were mounted onto 1% (w/v) gelatin/0.2% (w/v) chromalum coated slides, while the 
third, fourth, and fifth series were stored in lx PBS containing 0.02% (w/v) sodium azide
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at 4°C until being processed for immunohistochemistry. The fifth series was not used in 
this experiment and was stored for future analyses.
Cresyl Violet staining
The first series was stained with Cresyl violet and visually inspected under a lOx 
objective to determine if there was any structural damage to the hippocampus.
AChE staining
The second series was stained for AChE to get a qualitative image of cholinergic 
depletion in the hippocampus. I treated the slides for 30 minutes with 6.24 mg 
tetraisopropylpyrophosphoramide (Sigma) dissolved in 200 mL of distilled water, then 
rinsed the slides twice with distilled water and incubated them on a shaker table for four 
hours in a reaction mixture containing 5.72 g Trizma maleate, 2.04 g Trizma base, 100 
mg acetylthiocholine iodide, 294 mg dihydrous sodium citrate, 150 mg anhydrous cupric 
sulphate, 32.8 mg potassium ferricyanide dissolved in 200 mL distilled water (all 
chemicals were obtained from Sigma). Slides were rinsed twice with distilled water, and 
left to dry overnight, then cleared with HemoDe (Sigma) and coverslipped with Permount 
(Sigma) the next day.
Immunohistochemistry
The third and fourth series were processed for immunohistochemistry to 
determine the completeness and specificity of the cholinergic depletion. An antibody 
raised against parvalbumin was used to label y-aminobutyric acid (GABA)-ergic neurons, 
and one against choline acetyltransferase (ChAT) was used to label cholinergic neurons. 
Free floating sections were rinsed in lx PBS, and then placed in a 3% (v/v) H2O2 solution 
for four minutes to block endogenous peroxidases. After three washes in lx PBS,
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sections were blocked for 30 minutes in 15% (v/v) normal horse serum (for anti- 
parvalbumin; Vector Labs) or 15% (v/v) normal rabbit serum (for anti-ChAT; Vector 
Labs). Sections were incubated overnight in primary antibody [anti-ChAT polyclonal, 
1:1000 (Chemicon) or anti-parvalbumin monoclonal, 1:5000 (Sigma)] diluted in lx PBS 
with 7.5% (v/v) serum (horse for anti-parvalbumin; rabbit for anti-ChAT). Sections were 
then washed three times in lx PBS and incubated for 30 minutes in a biotinylated 
secondary antibody (ABC Elite Kit, Vector Labs), washed three times in lx PBS, 
incubated for 30 minutes with AB reagent (ABC Elite Kits, Vector Labs), washed three 
times in lx PBS then developed with diaminobenzidine (DAB) substrate (Vector Labs) 
according to manufacturers instructions. Sections were mounted onto 1% (w/v) 
gelatin/0.2% (w/v) chromalum coated slides, air dried overnight, then dehydrated in 
alcohol, cleared in HemoDe (Sigma) and coverslipped with Permount (Sigma).
Cell counts: Under light microscopy (AxioVision) ChAT positive neurons were counted 
in both hemispheres of the MS/VDB. I chose two sections to quantify; the first, at the site 
of injection and the second, in a section 200 pm caudal to the injection site. This 
quantification was not used as an accurate count of MS/VDB neurons, but instead to 
estimate the completeness of the cholinergic depletion. Each hemisphere was counted 
separately to confirm lesion symmetry, after which counts for both hemispheres were 
then totaled for a representative cell count over the two sections.
Histological results
All the cholinergic depleted rats used in these experiments had similar lesions so I 
grouped them for histological analysis [AC-stress (n=16), Stress («=15), AC (n=16)]. 
Control rats for the behavioural portions of this study were from a separate experiment
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(unpublished), and I did not have access to the tissue for histological analysis. However,
t;
comparisons of the Stress rats used here with control rats from previous work in our 
laboratory have repeatedly found no difference in ChAT positive cell counts or staining 
so I have included a separate representative Control group («=10) in the analysis here for 
comparative purposes.
Quantification o f cholinergic lesion
I confirmed the completeness and specificity of the cholinergic lesion in both AC 
and AC-stress group through AChE staining and immunohistochemistry for ChAT and 
parvalbumin. Lesioned animals had very few ChAT positive cholinergic neurons (Figure 
6.6A,B) combined with intact parvalbumin labeled GABA-ergic neurons confirming the 
specificity of the lesion to cholinergic neurons (Figure 6.6C,D). The AChE staining 
clearly showed a depletion of cholinergic activity in the hippocampus in lesioned animals 
compared to the sham operated groups (6.6E,F).
I quantified the extent of the cholinergic lesion by comparing ChAT positive cell
counts between groups. I combined the ChAT positive cell counts from the Stress and
Control groups, and used this average to determine the percent depletion for the lesioned
groups. I found 97% depletion in the AC-stress group and 98% depletion in the AC
group. An independent samples t-test showed no significant difference between the two
■*
groups [t(28)=-0.59, j?=0.56]. There were significantly fewer cholinergic neurons in AC 
and AC-stress compared to the Stress and Control group (Table 6.1). A one way ANOVA 
revealed a significant effect of group [E(3,51)=l 15.01, ^ ><0.01], Tukey post hoes showed 
that the AC and AC-stress groups had significantly fewer ChAT positive cells than either 
of the Stress and Control groups (p’s<0.05; Figure 6.7).
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Figure 6.6: Extent of the cholinergic lesion. ChAT labeled cholinergic neurons (A,B), 
parvalbumin labeled GABA-ergic neurons (C,D) and AChE staining (E,F) in a 
representative lesioned (A,C,E) and sham operated rat (B,D,F). Scale bars, 0.1 mm (A-D) 
and 1.0 mm (E-F).
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Table 6.1: The number of cholinergic neurons counted in two sections for rats averaged 
over all experiments.
Group Number of ChAT positive neurons
Section 1 Section 2 Total
Control 164.67+/-9.54 161.33+/-21.91 326.00 +/- 22.64
AC 6.12+/-2.40 0.00 +/- 0.00 6.12+/-2.40
Stress 134.33 +/- 12.57 173.40 +/- 17.30 307.73 +/-22.34
AC-stress 5.43+/-2.14 3.36+/-2.10 8.79 +/- 3.96
Data are given as means +/- SEM. Control rats are from a separate experiment and 
included only as a general comparison.
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Figure 6.7: Choline acetyltransferase (ChAT) positive cell counts show a clear depletion 
in AC (98%) and AC-stress (97%) rats compare to Stress and Control rats. Control rats 
are from a separate experiment and included only as a general comparison. Data are 
given as means +/- SEM.
Lesioned animals had areas of necrotic cell death in the MS/VDB surrounding the
•*
injection site. This non specific damage has been reported previously (Heckers et al., 
1994; Frick et al., 2004) and work in our laboratory has shown no correlation between 
lesion size (due to focal necrosis following infusion of the toxin) and water maze or fear 
conditioning performance (data not shown). Analysis of Cresyl violet stained slides under 
a lOx objective did not reveal any changes in hippocampal structure (Figure 6.8).
182
Figure 6.8: There was no gross hippocampal damage found in any of the experimental 
groups. Cresyl Violet stained sections from an AC rat (A), an AC-stress rat (B) and a 
Stress rat (C). Scale bars, 0.5 mm.
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4. Discussion
In this study I show that the combination of two commonly occurring risk factors 
for AD (cholinergic depletion and chronic stress) specifically impairs performance in the 
water maze task, while having no effect on performance of fear conditioning to tone and 
context. The finding that these two factors could cause such a significant deficit was 
unexpected as both risk factors on their own have been previously found to have few or 
no effects on the behavioural tasks used here.
Cholinergic depletion of the medial septum has been extensively studied in our 
laboratory and others. To the best of my knowledge, there have been no reports of a 
spatial impairment in the water maze resulting from a specific cholinergic lesion of the 
medial septum (Baxter et al., 1995; Bizon et al., 2003; Frielingsdorf et al., 2006) and my 
finding here, of no impairment in my depleted rats, adds further support to the existing 
literature. A similar finding was evident in the fear conditioning task. While there have 
been no previous reports on fear conditioning following a specific depletion of the medial 
septum, Frick et al. (2004) completely damaged basal forebrain cholinergic neurons 
(including the medial septum) and found no difference in levels of freezing to tone or 
context. My results support their data and add to the growing body of literature 
describing the role of septo-hippocampal cholinergic projections in mediating cognitive 
processes.
Mild to moderate stress prior to learning is generally believed to have no effect on 
acquisition, but can impair retrieval and retention in certain situations (reviewed in Shors, 
2006). The variable restraint stress used here, had no effect on spatial memory as 
demonstrated in the current study, and previously by our laboratory using the water maze
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task (McDonald et al., 2008). Other groups have reported similar results Q n  spatial 
learning following mild stress (Luine et al., 1996; Gouirand et al., 2006, but see Radecki 
et al., 2005). Moreover, I did not observe any ‘learned helplessness’ behaviour in either 
of my stressed groups. This is in agreement with previous reports looking at the 
performance of rats in the water maze or forced swim test following restraint stress 
(Gregus et al., 2005; McDonald et al., 2008). The same pattern of results is found with 
fear conditioning. Here I have reported no effect on fear conditioning to tone and context 
following chronic stress. This supports the previous findings of Miracle et al. (2006), but 
Skorzewska et al. (2006) reported an enhancement following chronic CORT treatment. 
Taken together, these studies suggest that the type and length of stressor is critical to the 
appearance of a cognitive deficit. It is likely that although my variable stress procedure 
was able to increase CORT levels, it was not sufficient to alter performance on these 
tasks.
The impairment in the water maze, combined with successful performance on the 
fear conditioning task suggests that this was a hippocampal specific deficit. A similar 
pattern of results is observed following complete lesions of the hippocampus. Previous 
studies have shown that rats with anterograde damage to the hippocampus are 
consistently impaired on the acquisition of the spatial version of the water maze (Morris 
et al., 1982; Sutherland et al., 1983; Ferbinteanu and McDonald, 2003; McDonald et al., 
2005). Furthermore, rats with anterograde damage to the hippocampus are not impaired at 
either fear conditioning to cue or context; however, rats with damage to the hippocampus 
after training impairs retention of fear conditioning to context but not to cue (Phillips and 
LeDoux, 1992; Sanders et al., 2003; Wiltgen et al., 2006). It would be interesting to see
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whether the combination of cholinergic depletion and stress administered after contextual 
fear conditioning would have a negative effect on retention. While this study has not been 
performed, I suspect that would be the case, providing further support to my claim that 
my manipulation specifically affects the hippocampus. It was surprising, given the extent 
of the observed impairment in spatial memory, that I did not detect any obvious damage 
or structural changes in the hippocampus. This suggests that a more subtle mechanism is 
interfering with hippocampal processing resulting in the observed deficit.
Possible mechanisms for the negative effect of stress in cholinergic depleted rats
Chronic stress and decreased levels of acetylcholine (ACh) are both commonly 
found in the aged population (McGeer et al., 1984; Fischer et al., 1991; Lupien et al., 
1998; Baskerville et al., 2006; Montaron et al., 2006). Each of these factors has been 
shown to independently affect a number of mechanisms purported to lead to cognitive 
decline or memory deficits in the absence of gross hippocampal abnormalities. One way 
that decreased levels of ACh and chronic stress may interact to produce memory 
impairment is through their effects on neurogenesis. Hippocampal neurogenesis is 
believed to play a role in spatial learning and memory (Nilsson et al., 1999; Shors et al., 
2001; Snyder et al., 2005). Both increased CORT and decreased levels of ACh, on their 
own, have been shown to significantly decrease hippocampal neurogenesis in the young 
rat (Cooper-Kuhn et al., 2004; Heine et al., 2004; Moh&pel et al., 2005). The 
combination of the two factors would likely decrease levels even more which could alter 
hippocampal functioning, and potentially effect cognition and memory.
Changes in neuronal plasticity are a second possible way that chronic stress and 
cholinergic depletion could have negative effects on learning and memory. The
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cholinergic system has been implicated in mediating recovery from injury (Borlongan et 
al., 1995; Gonzalez et al., 2006) and in regulating the expression of neurotrophic factors 
such as brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF) 
(Knipper et al., 1994; French et al., 1999). Chronic exposure to glucocorticoids can lead 
to hippocampal atrophy and neuronal cell death (Magarinos and McEwen, 1995; 
Sapolsky, 2000). A functional cholinergic system may play a role in compensating for the 
negative effects of chronic stress in the hippocampus.
Support for the multiple combinations of co-factors theory of aging
Previous work from our laboratory (Driscoll et al., 2007; McDonald et al, 2008) 
has suggested that the presence of a passive risk factor prior to the occurrence of an 
active risk factor results in increased hippocampal cell death leading to behavioural 
deficits. In the current study, I have proposed that the impairment results from the 
interaction of two passive risk factors, caused by an alternative mechanism, independent 
of gross hippocampal damage. This pattern of data suggests that different mechanisms 
underlie the cognitive deficits in the active/passive versus the passive/passive risk factor 
combinations. While the exact mechanism behind this vulnerability and resultant 
impairment is unknown, it is likely that reductions in neurogenesis, and subtle damage 
caused by prolonged exposure to CORT, in the absence of the neuroprotective effects of 
ACh, has prematurely ‘aged’ these rats to a stage where cognitive impairments become 
apparent.
Conclusion
Here I have shown that the interaction of two passive factors (cholinergic 
depletion and stress) commonly found in the elderly population can lead to impairment in
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hippocampal dependent learning and memory. My findings suggest a role for the 
cholinergic system in providing protection for hippocampal neurons, or mediating 
compensatory mechanisms following injury. I do not see the decline in ACh levels in the 
elderly as a causal factor, but instead, as an important risk factor that leads to the 
increased susceptibility of an individual to develop AD. Fully understanding the 
contribution of multiple different risk factors for AD, especially that of ACh, and their 
interactions with one another could be vital to describing an accurate etiology of AD. 
From that etiology, a series of effective treatment plans could be designed dependent on 
the specific risk factors present in each individual case.
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Chapter 7
Cholinergic depletion of the medial septum followed by phase shifting has no effect on
circadian rhythms or memory in rats
Modified from a paper submitted to Brain Research Bulletin. 
by Laura A. Craig, Nancy S. Hong, Joelle Kopp and Robert J. McDonald in 2008
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Abstract
The robustness of an individual’s circadian rhythms has been correlated with the quality 
of their cognitive aging. This has been observed in both human and non-human animals 
and circadian rhythms are especially disrupted in patients with Alzheimer’s disease (AD). 
It is possible that the circadian disruption observed in AD contributes to the cognitive 
decline in these patients; however, this has not been conclusively proven. A common 
observation in AD patients is the loss of basal forebrain cholinergic neurons, some of 
which project to the suprachiasmatic nucleus (SCN) responsible for maintaining circadian 
rhythms. I was interested to see if cholinergic depletion increased susceptibility to 
circadian disruption, and to explore possible interactions between these two factors on 
measures of learning and memory. I damaged the cholinergic neurons of the medial 
septum in rats using the specific immunotoxin 192 IgG Saporin and then disrupted 
circadian rhythms using a six day phase shifting procedure. I looked at measures of 
circadian rhythmicity, as well as behaviour on tasks designed to test hippocampal 
dependent (water maze) or hippocampal independent (fear conditioning) learning and 
memory. I found no difference between the groups on any of the measures examined 
suggesting that the cholinergic depletion of the medial septum does not increase 
susceptibility to circadian disruption, and that this combination of risk factors does not 
contribute to learning and memory impairments.
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1. Introduction
The suprachiasmatic nucleus (SCN) in the brain is responsible for maintaining 
daily circadian rhythms (Antle and Mistleberger, 2005).The responsiveness of the SCN to 
light can be affected by cholinergic projections originating in the basal forebrain and 
brainstem nuclei (Bina et al., 1993, 1997). Several studies have provided evidence for a 
role of cholinergic signaling in the maintenance of circadian rhythmicity. Specifically 
SCN acetylcholine (ACh) has been shown to be up-regulated in response to light and 
infusions of cholinergic agonists can mimic the phase shifting effects of a light pulse 
(Zatz and Herkendam, 1982; Murakami et al., 1984; Ferguson et al., 1999). Moreover, 
cholinergic antagonists such as mecamylamine can block the phase shifting effects of a 
sub maximal light pulse (Keefe et al., 1987; Zhang et al., 1993). These studies suggest a 
role for ACh in the maintenance of healthy circadian rhythms.
Loss of cholinergic activity in the brain is common in AD patients. It is possible 
that the decrease in ACh reduces the ability of the SCN to respond appropriately to light 
leading to increased circadian disruption during aging. Circadian disruption is a common 
complaint in patient’s suffering from AD and has been associated with cognitive 
impairments in both rats and humans (Fekete et al., 1985; Bonnet, 1989; Stone, 1989; 
Antoniadis et al., 2000). Antoniadis et al. (2000) have shown the strength of the circadian 
rhythm is correlated with the quality of cognitive aging in animals. Patients suffering 
from Alzheimer’s disease consistently report a number of circadian disturbances 
including disrupted sleep, shortened REM and increase night time awakenings (Moe et 
al., 1995; Hatfield et al., 2004). It is possible that the circadian disruption observed in AD
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patients may actually be contributing to the severity of the dementia, and to the 
progressive worsening of the disorder.
In the current experiment, I was interested in the effects of damaging the 
cholinergic neurons of the medial septum on measures of circadian rhythmicity and the 
ability of the rat to re-entrain following a series of phase shifts. Previous studies 
damaging cholinergic basal forebrain neurons found decreases in neuropeptide synthesis 
in the SCN that could affect the strength of the circadian clock (Madeira et al., 2004). 
Damaging the clock could lead to increased reliance on external zeitgebers (time cues 
used to reset the clock such as light, food and social contacts). With this in mind I 
predicted that depleted rats would have more difficulty re-entraining to a novel light/dark 
(LD) cycle following phase shifting than controls.
I was also interested in exploring the effects of cholinergic depletion and phase 
shifting on measures of learning and memory. Previous work in our laboratory has 
suggested increased hippocampal vulnerability following medial septal cholinergic 
lesions in rats (Craig et al., 2008). Circadian disruption induced by phase shifting has 
been reported to affect a number of mechanisms that can be detrimental to hippocampal 
function, such as stress (Sakelleris et al., 1975; Cho, 2000; Cho et al., 2001), abnormal 
neuronal spiking (Buzsaki, 1984), changes in the secretion pattern of hormones such as 
melatonin and cortisol (Moore-Ede et al., 1984; Goichot et al., 1998) and sleep 
disturbances (Sei et al., 1992; Ohayon et al., 2002). Moreover, repeated phase shifts have 
been shown to impair spatial memory in rats, while a single phase shift had no effect 
(Craig and McDonald, 2008). I predicted that in the absence of a functional cholinergic
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system, rats would be less able to cope with the negative effects of a single session of 
phase shifting and exhibit cognitive impairment.
Here I looked at the effects of phase shifting in rats following cholinergic 
depletion of the medial septum. I predicted that these rats will be impaired in their ability 
to re-entrain following a single phase shifting session. I also expected that the combined 
group would demonstrate a specific impairment in the water maze task, while retaining 
the ability to successfully learn a fear conditioning to tone and context task. This would 
suggest that a hippocampal specific deficit had resulted from the converging effects of 
phase shifting and cholinergic depletion on hippocampal functioning.
Experiment 1: The effects of cholinergic depletion of the medial septum on measures 
of circadian rhythmicity and their response to phase shifting
My first experiment was designed to detect changes in the ability of the rat to 
entrain to a 12 hour LD schedule following cholinergic depletion of the medial septum. I 
then looked at the ability of these rats to re-entrain to a novel LD schedule after six days 
of circadian disruption.
2.1. Materials and Methods 
Animals
Forty male Long Evans hooded rats (300-400g) were obtained from Charles 
River (Saint-Constant, PQ) and used for both experiments. Rats were divided into four 
groups: AC (n=T0) had a cholinergic depletion only; Phase shift («=11) had a sham 
surgery and then were phase shifted; AC-phase shift (n=10) had a cholinergic depletion 
and then were phase shifted; and Control (n=10) had a sham surgery only. Animals were 
housed individually in polypropylene cages equipped with a 42.5 cm diameter running
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wheel, with food and water ad libitum. Rats were originally entrained to a 12 hour LD 
schedule with lights off at 19:30. All animals were handled in accordance to guidelines 
set out by the Canadian Council for Animal Care.
Surgery
Surgery was performed under Isoflurane anaesthesia (4% with 2.0 L/min of 
oxygen for induction and 2% after surgical plane was established) in a standard 
stereotaxic apparatus. An incision was made in the scalp and periosteum down the 
midline. The fascia was pushed to the edges of the skull with a sterile gauze swab and 
the skin retracted to expose the skull surface. Holes were drilled into the skull using a 1 
mm drill bit attached to a high speed drill. Following surgery all animals were given 
buprenorphine (Temgesic; 0.1 mg/kg subcutaneously) as an analgesic.
Cholinergic depletion
The specific neurotoxin 192 IgG Saporin (IgG SAP; Chemicon) has been 
commonly used to induce selective cholinergic lesions in rats depending on the site of 
infusion. I chose to damage cholinergic neurons in the medial septum and vertical limb of 
the diagonal band of Broca (MS/VDB) which leads to a reduction in levels of 
hippocampal acetylcholinesterase (AChE). I lowered a 30 gauge cannula, through holes 
drilled in the skull, into the MS/VDB (AP +0.45; ML +/-0.6; DV -6.6 and -8.0 mm from 
bregma and the skull) and bilaterally infused IgG SAP-[0.15 pg/pl dissolved in sterile lx 
phosphate buffer saline (PBS; pH 7.4)] at a rate of 0.05 pl/min using a Harvard mini­
pump. Each animal received a total volume of 0.3 pi per side at the first injection site 
(DV -8.0), and 0.2 pi per side at the second site (DV -6.6). The cannula was left in place 
for six and four minutes after the first and second injection respectively to ensure
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diffusion of the toxin. Sham operated rats underwent the identical procedure except they 
were infused with lx sterile PBS instead of IgG SAP.
Phase Shifting
The phase shifting procedure used here was designed to create a state of circadian 
disruption for a specified length of time (six days) and to look at the ability of the rats to 
partially re-entrain prior to behavioural testing. This procedure has been previously used 
in our laboratory to examine learning and memory following circadian disruption (Devan 
et al., 2001; Craig and McDonald, 2008). Animals were phased advanced by three hours 
a day for six days. This phase advancement was followed by ten days of re-entrainment 
to allow the animals a partial recovery (ten days is approximately half the normal re­
entrainment time required in this paradigm; Devan et al., 2001). Table 7.1 shows the time 
of lights off for the duration of the phase shifting procedure.
Table 7.1: Schedule of phase shifting used to induce circadian disruption
DAY
1 Lights off at 16:30
2 Lights off at 13:30
3 Lights off at 10:30
4 Lights off at 07:30
5 Lights off at 04:30
6 Lights off at 01:30
7-16 Re-entrainment: Lights off at 22:30
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Data Collection
Animals were housed individually in polypropylene cages equipped with a 42.5 
cm diameter running wheel attached via a microswitch to a computer. Animals were 
exposed to a 12 hour LD cycle and activity (wheel running) was monitored continuously 
using a ClockLab data analysis and collection system for circadian rhythms. Actograms 
for each animal were double plotted to clearly show general patterns of activity. Total 
activity per day, percentage of activity during the light phase, and period length were 
calculated for each animal using the ClockLab analysis program (ActiMetrics Software). 
All three measures were calculated for the four days before surgery (baseline), four days 
prior to the start of phase shifting session (pre) and for the four days following phase 
shifting (post). Activity was recorded in wheel revolutions per minute, and was separately 
calculated for the light phase as well as total activity per day. The period was calculated 
by fitting a regression line to activity onsets using ClockLab analysis software.
3.1. Results
Five rats assigned to the AC and AC-phase shift groups were removed from this
experiment due to incomplete cholinergic lesions (< 40% cell loss). The following
histological, behavioural and circadian rhythms analyses include six animals in the AC
group and eight rats in the AC-phase shift group. Circadian rhythms were continuously
•*
recorded throughout the study using a running wheel connected to a computerized data 
collection system. Due to minor technical difficulties with the microswitches on the 
wheels, the data from one or two days was occasionally lost for individual rats. For these 
rats, the averages were calculated from the remaining days in each time segment.
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Circadian rhythms
A representative actogram is shown from each group illustrating the initial 
entrainment, phase shifting and re-entrainment for a Control rat (Figure 7.1 A), a Phase 
shift rat (7.IB), an AC rat (7.1C), and an AC-phase shift rat (7. ID).
A
Figure 7.1: Representative actograms from a Control rat (A), a Phase shift rat (B), an AC 
rat (C) and an AC-phase shift rat (D) showing initial entrainment, phase shifting and re­
entrainment. Actograms are double plotted over forty eight hours for clarity. Each 
horizontal line represents two days, and the vertical bands represent wheel running. The 
shaded portions refer to when the lights were off.
During the initial entrainment the rats predictably began running shortly after 
lights off and ceased running when the time lights came on again. These onsets were used 
to determine the period length for each animal. The period was calculated for the four 
days before surgery (baseline), the four days before the phase shift (pre) and the four days
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immediately following the phase shift (post). All groups had a near 24 hour period which 
was not significantly affected by the phase shift (see Table 7.2 for a summary of 
circadian rhythm measures). A two-way mixed analysis of variance (ANOVA) with 
Group (Control versus AC versus Phase Shift versus AC-phase shift) as a between 
subjects variable, and Phase shift (baseline versus pre versus post) as the repeated 
measure found a marginally significant effect of group [F(3,28)=2.95,_p=0.05], but no 
effect of phase shift [i7(2,56)=0.61, /?=0.55] and no interaction [i?(6,56)=2.01,p=0.08]. 
Tukey post hoes found no difference between groups ip's<0.05).
Activity analysis
Normal rats will confine the majority of their activity to the dark phase of the
light cycle, while spending the light phase resting. Therefore, the proportion of activity
during the light phase (light activity) is a good measure of rhythm fragmentation. During
the initial entrainment the rats predictably confined their activity to the dark phase.
Following the first phase shift, there was a slight increase in the proportion of light
activity in both phase shifted groups, but this increase was not significant (Table 7.2). A
two-way mixed ANOVA with Group as a between subjects variable and Phase Shift
(three levels) as the repeated measure found no effect of group [i7(3,28)=0.39,/?=0.76] or
phase shift [F(2,56)=0.82,/?=0.45] and no interaction [F(6,56)=1.63,/?=0.16].
■*
I also looked at total daily activity and found all groups decreased their activity 
over the course of this study. Total daily activity, measured as counts per day (cpd; one 
wheel revolution is equal to one count) was highest during initial entrainment (1645.54 
+/- 351.12 cpd averaged over all groups) and gradually decreased after surgery (897.83 
+/- 199.89 cpd), and again after the phase shift (827.82 +/- 190.77 cpd). This drop in
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activity was most likely due to the effects of surgery (depletion or sham) and there were 
no differences between groups (Table 7.2). A two-way mixed ANOVA with Group as a 
between subjects variable, and Phase Shift (three levels) as the repeated measure found a 
significant effect of phase shift [F(2,56)=3.61,/?<0.05], but no effect of group 
[F(3,28)=0.96,/?=42] and no interaction [F(6,56)=0.30,/?=94]. Tukey post hoes revealed 
that all groups became slightly less active following surgery (p=0.06) and following the 
phase shift were significantly less active (p’s<0.05).
There were no effects of cholinergic depletion of the medial septum on the ability 
of rats to entrain to a 12 hour LD schedule. Following phase shifting, there were no 
differences between groups on measures of period length, total activity and rhythm 
fragmentation.
Table 7.2: Measures of circadian rhythmicity
Control AC Phase shift AC-phase shift
Total Baseline 921.61 +/-248.27 1514.65+/-465.17 1843.92+/-701.30 2268.97 +/- 1026.24
Activity Pre 603.95 +/- 154.38 513.96+/- 130.70 1173.93+/-347.04 1173.44+/-712.75
Post 632.17+/- 189.30 483.83 +/- 242.85 1062.36+/-339.10 964.86 +/- 627.50
Light Baseline 13.80+/-3.86 13.96 +/- 3.92 10.33 +/-1.63 9.47 +/- 2.57
Activity Pre 10.50+/-2.19 13.58 +/- 2.62 12.03 +/- 2.48 14.30 +/- 3.54
Post 9.04+/- 1.73 10.85+/-4.23 19.77 +/- 3.73 17.31 +/- 4.27
Period Baseline 24.04 +/- 0.09 23.94 +/- 0.07 23.99+/-0.11 23.96 +/- 0.07
Pre 24.07 +/- 0.09 24.16+/- 0.05 24.11 +/-0.08 24.00 +/- 0.07
Post 23.86+/- 0.07 23.84 +/- 0.08 24.50+/-0.15«* 24.00 +/- 0.30
Data are given as means +/- SEM. Total activity is measured in counts per day, Light 
activity is measured as % of total activity and Period is measured in hours.
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Experiment 2: The effects of cholinergic depletion of the medial septum followed by 
phase shifting on measures of learning and memory
This experiment was designed to explore the effects of cholinergic depletion of 
the medial septum and phase shifting on measures of learning and memory. Rats were 
tested on a version of the spatial water maze task as a test of hippocampal dependent 
memory and on fear conditioning to tone and context to examine hippocampal 
independent memory.
2.2. Materials and Methods:
Animals
The same animals used in Experiment 1 were used for behavioural testing. 
Behavioural Testing
Behavioural testing began ten days following the phase shifting session. To 
control for possible effects of circadian phase on performance, all groups were tested at 
the equivalent circadian phase. Phase shifted rats were tested at 13:30 (three hours after 
lights on), while non-phase shifted rats were tested at 10:30 (three hours after lights on). 
Behavioural testing consisted of a six day version of the water maze task to test for 
deficits in hippocampal processing, followed by three days on a cued and contextual fear 
conditioning task.
Water maze: Rapid Acquisition Task
I used a three stage spatial version of the water maze task (McDonald et al. 2005). 
A white plastic circular pool 1.4 m in diameter and 40 cm deep was filled to within 20 cm 
of the top of the wall with water (20-22°C) made opaque by adding skim milk powder.
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The invisible platform was 12 cm in diameter and made of white Plexiglas with holes 
drilled into the top of it to provide grip for the animals. During training the platform was 
submerged 2 cm under water. Extra-maze cues in the training room included five posters 
of different sizes and orientations mounted on three of the four walls, a computer rack, a 
door, an animal rack and the experimenter. Four different start points were used [N, S, E, 
W (not true compass headings)], equally spaced around the pool. The order was 
randomly selected for each day and each start point was used twice for days one to four 
and day six. On day five only the three start points farthest from the platform were used 
(N, E, S) with the initial start point repeated at the end for a total of 16 trials.
In the first stage (Original location training) rats were trained over four days for 
eight trials a day, to swim to a fixed, spatial location. Twenty four hours after completion 
of stage one the second stage (New location training) began. This stage consisted of new 
spatial location training as animals were re-trained to swim to the new platform location 
over sixteen trials within two hours on a single day. Stage two allowed me to ask if rats 
could learn to go to a new location, during a single intensive training session. The third 
stage (Re-training to original location) occurred twenty four hours after stage two with 
the platform returned to its original (stage one) location and each animal was given eight 
trials. This stage allowed me to ask how the massed new location training during stage 
two affected re-learning to the original location.
This version of the water maze was selected due to its sensitivity to hippocampal 
damage. The first stage allowed me to identify impairment in acquisition and short term 
memory of an invariant location. If no differences were apparent, the second stage would 
test the ability of the rat to rapidly form a novel representation in a familiar context. For
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the third stage the rats are required to re-leam the original location. There is evidence that 
these stages place a higher-demand on hippocampal function so they may allow me to 
detect more subtle hippocampal dysfunction (McDonald et al., 2005).
Data collection: A computer based rat tracker (Ethovision) was used to collect and 
analyze data obtained from an overhead video camera. If a rat did not reach the platform 
60 seconds after release, the rat was guided manually to the platform and allowed to 
remain on the platform for 10 seconds before being removed to a holding cage until the 
next trial. For all three stages the measure of performance was latency to platform (in 
seconds) as well as path length to platform (in meters). Path length is a highly sensitive 
measure that can control for potential differences in swim speed between groups.
Fear conditioning
Twenty four hours after the final day of water maze training, rats were tested on a
fear conditioning task. A three day procedure was used to assess fear conditioning to tone
and to context. Animals were placed into Context A (an operant chamber, metal walls,
bars on floor, scented with Quatsyl®~D Plus disinfectant) and allowed to habituate for
two minutes. They were presented with a 10 second tone (80 db), followed by a two
second shock (1.0 mA). This tone-shock pairing was repeated every 70 seconds for five
repetitions. Sixty seconds following the final shock, the animals were removed from the
*
chamber, and returned to their home cage. Twenty four hours later the animals were 
placed in a novel context, Context B (Plexiglas walls, bedding on the floor, unscented), 
and after two minutes of habituation, were presented with an eight minute tone (80 db), 
with no shock and scored for freezing behaviour. Freezing behaviour is commonly used 
as a reliable measure of fear, and can be defined as a period of complete immobility
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except for breathing movements in the animal (Blanchard and Blanchard,,1969). Forty 
eight hours later animals were returned to Context A for a five minute trial (no shock, no 
tone) to assess freezing behaviour in response to the original conditioning context.
3.2. Results
Water maze: Rapid Acquisition Task
Original location training
The results of the original platform location training are depicted in Figure 7.2A. 
There were no differences between groups as all rats were able to learn the platform 
location during the original location training stage of this task. All groups showed a 
significant decrease in latency to find the platform from day one (26.67 +/- 3.25 seconds) 
to day four (7.67 +/- 0.87 seconds). The latency (in seconds) to find the platform was 
recorded and averaged over the eight daily trials to obtain a single daily latency score for 
each animal. The daily scores for all four days of original location training were 
subjected to a two-way mixed ANOVA with Group (AC-phase shift versus AC versus 
Phase shift versus Control) as the between subjects variable, and Training Day (four 
levels) as a repeated measure, and revealed a significant effect of day [F(3,93)=90.91, 
/K0.01], but no effect of group [F(3,31)=2.14,/?=0.12] or interaction [A(9,93)=0.64, 
p=0.76].
The same pattern of results was found using path length to platform as the 
dependent variable (7.2B). This is a highly reliable measure that can control for potential 
differences in swim speed. A two-way mixed ANOVA with Group as a between subjects 
variable and Training Day as a repeated measure, revealed a significant effect of day
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[F(3,93)=l 00.26, /K0.01], but no effect of group [F(3,31)=2.02,/>=0.13] or interaction 
[F(9,93)=0.51, ji?=0.86].
New location training
The platform was moved to the opposite quadrant of the pool and the latency (in 
seconds) to find the new platform location was recorded and averaged into eight discrete 
trial blocks (two trials per block). There were no differences between groups in their 
ability to rapidly acquire a new platform location on this stage of the task (Figure 7.2C). 
All groups showed a significant decrease in latency to find the platform from trial block 
one (34.90 +/- 5.09 seconds) to trial block eight (8.72 +/- 2.57 seconds). A two-way 
mixed ANOVA with Group as a between subject variable and Trial Block (eight levels) 
as a repeated measure, was used to assess the new location training and found a 
significant effect of trial block [F(7,217)=42.15,/><0.01], but no effect of group 
[F(3,31)=T.34,/?=0.28] or interaction [F(21,217)=1.34,/?=0.15].
The same pattern of results was observed using path length to platform as the 
dependent measure (7.2D). A two-way mixed ANOVA with Group as the between 
subjects variable and Trial Block as the repeated measure was performed and found a 
significant effect of trial block [F(7,210)=43.74,/?<0.01], but no effect of group 
[F(3,30)=1.38,/?=0.27] or interaction [F(21,210)= 1.02, £=0.44],
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Figure 7.2: All groups were able to successfully learn all stages of the spatial water maze 
task. Both latency to platform and path length data is shown for all groups on original 
location training (A,B), new location training (C,D) and re-training to the original 
platform location (D,E). Data are given as means +/- SEM.
Re-training to original location
The platform was returned to the original location (from the acquisition phase) 
and the latency (in seconds) to find this location was recorded over eight trials on the 
final day of testing. The results of the re-training trials are displayed in Figure 7.2E 
showing that all groups were able to re-leam the original location. All groups showed a 
significant decrease in latency to find the platform from trial one (19.95 +/- 5.12 seconds) 
to trial eight (6.72 +/- 2.01 seconds). A two-way mixed ANOVA, with Group as the 
between subjects variable, and Trial (eight levels) as a repeated measure revealed a 
significant effect of trial [F(7,217)=42.15,jp<0.01], but no effect of group [F(3,31)=1.34, 
p=0.28] or interaction [F(21,217)=1.34, p=0.15].
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The same pattern of results was seen using path length to platform : as the 
dependent measure (7.2F). A two-way mixed ANOVA with Group as the between 
subjects measure and Trial as the repeated measure revealed a significant effect of trial 
[F(7,196)=9.34,p<0.01], but no effect of group [F(3,28)=0.28, p=0.84] or interaction 
[F(21,196)=1.07,p=0.38].
There was no effect of combining cholinergic depletion and phase shifting on 
performance of rats on a hippocampal dependent task (water maze). All groups were able 
to successfully learn the platform location on all three stages of the water maze task.
Fear conditioning
The three day fear conditioning procedure used here was designed to test 
hippocampal independent learning and memory on two related tasks: fear conditioning to 
tone (cue) and to context. A malfunction with the shock boxes resulted in ten rats being 
removed from the analysis, leaving the final groups as follows: AC- n=3; AC-phase shift- 
n=6; Phase shift- n=9 and Control- n=l.
Conditioning to tone
All groups were able to learn the tone-shock association, and showed an increase 
in freezing behaviour in the presence of the tone. The percentage of freezing during the 
first four minutes exposed to the tone was calculated andcompared to the Context B 
habituation period. This percentage of freezing for all groups was significantly greater in 
the presence of the tone (72.28% +/- 9.54% versus 18.12% +/- 4.47%; Figure 7.3A). A 
two-way mixed ANOVA with Group as a between subjects variable, and Tone 
(habituation versus tone presentation) as a within subjects variable, revealed a significant 
effect of tone [F(l,21)=77.72,p<0.001], but no group effect [F(3,21 )=2.22, p=0.12] or
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interaction [F(3,21)=0.83, p=0A9\. Tukey post hoes showed that all groups froze 
significantly more in the presence of the tone (p’s<0.05).
Conditioning to context
All groups were able to learn the context-shock association, and showed an 
increase in freezing behaviour when returned to Context A on day three. I measured the 
percentage freezing for the total time exposed to Context A on day three and compared it 
to the Context A habituation on day one. The percentage of freezing to context for all 
groups was significantly greater on day three compared to day one, although AC-phase 
shift and Phase shift rats showed a larger increase in freezing behaviour compared to AC 
and Control rats (69% and 78% increase in AC-phase shift and Phase shift rats versus 
45% and 37% increase in AC and Control rats; Figure 7.3B). A two-way mixed ANOVA 
with Group as a between subjects variable, and Context (day one versus day three) as a 
within subjects variable, revealed a significant effect of context [A(l,21)=265.28, 
/><0.01], and of group [F(3,21 )=3.15, p=0.046], but no interaction [F(3,21)=2.17, 
p=0.12], Tukey post hoes showed that all groups froze significantly more to the context 
on day three (p’s<0.05). Further analysis of the group effect using Tukey post hoes found 
no difference between groups, however Holm-Bonferroni post hoes revealed significantly 
more freezing in AC-phase shift and Phase shift rats when compared to Control rats 
(p’s<0.05).
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Figure 7.3: Performance on the fear conditioning task. There was no impairment in any 
of the groups on either fear conditioning to tone (A) or to context (B). Both phase shifted 
groups exhibited significantly more freezing in response to tone, but all groups 
demonstrated successful conditioning to tone in this task. Data are given as means +/-
SEM.
Following the combination of cholinergic depletion and phase shifting, rats
retained their ability to successfully learn a hippocampal independent task (fear
conditioning to tone and context). Moreover, the phase shifting appears to enhance
freezing behaviour as both AC-phase shift and Phase shift rats tended to freeze more than
*■»
AC or Control rats.
Histology
Following behavioural testing all animals were sacrificed with an overdose of 
Euthanol and transcardially perfused with lx PBS followed by 4% (w/v) 
paraformaldehyde (PFA). The brains were carefully extracted and placed in 4% PFA at
208
4°C for 24 hours. Brains were then transferred to a 30% (w/v) sucrose solution, 
containing 0.02% (w/v) sodium azide at 4°C for at least three days. Brains were sectioned 
on a freezing cryostat at 40 pm in a series of five. The first two sections of each series 
were mounted onto 1% (w/v) gelatin/0.2% (w/v) chromalum coated slides, while the 
third, fourth, and fifth series were stored in lx PBS containing 0.02% (w/v) sodium azide 
at 4°C until being processed for immunohistochemistry. The fifth series was not used in 
this experiment and was stored for future analyses.
Cresyl violet staining
The first series was stained with Cresyl violet and examined under a lOx objective 
to detect any gross hippocampal damage.
AChE staining
The second series was stained for AChE to get a qualitative image of cholinergic
depletion in the hippocampus. I treated the slides for 30 minutes with 6.24 mg
tetraisopropylpyrophosphoramide (Sigma) dissolved in 200 mL of distilled water, then
rinsed the slides twice with distilled water and incubated them on a shaker table for four
hours in a reaction mixture containing 5.72 g Trizma maleate, 2.04 g Trizma base, 100
mg acetylthiocholine iodide, 294 mg dihydrous trisodium citrate, 150 mg anhydrous
cupric sulphate, 32.8 mg potassium ferricyanide dissolved in 200 mL distilled water (all
«*
chemicals were obtained from Sigma). Slides were rinsed twice with distilled water, and 
left to dry overnight, then cleared with HemoDe (Sigma) and coverslipped with Permount 
(Sigma) the next day.
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Immunohistochemistry
The third and fourth series were processed for immunohistochemistry to 
determine the completeness and specificity of the cholinergic depletion. An antibody 
raised against parvalbumin was used to label y-aminobutyric acid (GABA)-ergic neurons, 
and one against choline acetyltransferase (ChAT) was used to label cholinergic neurons. 
Free floating sections were rinsed in lx PBS, and then placed in a 3% (v/v) H2O2 solution 
for four minutes to block endogenous peroxidases. After three washes in lx PBS, 
sections were blocked for 30 minutes in 15% (v/v) normal horse serum (for anti- 
parvalbumin) or 15% (v/v) normal rabbit serum (for anti-ChAT). Sections were incubated 
overnight in primary antibody [anti-ChAT polyclonal, 1:1000 (Chemicon) or anti- 
parvalbumin monoclonal, 1:5000 (Sigma)] diluted in lx PBS with 7.5% (v/v) serum 
(horse for anti-parvalbumin; rabbit for anti-ChAT). Sections were then washed three 
times in lx PBS and incubated for 30 minutes in a biotinylated secondary antibody [ABC 
Elite Kit (mouse for parvalbumin and goat for ChAT), Vector Labs], washed three times, 
incubated for 30 minutes with AB reagent (ABC Elite Kit, Vector Labs), washed three 
times then developed with diaminobenzidine (DAB) substrate (Vector Labs) according to 
the manufacturer’s instructions. Sections were then mounted onto 1% (w/v) gelatin/0.2% 
(w/v) chromalum coated slides, air dried overnight, dehydrated in alcohol, cleared in 
HemoDe and coverslipped with Permount (Sigma).
Cell counts: Under light microscopy (AxioVision) ChAT positive neurons were counted 
in both hemispheres of the MS/VDB. I chose two sections to quantify; the first, at the site 
of injection and the second, in a section 200 pm caudal to the injection site. This 
quantification was not used as an accurate count of MS/VDB neurons, but instead to
210
estimate the completeness of the cholinergic depletion. Each hemisphere was counted 
separately to confirm lesion symmetry, after which counts for both hemispheres were 
totaled for a representative cell count over the two sections. I combined the ChAT 
positive cell counts from the Phase shift and Control groups, and used this average to 
determine the percent depletion for the AC and AC-phase shift groups. Any animal with 
less than 40% depletion was excluded from the experiment.
Histological Results
Quantification o f cholinergic lesion
I confirmed the completeness and specificity of the cholinergic lesion of the 
medial septum in both the AC and AC-phase shift groups through AChE staining and 
immunohistochemistry for ChAT and parvalbumin. Lesioned animals had very few 
ChAT positive cholinergic neurons (Figure 7.4A-C) combined with intact parvalbumin 
labeled GABA-ergic neurons outside the area of necrosis, confirming the specificity of 
the lesion to cholinergic neurons (7.4D-F). The AChE staining showed a depletion of 
cholinergic activity in the hippocampus in lesioned animals compared to the sham 
operated groups (6G -I).
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Figure 7.4: Extent of the cholinergic lesion. ChAT labeling in the MS/vDB of a Control 
rat (A), an AC rat (B) and an AC-phase shift rat (C) confirm the near total loss of 
cholinergic neurons in this area following infusion of IgG SAP. Parvalbumin labeled 
GABA-ergic neurons in the MS/vDB from a Control rat (D), an AC rat (E) and an AC- 
phase shift rat (F) confirm the specificity of this lesion to cholinergic neurons. Normal 
AChE staining apparent in the dorsal hippocampus (lx) of a Control rat (G) is reduced 
following cholinergic depletion in the hippocampus of an AC rat (H) and an AC-phase 
shift rat (I). Scale bars, 0.1 mm (A-F) and 1.0 mm (G-I).
I quantified the extent of the cholinergic lesion by comparing the ChAT positive
*»
cell counts between groups. I combined the ChAT positive cell counts from the Phase 
shift and Control groups, and used this average to determine the percent depletion for the 
lesioned groups. I found 70.91 +/- 3.73% depletion in the AC group and 71.04 +/- 8.00% 
depletion in the AC-phase shift group. An independent samples t-test showed no 
significant difference between the amount of depletion in the two groups [/(12)=-0.01,
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p=0.99]. There were significantly fewer cholinergic neurons in AC and AC-phase shift 
compared to the Phase shift and Control group [Table 7.3; F(3,31)=13.52,/K0.01]. 
Tukey post hoes showed that the AC and AC-phase shift groups had significantly fewer 
ChAT positive cells than either of the Phase shift and Control groups (p’s<0.05; Figure 
7.5).
Table 7.3: The number of cholinergic neurons counted in two sections.
Group Number of ChAT positive neurons
Section 1 Section 2 Total
Control 93.90 +/- 8.67 106.30+/- 12.34 200.20+/- 17.61
AC 26.00 +/- 6.49 33.50 +/- 6.47 59.50 +/- 7.62
Phase shift 89.91 +/- 16.75 118.64+/-15.51 208.55+/- 28.81
AC-phase shift 21.13+/-6.70 38.13+/-10.43 59.25 +/- 16.34
Data are given as means +/- SEM.
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Figure 7.5: Choline acetyltransferase (ChAT) positive cell counts show a clear depletion 
in AC (71%) and AC-phase shift (71%) rats compare to Phase shift and Control rats. Data 
are given as means +/- SEM.
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Figure 7.6: Photomicrographs (5x) of Cresyl violet stained hippocampal sections from a 
Control rat (A), a Phase shift rat (B) and an AC-phase shift rat (C) showing no obvious 
damage. Scale bars, 1.0 mm.
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Lesioned animals had areas of necrotic cell death in the MS/VDB surrounding the 
injection site. This non specific damage has been reported previously (Frick et al. 2004) 
and work in our laboratory has shown no correlation between lesion size (due to focal 
necrosis following infusion of the toxin) and water maze or fear conditioning 
performance (data not shown). Analysis of Cresyl violet stained slides under a lOx 
objective did not reveal any changes in hippocampal structure (Figure 7.6).
4. Discussion
Here I show that a specific cholinergic depletion of the medial septum has no 
effect on the rats’ ability to entrain to light, or to re-entrain following phase shifting. 
Moreover, the combination of cholinergic depletion and phase shifting did not affect 
learning and memory on the tasks used here. All four groups were able to learn the 
location of both platforms during water maze training and successfully demonstrate fear 
conditioning to both tone and context. There was a slight increase in the amount of 
freezing observed in the groups that had been phase shifted dining contextual fear 
conditioning. This was likely due to the stress of the phase shift (Sakellaris et al., 1975) 
as increased freezing during this task has been reported previously in rats treated 
chronically with corticosterone (CORT; Skorzewska et al., 2006). There were no 
differences between the two phase shifted groups, suggesting that the cholinergic 
depletion did not modify this behaviour. In addition, all four of the groups exhibited 
increased freezing when returned to the original context demonstrating that they were 
able to learn this task. Histological analyses of the lesion confirmed a specific loss of 
cholinergic neurons in the MS/VDB and a corresponding reduction of AChE staining in 
the hippocampus.
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The lack of impairment in spatial memory in my combined group (cholinergic 
depletion and phase shifting) was an unexpected finding. Specific depletion of medial 
septal cholinergic neurons does not impair learning and memory on either water maze 
(Baxter et al., 1995; Bizon et al., 2003; Frielingsdorf et al., 2006) or fear conditioning 
(cued and contextual) tasks (Frick et al., 2004; Craig et al., 2008); however, previous 
work in our laboratory has suggested that this depletion increases hippocampal 
vulnerability to secondary insults, such as stress, non-convulsive seizures and sub­
threshold stroke (Craig et al., 2008; Craig et al., submitted). When these secondary risk 
factors are presented at sub-threshold levels, there is no effect on learning and memory, 
but in rats with a cholinergic depletion of the medial septum, these combinations lead to 
impairment on the spatial version of the water maze task in the absence of a general 
performance deficit (Craig et al., 2008; Craig et al., submitted). I expected a similar 
pattern of results to appear with the combination of phase shifting and cholinergic 
depletion. The observation that this combination does not impair learning, stresses the 
importance of recognizing what risk factors, and importantly, which combination of risk 
factors play a role in the development of dementia.
Cholinergic projections and circadian rhythms
The discovery of cholinergic projections from the basal forebrain to the SCN led 
to a number of experiments exploring the role of these.projections on circadian 
rhythmicity and sleep (Bina et al., 1993,1997). Most of these experiments have used 
cholinergic agonists and antagonists to suggest a role for ACh in mediating the phase 
shifting response to light (Zatz and Herkenham, 1981; Murakami et al., 1984; Zhang et 
al., 1993; Ferguson et al., 1999). To the best of my knowledge there have been few
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studies exploring the effects of cholinergic depletion of the basal forebrain on these 
functions. Bassant et al. (1995) and Kapas et al. (1996) both reported transient sleep 
disturbances following an intraventricular infusion of IgG SAP that destroyed the 
majority of cholinergic neurons in the basal forebrain. Erhardt et al. (2004) looked at 
circadian rhythms following interventricular infusion of IgG SAP and found no effect on 
the ability of the rat to entrain to a 12 hour LD schedule, but depleted rats demonstrated 
abnormal responses to light pulses. This is in agreement with the findings of Beule and 
Amir (2002) who found no change in photic entrainment after intra-ventricular or intra- 
SCN infusions of IgG SAP. To further examine the contribution of specific basal 
forebrain nuclei, Madeira et al. (2004) used quinolinic acid to lesion the nucleus basalis 
in rats and found decreased synthesis and expression of neuropeptides [vasopressin (VP) 
and vasoactive intestinal peptide (VIP)] in the SCN. However, other groups have reported 
no change in VIP expression following intraventricular infusion of IgG SAP (Moga,
1998; Erhardt et al., 2004).
This is the first study designed to examine the effects of a specific MS/VDB 
cholinergic lesion on measure of circadian rhythmicity. There are fewer projections from 
the MS/VDB to the SCN than observed in the NB, and my results clearly show these few 
projections are not essential to the rats’ ability to entrain to light, or to adapt to a 
strenuous phase shifting schedule. One shortcoming of the current study is the lack of 
data recorded during constant darkness which would reveal changes in the free running 
period that can be “masked” in the presence of a strong zeitgeber such as light. Despite 
this limitation, changes in the free running period are rarely observed following 
cholinergic depletion (Endo et al., 2001; Beaule and Amir, 2002) and I would not expect
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to see changes in period length here. Taken together these experiments suggest a role for 
cholinergic projections in modulating circadian rhythms, but more studies are required to 
describe the exact nature of this relationship.
Circadian disruption and cognition
This is the first study to look at the behavioural effects of phase shifting in rats 
following cholinergic depletion. The phase shifting schedule used here does not affect 
learning and memory when rats are trained and tested ten days post phase shift; however, 
if rats are trained on the water maze during the six days of phase shifting and tested on a 
probe trial, without the platform, 17 days later, they exhibit impaired memory for the 
platform location, suggesting a consolidation deficit (Deven et al., 2001). Furthermore, 
repeated phase shift and re-entrainment sessions have been found to impair water maze 
performance, but not fear conditioning (Craig and McDonald, 2008). Fekete et al. (1985) 
found that there was a discrepancy between time taken to re-entrain following a phase 
shift, and the length of time required for learning and memory processes to recover.
Three days were required for the acquisition of new information following a single phase, 
while re-entrainment did not occur till later. Tapp and Holloway (1981) reported 
retrograde amnesia for a task leamt prior to a single phase shift. Retention of this memory 
was impaired both 24 hours and seven days after the phase shift. Taken together these 
studies suggest that a threshold exists for the type, timing and duration of circadian 
disruption in relation to learning.
Similar findings have been reported in humans following circadian disruption due 
to shift work or jet lag. Rouch et al. (2005) have examined the effects of circadian 
disruption due to shift work in humans and reported that short term shift work has few
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effects on cognition; however, long term shift work is correlated with impaired cognition. 
Cho and colleagues (Cho, 2000; Cho et ah, 2001) found similar cognitive impairments in 
flight attendants suffering from chronic jet lag. These individuals also had increased 
levels of cortisol and atrophy of the right temporal area suggesting possible mechanisms 
for the observed impairment following chronic circadian disruption.
Circadian rhythms and cholinergic depletion in Alzheimer’s disease
Cholinergic depletion has been found early on in the development of AD (Bowen 
et al., 1992; Perry et ah, 1992; Schliebs and Arendt, 2006) and reduced melatonin levels 
have been proposed as an early marker of AD (Liu et ah, 1999; Wu et ah, 2003). These 
studies suggest that an early interaction between these two factors may play a role in the 
development of the disorder. The circadian disruption observed in AD patients has been 
linked with the severity of their dementia and with the integrity of the SCN (van Someran 
et ah, 1996). Loss of cholinergic projections to the SCN could accelerate the appearance 
of circadian disruption in these patients leading to increases in the severity of dementia. 
Apart from affecting circadian rhythmicity, cholinergic projections to the SCN could 
have an indirect effect on learning and memory through alterations in VP expression. 
Madeira et ah (2004) has reported a significant decline in VP synthesis and expression 
following a lesion of the cholinergic neurons of the NB. Interestingly, VP has been 
implicated in learning and memory, specifically in social interactions, but also in a 
number of behavioural task such as radial maze, passive avoidance and water maze (for a 
review see Caldwell et ah, 2008). It would be interesting to explore whether there are 
decreases in VP expression following specific cholinergic depletion of the MS/VDB. I 
did observe any change in circadian rhythmicity or learning and memory following this
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lesion, suggesting MS/VDB projections are not essential for the modulating effects of 
ACh in the SCN.
Multiple combinations of co-factors theory of aging
I have conducted a number of studies that provide support for the multiple 
combinations of co-factors theory of aging proposed by McDonald (2002). This theory 
describes passive and active risk factors that can have negative effects on the 
hippocampus. Passive factors (such as cholinergic depletion, stress, phase shifting) act to 
increase the vulnerability of hippocampal neurons, while active factors (stroke, seizures, 
head trauma) can directly damage or kill hippocampal neurons. I have explored the 
histological and cognitive effects of both passive-active combinations of risk factors and 
passive-passive combinations of risk factors. I found consistent impairment in spatial 
learning and memory as tested in the water maze task, but no impairment on tests of non- 
spatial learning such as cued water maze training, or fear conditioning (Craig et al., 2008; 
McDonald et al., 2008; Driscoll et al., 2007; Craig et al., submitted). One concern with 
the above mentioned studies is the suggestion that the observed impairment is simply the 
result of an additive effect of two insults on the brain, irrespective of what those insults 
may be. The current study argues against that explanation as the passive-passive 
combination used here has no effect on measures of learning and memory, or on 
circadian rhythmicity and hippocampal integrity that could develop into cognitive deficits 
over time. If a simple “two-hit” model could explain the mnemonic deficits previously 
observed, I would expect to see impairment in the current study.
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Conclusion
In conclusion, I have shown that specific cholinergic depletion of the medial 
septum does not effect entrainment to a 12 hour LD cycle, or the ability of the rat to re­
entrain following phase shifting. In addition, the combination of these two factors 
(cholinergic depletion and phase shifting) does not impair learning and memory on the 
tasks used here. This was in contrast to previous studies examining the effects of various 
risk factors for AD following cholinergic depletion and finding deficits in hippocampal 
based learning and memory in rats subjected to two factors. Future studies will look at the 
effects of repeated phase shifting sessions to determine whether the previously reported 
chronic phase shifting deficit occurs earlier in cholinergic depleted rats due to increased 
hippocampal vulnerability.
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Chapter 8
General Discussion
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Two basic questions that drive Alzheimer’s disease research are: What causes 
Alzheimer’s disease? And what can be done to prevent or cure it? Without an 
understanding of the accurate etiology of this disorder, we will be no closer to developing 
an effective cure than we are today. The multiple combinations of co-factors theory of 
Alzheimer’s disease appears to be a plausible model that could open the door to novel 
treatment strategies. I have used this model, in combination with the original cholinergic 
hypothesis of AD to propose a “new” cholinergic hypothesis that is presented in this 
thesis. This new version takes into account recent findings from the literature and my 
reports of increased hippocampal vulnerability to secondary insults following cholinergic 
depletion of the medial septum. I will first summarize the experimental results from this 
thesis (Table 8.1) and discuss some potential mechanisms that could explain my results. I 
will then present my ‘new’ version of the cholinergic hypothesis and how it relates to the 
field of AD research today. Finally I will discuss some of the implications for treatment 
that arise from this model and present some directions for future study.
Sub-threshold models of risk factors for Alzheimer’s disease
There are many animal models of brain injury in use today, but most of these 
model acute injuries that result in both functional and pathological impairment. I was 
interested in the cumulative effects of subtle damage that could better model the 
‘damage’ that the brain is habitually subjected to and compensates for on a regular basis 
in the absence of noticeable impairment. In order to do this, I developed four novel 
models of sub-threshold risk factors for future use in studying the contribution of 
different risk factors to AD (e.g., stress, seizures, stroke and circadian disruption).
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The first three risk factors (stress, seizures and stroke) have been previously 
shown to damage hippocampal neurons and produce behavioural impairment on learning 
and memory tasks. For my purposes, it was important to develop procedures that could 
act via the same mechanism (elevated corticosterone (CORT), epileptiform activity, 
ischemic damage), but not affect behaviour as tested on a hippocampal dependent version 
of the water maze. Chronic stress was modeled using a restraint stress procedure that 
varied the duration of the stress each day for two weeks. This procedure reliably elevated 
CORT levels, but did not impair learning and memory. Non-convulsive seizure activity 
was induced by systemic injection of a low dose of kainic acid that was able to cause 
local epileptiform activity in the brain without progressing to convulsive seizures. This 
procedure did not lead to cognitive deficits or hippocampal damage. Finally I found that a 
low dose of the vasoconstrictor Endothelin-1 infused directly into the hippocampus was 
able to mimic the minor subcortical damage resulting from a ‘silent’ stroke, in the 
absence of behavioural impairment.
My fourth risk factor, circadian disruption, had not been previously shown to 
disrupt learning and memory when presented well before initial training, but reports from 
the human literature suggests that prolonged circadian disruption may be associated with 
memory impairment and hippocampal atrophy. Here I presented an acute and a chronic 
version of a circadian ‘challenge’ that in its acute version'does not affect learning and 
memory. However, when rats were subjected to the chronic phase shifting procedure, 
they demonstrated impaired spatial learning and memory in the water maze, but had no 
difficulty learning a fear conditioning task. From these results I chose to use the acute 
phase shifting procedure as a sub-threshold model of circadian disruption.
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Cholinergic depletion combined with an active risk factor
According to McDonald’s (2002) multiple combination of co-factors theory of 
AD, the presentation of a passive risk factor prior to the occurrence of an active risk 
factor, both targeted at the hippocampus, should result in impaired hippocampal learning 
and memory, most likely due to increases in the severity of neuronal damage. I did 
observe learning and memory impairment in rats subjected to both a passive and an active 
factor; however, I did not observe increased hippocampal damage. My third experiment 
combined cholinergic depletion of the medial septum (a passive factor) with seizures (an 
active factor). I observed a trend towards increased seizure severity in the combined 
group and reported impairment on the spatial version of the water maze. However, there 
were no differences in hippocampal pathology in the seizure-only or combined groups.
My fourth experiment also supported this prediction. I combined cholinergic 
depletion (a passive factor) with stroke (an active factor) and reported impaired spatial 
learning and memory in the combined group. Volumetric analysis of the hippocampus 
revealed a moderate amount of damage due to stroke, but this amount was comparable 
between the stroke-only and combined group. Taken together these two experiments 
confirm that a passive factor combined with an active factor can impair hippocampal 
learning and memory. Surprisingly this impairment was not accompanied by an increase 
in pathology suggesting that more subtle interference in hippocampal processing is likely 
responsible for the cognitive deficit.
Cholinergic depletion combined with a passive risk factor
The combination of two passive factors was not expected to impair learning and 
memory on either task. This combination should have increased vulnerability of the
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hippocampus, but not to the extent where cognition would be affected. My fifth 
experiment looked at cholinergic depletion of the medial septum (a passive factor) 
combined with chronic stress (a 2nd passive factor). Surprisingly, this combination 
impaired performance on the spatial version of the water maze, but did not affect fear 
conditioning to tone, or to context. Moreover, there were no differences in overall levels 
of CORT in the stress-only or combined group, and once again, there was no obvious 
damage to hippocampal neurons suggesting an alternate mechanism was responsible for 
the impairment.
My sixth experiment combined cholinergic depletion (a passive factor) with 
circadian disruption (a 2nd passive factor) and found no effect of this combination on 
measures of circadian rhythmicity, or on learning and memory as tested on the spatial 
water maze, and fear conditioning. This was a surprising finding as I had previously 
attributed the impairment following chronic phase shifting to the stressfulness of the 
procedure. It follows that if cholinergic depletion and stress impair memory, then 
cholinergic depletion followed by phase shifting (a presumably stressful event) should 
have a similar effect. The absence of such an effect points to several alternative 
explanations for my chronic phase shifting data, and more importantly demonstrates that 
this the co-factor model is not simply a “two-hit” hypothesis, but that the nature of the 
‘hits’ is important. It is possible that the single session of phase shifting used here was 
not close enough to threshold (four sessions) to produce impairment, but two or three 
sessions may impair hippocampal memory in the depleted rat, similar to the impairment 
observed following four sessions of phase shifting (Craig and McDonald, 2008). 
Alternatively the presence of a running wheel (an intervention shown to enhance spatial
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memory and increase the expression of neurotrophic factors; Adlard et ah, 2004; 
Vaynmann et al., 2004; Alaei et al., 2007) was able to compensate for the combination of 
the two risk factors resulting in the lack of impairment in this group.
Table 8.1: Summary of behavioural testing and gross hippocampal pathology
Effect of 
secondary 
risk factor 
in depleted 
rats
Hippocampal
Damage
Spatial
water
maze
Fear
conditioning
Visible 
water maze
Cholinergic Trend No gross Combined N/A No
depletion towards hippocampal group was difference
and
seizures
increased
seizure
severity
damage impaired on 
all stages
between
kainic-only
and
combined
rats
Cholinergic No Moderate Combined N/A No
depletion difference in hippocampal group was difference
and stroke extent of 
hippocampal 
damage
damage in both 
groups
impaired on 
all stages
between 
combined 
rats and 
controls
Cholinergic Similar No gross Combined No N/A
depletion 
and stress
elevation of 
CORT
hippocampal
damage
group was 
impaired on 
all stages
impairment
Cholinergic Similar No gross No No N/A
depletion
and
circadian
disruption
responses to 
phase 
shifting
hippocampal
damage
impairment impairment
The cholinergic hypothesis of Alzheimer’s disease
It is now 26 years after the cholinergic hypothesis of geriatric memory 
dysfunction was first proposed by Bartus et al. (1982). After an initially promising start, 
recent studies have called many of the previous findings supporting this theory into 
question and it is no longer widely believed that the cholinergic depletion alone is
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responsible for causing AD. This has been clearly demonstrated by the lack of efficacy of 
acetylcholinesterase inhibitors (AChEIs) in clinical trials (Mohs et al., 2001; Winblad et 
al., 2001) and the finding that cholinergic depletion does not result in severe memory 
deficits in rats (Mesulam, 2004; Parent and Baxter, 2004). However, I am now beginning 
to revisit the role of the cholinergic depletion from a different angle. Using the co-factors 
model as a theoretical framework, and based on the findings that a loss of cholinergic 
neurons and/or activity is an early event in the development of AD (Perry et al., 1992; 
Geula et al., 2008), I propose that this depletion leads to a reduction in the ability of the 
brain to compensate for secondary insults. This view of the cholinergic depletion differs 
from that proposed originally by Bartus et al. (1982) who saw the depletion as being 
causative on its own. My proposed model is also distinct when compared to more recent 
theories suggesting that the reduction in cholinergic activity results from the 
accumulation of A(3 and initiates an unfavorable feedback loop leading to the cognitive 
impairment seen in AD (Auld et al., 1998; Auld et al., 2002). In my model, this depletion 
would not be causative, or affect learning and memory on its own, as supported by 
literature in rodents, non-human and human primates, but would reduce the ability of the 
brain to compensate for the accumulation of risk factors that occur with increasing 
frequency during the aging process.
A neuroprotective or compensatory role for acetylcholine in response to injury
The cholinergic system has been implicated in mediating plasticity in the brain in 
response to experience or injury. There are three lines of evidence that support this 
hypothesis. First, there are numerous reports of the beneficial effects of cholinergic 
agonists on enhancing recovery and minimizing neuronal damage in various injury
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models. Secondly, cholinergic depletion has been found to impair experience-dependent 
plasticity in the cortex and hippocampus and similar mechanisms are involved in 
mediating recovery from injury. Thirdly, acetylcholine modulates the expression of 
neurotrophic factors such as BDNF that play a major role in neuronal survival in 
adulthood.
Beneficial effects o f nicotine and cholinergic agonists on recovery from injury and 
neurodegenerative disorders
A neuroprotective role for the cholinergic agonist nicotine has been proposed and 
this role of the cholinergic system could begin to explain my findings (Borlongan et al., 
1995; Takada et al., 2003; Gonzalez et al., 2006; Mudo et al., 2007). The neuroprotective 
effects of the cholinergic system are largely mediated through stimulation of nicotinic 
AChRs, either directly through nAChR agonists (e.g., nicotine) or indirectly via AChEIs 
(e.g., donepezil) that increase the availability of ACh that can then bind to nAChRs. 
Muscarinic agonists may also be a promising approach for treating the neuropathology 
and cognitive decline observed in AD and aging (Wanibuchi et al., 1994; Suzuki et al., 
1995; Suzuki et al., 1995b; Fisher, 2000) as well as stroke (Yamaguchi et al., 1995); 
however, their ability to successfully treat a wide variety of neurodegenerative disorders 
has not been demonstrated. In contrast to the scarcity of reports on muscarinic agonists, 
the ability of nicotine to produce neuroprotective effects in a wide variety of 
neurodegenerative models has been well documented. In vitro studies show nicotine can 
protect cortical and hippocampal neurons from NMDA-mediated excitotoxicity (Akaike 
et al., 1994; Dajas-Bailador et al., 2000) and cultured hippocampal neurons from PA 
induced neurotoxicity (Zamani et al., 2001). Moreover, nicotine has been shown to
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reduce neuronal damage and ameliorate behavioural deficits in animal models of stroke 
(Nanri et al., 1998; Fujiki et al., 2005; Gonzalez et al., 2006), Parkinson’s disease 
(Maggio et al., 1998; Costa et al., 2001), Huntington’s disease (Tariq et al., 2005), 
traumatic brain injury (Verbois et al., 2003) as well as kainic acid induced seizures 
(Borlongan et al., 1995; Shin et al., 2007). Taken together, these studies suggest an 
important role for nicotine acting via the nAChR in compensating for damage. There is a 
reduction in the number of nAChRs in the hippocampus and cortex of patients diagnosed 
with AD which may explain their difficulty recovering from secondary risk factors 
(Nordberg, 2001).
Impaired experience-dependent plasticity in cholinergic depleted animals
Experience-dependent plasticity refers to changes in the brain in response to a 
specific event or experience. For example, acquisition of a skilled reaching task in 
rodents, humans and non-human primates has been associated with an expansion of the 
motor map, specifically in the forelimb area. Specific lesions of the basal forebrain 
cholinergic neurons in adult rats have been shown to decrease this normal expansion of 
the motor map during skilled reaching training (Conner et al., 2003). A similar role for 
ACh is apparent in the somatosensory barrel cortex of rodents, where cholinergic 
depletion reduces experience-dependent plasticity in this area (Baskerville et al., 1997; 
Zhu et al., 1998). The reverse can also be shown as stimulating cholinergic neurons of the 
nucleus basalis enhances experience-dependent plasticity in the auditory cortex (Kilgard 
and Merzenich, 1998). Experience-dependent plasticity can also be associated with 
changes in dendritic branching and spine density, with greater branching often 
associating with greater capacity for change. Damaging the nucleus basalis has been
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found to reduce branching of pyramidal neurons in the frontal cortex a finding that could 
explain the reduced plasticity in cortical neurons (Harmon and Wellman, 2003; Works et 
al., 2004). Moreover, neonatal depletions have been shown to decrease dendritic 
branching in cortical neurons examined in adulthood (Robertson et al., 1998; Sherren and 
Pappas, 2005).
There have been fewer studies looking at ACh and hippocampal plasticity, but 
those that do appear to follow a similar pattern of results. Long-term potentiation (LTP) 
is a model of neural plasticity and natural mechanisms similar to LTP are thought to be 
the basis for learning and memory in the brain. Indeed, by blocking or enhancing LTP 
expression, animals tend to show memory deficits or improvements respectively 
(Stevens, 1998; Martin et al., 2000). Some studies have suggested that the ability to 
induce hippocampal LTP in rats following cholinergic depletion is reduced (Motooka et 
al., 2001; but see Jouvenceau et al., 1996). In addition, nicotine has been shown to 
enhance the ability to induce LTP, likely through stimulation of nAChRs (Matsuyama et 
al. 2000; Fujii et al., 2001; Ji et al., 2001; McGehee, 2002). These studies suggest that 
both cortical and hippocampal ACh projections are important for experience-dependent 
plasticity and learning.
Effects o f ACh on neurotrophin expression and neurogenesis
One of the proposed mechanisms for the effects of ACh on plasticity and response 
to injury is its ability to modulate the expression of neurotrophin factors and 
neurogenesis. Neurotrophins such as brain derived neurotrophic factor (BDNF), nerve 
growth factor (NGF) and fibroblast growth factor (FGF-2) play an important role in 
neuronal growth and survival in adulthood. Interestingly, all of these neurotrophins are
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increased following treatment with nicotine (Belluardo et al., 1998; Maggio et al., 1998; 
Kenny et al., 2000; Martinez-Rodriguez et ah, 2003) and Maggio et al. (1998) found that 
the beneficial effects of nicotine in the Parkinson’s disease mouse model were correlated 
with increases in FGF-2 and BDNF. There are no changes in basal levels of hippocampal 
BDNF or NGF mRNA one to four weeks after cholinergic depletion in rats (Yu et al., 
1995; Gu et al., 1998), but at later time points significant decreases were reported in the 
hippocampus and cortical areas (Kokaia et al., 1996; Ferencz et al., 1997). Interestingly, 
this depletion also eliminated the seizure mediated increase in BDNF and NGF 
suggesting a role for acetylcholine in mediating the endogenous response of 
neurotrophins to injury (Kokaia et al., 1996; Ferencz et al., 1997).
Hippocampal neurogenesis has also been suggested to play a role in learning and 
memory and decreased neurogenesis has been correlated with poor aging in rats (Driscoll 
et al. 2006). Enhancing neurogenesis through enriched environment, exercise or specific 
drugs (anti-depressants) has been shown to improve memory and performance on 
hippocampal dependent tasks (Nilsson et al., 1999; van Praag et al., 1999; Malberg et al., 
2000). Conversely, blocking neurogenesis through radiation, adrenalectomy, or drugs 
targeting new neurons, has been shown to impair performance in a number of tasks 
dependent on the hippocampus (Shors et al., 2001; Snyder et al., 2005; Spanswick et al., 
2007). Following cholinergic depletion rates of neufogenesis are significantly decreased 
(Cooper-Kuhn et al., 2004; Mohapel et al., 2005).
Taken together these studies have demonstrated the importance of ACh in 
experience-dependent plasticity and response to injury, most likely through its effects on 
neurotrophins, (especially BDNF), neurogenesis, and dendritic branching.
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A look at my results using the ‘new’ cholinergic hypothesis
Using the hippocampus as the initial site of AD memory loss and pathology, I 
proposed that the normal role of ACh is to mediate a number of compensatory 
mechanism (neurogenesis, neurotrophin factors, changes in dendritic branching) that 
participate in learning and memory and functional recovery from injury. An explanation 
of my results using the ‘new’ cholinergic hypothesis is depicted in Figure 8.1. In a 
normal, healthy individual a sub-threshold injury often goes unnoticed as ACh-mediated 
compensatory mechanisms are sufficient to compensate for the damage (8.1 A). 
Unfortunately, following a major insult such as stroke these compensatory mechanisms 
are not sufficient to fully overcome the damage from stroke leading to memory 
impairment (8. IB). However, in the absence of cholinergic projections to the 
hippocampus, a minor sub-threshold insult (mild ischemia, elevated glucocorticoids, 
epileptiform activity) can lead to memory impairment due to the loss of these ACh- 
mediated compensatory mechanisms as was shown in the current series of studies (8.1C). 
This model also provides a possible explanation for the lack of impairment observed 
following circadian disruption and cholinergic depletion. In this situation, animals had 
access to running wheels, an intervention that has been shown to enhance neurogenesis, 
increase the secretion of neurotrophic factors (e.g., BDNF, FGF, NGF), enhance dendritic 
branching, and has been correlated with improved functional recovery on behavioural 
tasks. At least one of these compensatory mechanisms (increased BDNF) has been shown 
to be increased by wheel running independent of the septo-hippocampal cholinergic 
system (Berchtold et al., 2002). Increased BDNF has been shown to enhance learning and 
memory and promote recovery from stroke (Ferrer et al., 2001; Schabitz et al., 2004;
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Vaynmann et ah, 2004). This suggests that in the absence of ACh-mediated 
compensation, wheel running activity may have provided similar support to the 
hippocampus through increases in BDNF and no impairment was observed (8.ID).
Figure 8.1: Explanation of presented results using the ‘new’ cholinergic hypothesis
This model suggests a potential role for ACh in mediating functional recovery 
from sub-threshold insults targeting the hippocampus through its effects on BDNF. Using 
this theoretical framework the development and progression of AD can be explained. The 
earliest forms of memory to be lost in AD (e.g., episodic, spatial, declarative) are
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hippocampal dependent. This loss is most likely because of the exceptional sensitivity of 
the hippocampus to exogenous damage (e.g., ischemia, excitotoxicity, glucocorticoids). 
However, the cholinergic depletion reported in aged humans and in those with AD is 
global in nature, affecting both hippocampal and cortical areas. As aging progresses, 
individuals are subjected to potentially damaging risk factors that initially affect the 
hippocampus, and over time effect depleted cortical regions as well, resulting in the more 
global memory loss observed in the late stages of AD. Interestingly, cholinergic neurons 
in the striatum remain relatively intact in AD, memory tasks dependent on the striatum 
are not nearly as severely affected in AD patients (Carlesimo and Oscar-Berman, 1992). 
Multiple combinations of co-factors model of Alzheimer’s disease
The present data, combined with previous work (Driscoll et al., 2007; McDonald 
et al., 2008) has provided support for the co-factor theory of AD. Five out of the six 
combinations of co-factors examined on measures of learning and memory and 
hippocampal damage, resulted in hippocampal dependent memory impairment. 
Interestingly only two combinations [aging and stroke (Driscoll et al., 2007) and stress 
and stroke (McDonald et al., 2008)] reported an increase in hippocampal damage 
following the second factor that was likely responsible for the cognitive deficit. The 
remainder of the studies found no sign of gross hippocampal damage that could explain 
the impairment. Taken together, these studies stress the importance of using behavioural 
assessment in conjuncture with histological measures when assessing with animal models 
of disease, and tracking recovery from injury, or response to treatment.
Many reports in the literature focus solely on decreased lesion size as an end point 
measure of a successful treatment without conducting careful behavioural analysis.
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Histological measures are essential for basic research and for understanding mechanisms; 
however, from a clinical perspective, functional recovery is the desired outcome, 
regardless of what effect a treatment has on overall lesion size. This is illustrated here as I 
clearly show that a cognitive deficit due to AD risk factors can be apparent in the absence 
of gross hippocampal damage. These findings are particularly relevant to AD as the 
amount of variability between aged individuals is extreme and there is no clear-cut 
correlation between neuropathology and the severity of cognitive decline or dementia. 
Many non-demented aged individuals have numerous plaques and tangles and there are 
just as many demented individuals that show little pathology. The co-factor model 
proposes a way to encompass all varieties of cognitive decline by looking carefully at the 
risk factors involved and forming specific subgroups, for which customized treatments 
can be designed.
Treatment implications
The subgroup described in this thesis can be defined by its early cholinergic 
depletion and associated decrease in compensatory mechanisms as the driving force 
behind the progression of this disorder. I do not see this decline in ACh levels as a causal 
factor, but instead, as an important risk factor that leads to the increased susceptibility of 
an individual to develop AD. This subgroup would have several proposed treatment 
options focused on prevention, or early intervention that would enhance available ACh, 
and/or increase the activity of alternative compensatory pathways. Current treatments for 
AD using AChEIs are not initiated until clinical signs of memory loss are present (when 
neuropathological damage is likely present) and reports have shown this is too late. When 
AChEIs are prescribed early on in AD, there is more success in slowing the progression
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of this disorder, but an overall decline in cognitive function still occurs in all patients 
(Doody et al., 2001).
Early treatment of dementia with cholinomimetics was first proposed by Bartus et 
al (1980, 1982), but few studies have explored the preventative effects of these drugs. 
Current AChEIs have too many side effects to make them desirable or feasible as 
preventative medicine, but choline and lecithin (precursors to ACh) are well tolerated and 
can be readily obtained through specific foods (e.g., eggs, beef, liver, nuts, broccoli, 
potatoes). Studies examining the effects of these ACh precursors have found no 
improvements in AD patients on the whole, but dietary choline was found to prevent the 
age related impairments in passive avoidance learning in mice (Bartus et al., 1980). The 
role for ACh presented here would predict that the choline supplement occurred too late 
in the human subjects (i.e. once AD symptoms were already present) and that early 
treatment with ACh precursors could stave off this disorder. A choline rich diet could 
protect against subsequent risk factors and prevent the changes in hippocampal 
processing that could eventually lead to mnemonic impairment and the development of 
AD neuropathology. Alternatively, regular testing of ACh levels in the 40-60 year old 
population could be helpful to initiate preventative cholinergic therapy as soon as a 
decline is detected. This is the age when the difference between the dramatic cholinergic 
depletion observed in AD patients and the normal arge-related decline in ACh levels 
becomes most evident (Perry et al., 1992). A treatment designed to counteract the 
cholinergic decline as soon as it occurs may be able to prevent or reduce the onset and 
severity of AD by prolonging the ability of ACh to provide neuroprotection in the aging 
brain.
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The second area for treatment focuses on enhancing alternative compensatory 
mechanisms in the brain that could replace the deficient ACh-mediated compensation. 
Environmental enrichment, exercise, and training have all been shown to have positive 
effects on measures of plasticity (e.g., neurogenesis, neurotrophin expression, dendritic 
morphology) and enhance recovery in animal models (Kolb and Gibb, 1991; Kolb et al., 
1998; Nilsson et al., 1999; Ickes et al., 2000; van Praag et al., 2000; Faherty et al., 2003; 
Mora et al., 2007). In humans, high levels of education, participation in leisure activities 
and exercise have all been found to decrease one’s chances on developing AD (Larson et 
al., 2006; Stem, 2006; Roe et al., 2007) providing further support for a preventative view 
of treating AD. The benefit of these interventions is that they would still be effective in 
the absence of a functional cholinergic system or one that does not respond to cholinergic 
drugs. Moreover the benefit of exercise has also been demonstrated for reducing stress 
and cardiovascular disease; both risk factors linked to AD. This model describes how 
these interventions could be beneficial and attempts to explain the discrepancy between 
healthy aged individuals with decreased ACh, and aged individuals that develop AD. 
Future studies
I have proposed the co-factor theory of AD and described an important role for 
cholinergic depletion in the development of hippocampal dependent memory 
impairments that are reminiscent of those seen in early AD. Though I was able to 
replicate the hippocampal specific cognitive impairment, as well as the cholinergic 
depletion, I did not look for other two classic hall marks of AD: plaques and tangles. 
Nonetheless, I have set the stage for future research into this area, and I predict I will 
detect AD pathology in the brains of my animals subjected to multiple risk factors. For
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the sake of simplicity, and with the awareness that no single model can adequately mimic 
all signs of AD, I chose to focus on the hippocampus alone and the early stages of 
memory loss in AD to gain a better understanding of the etiology of AD. Future studies 
will begin to explore some of the ACh-mediated compensatory mechanisms that are 
reduced in AD. For example these compensatory mechanisms can be explored directly by 
measuring rates of neurogenesis, levels of neurotrophic factors and changes in dendritic 
morphology or indirectly by examining the effects of therapies designed to enhance 
cholinergic activity or increase the levels of beneficial neurotrophins such as BDNF. 
There are a few specific experiments that would further clarify this model. First, would 
be to replicate the cholinergic depletion and phase shifting experiment using telemetry to 
monitor circadian rhythms which would eliminate the confound of wheel running, and 
secondly, to repeat the combinations that did produce an impairment in rats housed in 
running wheels to see whether this treatment was effective. Finally, measurement of 
BDNF levels before and after the secondary risk factor would be essential for describing 
the role of this neurotrophin with or without ACh. The results of these studies would 
provide support and additional clarification of the role of ACh in the development of AD. 
Conclusions
My primary conclusion is that the cholinergic depletion impairs the rats’ ability to 
compensate for secondary insults that target the hippocampus. I present a ‘new’ version 
of the cholinergic hypothesis to explain my results and have discussed the importance of 
prevention and early intervention when treating AD. I remain unaware of the specific 
underlying mechanism of this effect, but I suggest decreases in BDNF may be important. 
It is clear from a behavioural perspective that the removal of cholinergic projections to
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the hippocampus severely compromises the ability of the rat to compensate for 
subsequent injury. Moreover, the lack of impairment in cholinergic depleted rats 
following phase shifting suggests that the nature of the secondary insult is important for 
the appearance of the memory deficit. My findings suggest a role for the cholinergic 
system in providing protection for hippocampal neurons, and/or mediating compensatory 
mechanisms following injury.
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